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Abstract 
 
In eukaryotes the assembly of complex glycoconjugate structures takes place in the 
endoplasmic reticulum (ER) and Golgi apparatus, where a number of specific membrane-
bound glycosyltransferases transfer sugar moiety from soluble or lipid linked activated sugar 
nucleotides to variety of acceptors with correct stereo and regioselectivity.  Many 
glycoconjugates structures have been elucidated; however, most glycosyltransferases 
involved in their biosynthesis have not been identified and characterised.  Currently, cell-free 
radiolabelled assays are widely used to detect their activities.  These types of assays are 
sensitive and broadly applicable, but can be complicated by well-known factors related to the 
application of radioactive substances.   
The purpose of this study was the development of simple and sensitive fluorescence-based 
methodology to detect membrane-bound glycosyltransferases activities, which could replace 
traditional radiolabelled methods used in the field.  Fluorescent acceptors, such as 4-(1-(7-
hydroxy-coumarin-3-yl)-1H-1,2,3-triazol-4-yl)-)propyl α-D-mannopyranoside (α-Man-HTC) 
(2.12) and 4-(1-(7-hydroxy-coumarin-3-yl)-1H-1,2,3-triazol-4-yl)-)propyl α-D-
mannopyranosyl-(1→6)-α-D-mannopyranoside (α-Man-1,6-α-Man-HTC) (2.13) were 
designed to have linkages that mimic the authentic acceptors.  The fluorescence-based assays 
were benchmarked against established radiolabelled assays to detect mannosyltransferase 
activities involved in the biosynthesis of lipoarabinomannan in Mycobacterium smegmatis 
and galactosyltransferase activities involved in the decoration of GPI anchor in Trypanosoma 
brucei.  Further application of this methodology allowed detection and characterisation of 
mannosyltransferase activities responsible for biosynthesis of N-glycans in Euglena gracilis, 
along with detection of N-acetylglucosamine-1-phosphate transferase activity. 
In a separate study, a series of linear and cyclic 1,4/1,5-triazole-linked-pseudo-
galctooligomers were synthesised from 2-(2-(2-azidoethoxy)ethoxy)ethyl 6-O-(prop-2-ynyl)-
β-D-galactopyranoside (4.07) utilising Cu(I)-catalysed click reactions.  These compounds 
were used to mimic authentic substrates for Trypanosoma cruzi trans-sialidases in order to 
block Trypanosoma cruzi macrophage invasion.  
  
iv 
 
 
 
 
 
 
 
                      “Wherever you go, go with all your heart.” 
                                                                                                         Confucius 
 
  
v 
 
Acknowledgements 
 
To begin with, I would like to thank my supervisor Prof Rob Field for giving me this 
opportunity to be a part of your group and to work alongside with so many remarkable 
people.  Thank you for your patience and positive approach to life, for continuous support, 
constant encouragement and lots of helpful advices during the whole period of my PhD.  You 
allowed me to grow and developed from a hesitant undergraduate to a more confident 
scientist.  And who can forget, I will always be grateful to you for allowing me to experience 
Chinese science and culture, and making it a worry-free experience.  You are an amazing 
supervisor, Thank you. 
I also would like to thank my second supervisor Prof Sarah O’Connor for your inquisitive 
questions and helpful advices relating to my project during our progress meetings.  And a 
warm thank you to Prof Biao Yu for hosting me in your group at Shanghai Institute of 
Organic Chemistry and allowing me to learn new aspects of carbohydrate synthesis.  I would 
especially like to thank Dr. Sergey Nepogodiev and Dr. Martin Rejzek for your invaluable 
guidance related to the carbohydrate chemistry, for teaching me to be very thorough in my 
experimental approaches and for all those stimulating conversations we had over these years.  
I also thank Gerhard Saalbach and Lionel Hill for their help and advice with analytical aspect 
of this project. 
I would like to thank all the past and present members of Rob Field’s group Matt Donaldson, 
Ellis O’Neill, Stephan Goetz, Mike Rugen, Ben Wagstaff, Edward Hems, and Sue Sakonwan 
for making it an enjoyable place to work and helping me with any queries I had.  I would like 
to thank my newly made and old friends Matilde Aguilar-Moncayo, Giulia Pergolizzi, Ivone 
Carvalho, Ausra Jablonskyte and Amanda Hill for being there for me when I needed you the 
most.   
I would like to thank my father for setting up an example that it is never too late to study and 
my mother for your unconditional love and support.   
And finally, I would like to thank Douglas Powell for putting up with my late evenings and 
weekends, for letting me gallivanting to all places without ever complaining, for feeling so 
proud of my achievements, and therefore, I dedicate this thesis to you.  
vi 
 
Table of Contents 
1 INTRODUCTION .................................................................................... 1 
1.1 Essentials of glycoconjugates .............................................................................. 2 
1.2 The structures and biosynthesis of glycoconjugates of interest ....................... 2 
1.2.1 Glycosylphosphatidylinositol anchors ............................................................... 3 
1.2.2 Mycobacterial lipoarabinomannan ..................................................................... 6 
1.2.3 Eukaryotic N-linked glycoproteins..................................................................... 8 
1.2.4 Eukaryotic O-linked glycoproteins .................................................................. 15 
1.3 Glycosyltransferases involved in the biosynthesis of glycoconjugates .......... 17 
1.4 Methods to probe activities of glycosyltransferases ........................................ 19 
1.4.1 Radiolabelled methodologies to probe glycosyltransferase activities.............. 20 
1.4.2 Fluorescence-based methodologies to probe glycosyltransferase activities .... 21 
1.5 Requirement for the new fluorescence-based methodology........................... 26 
1.6 Project aims and objectives ............................................................................... 28 
2 DEVELOPMENT AND VALIDATION OF FLUORESCENCE-BASED 
METHODOLOGIES TO PROBE BIOSYNTHESIS OF GLYCOCONJUGATES ....... 29 
2.1 Underlying aspects of fluorescence-based methodologies .............................. 30 
2.2 Design of non-fluorescent and fluorescent mannoside substrates for 
fluorescence-based methodologies ............................................................................... 34 
2.3 Chemical synthesis of non-fluorescent and fluorescent α-D-
mannopyranoside derivatives for methodology I....................................................... 37 
2.3.1 Chemical synthesis of non-fluorescent azidocoumarinyl α-D-mannopyranoside 
derivatives ....................................................................................................................... 37 
vii 
 
2.3.2 Chemical synthesis of fluorescent coumarinyl α-D-mannopyranoside 
derivative under strain-promoted click conditions ......................................................... 38 
2.4 Chemical synthesis of non-fluorescent and fluorescent α-D-
mannopyranoside derivatives for methodology II ..................................................... 39 
2.4.1 Chemical synthesis of non-fluorescent 5-hexynyl α-D-mannopyranoside 
derivatives ....................................................................................................................... 39 
2.4.2 Chemical synthesis of fluorescent coumarinyl α-D-mannopyranoside 
derivatives under Cu(I)-catalysed click conditions......................................................... 40 
2.5 Spectroscopic studies of fluorescent coumarinyl α-D-mannopyranoside 
derivatives ...................................................................................................................... 42 
2.6 Examination of detection limits of fluorescently labelled coumarinyl α-D-
mannopyranoside derivatives ...................................................................................... 46 
2.6.1 TLC analyses .................................................................................................... 46 
2.6.2 Solution analyses .............................................................................................. 47 
2.7 Validation of fluorescence-based methodologies against established 
radiolabelled assay ........................................................................................................ 49 
2.7.1 Insight into studying biosynthesis of glycoconjugates in mycobacteria .......... 49 
2.7.2 Literature radiolabelled assay to probe α-1,6-mannosyltransferase activities 
responsible for the biosynthesis of LAM in mycobacterial species ............................... 50 
2.7.3 Fluorescence-based methodologies to probe α-1,6-mannosyltransferase 
activities in Mycobacterium smegmatis .......................................................................... 52 
2.7.4 TLC results from the fluorescence-based methodology I ................................ 53 
2.7.5 TLC results from the fluorescence-based methodology II ............................... 54 
2.7.6 Identification of fluorescent products by LC-MS ............................................ 56 
2.7.7 Linkage analysis through exo-mannosidase digestions .................................... 58 
2.7.8 Summary of fluorescence-based methodologies in Mycobacterium smegmatis59 
2.8 Validation of fluorescence-based methodology II against established 
radiolabelled assay ........................................................................................................ 60 
2.8.1 Insight into studying biosynthesis of glycoconjugates in Trypanosoma brucei60 
viii 
 
2.8.2 Literature radiolabelled assay to probe galactosyltransferase activities 
responsible for decoration of GPI anchors in Trypanosoma brucei ............................... 61 
2.8.3 Fluorescence-based methodology II to probe galactosyltransferase activities 
responsible for α-galactosylation of GPI anchors in Trypanosoma brucei .................... 64 
2.8.4 Identification of fluorescent product by LC-MS .............................................. 68 
2.8.5 Linkage analysis through exo-galactosidase digestions ................................... 68 
2.8.6 Investigation of number of isomeric structures by IM-MS .............................. 70 
2.8.7 Summary of fluorescence-based methodology II in Trypanosoma brucei ...... 71 
2.9 Conclusion and future work ............................................................................. 72 
3 THE QUEST FOR GLYCOSYLTRANSFERASE ACTIVITIES IN EUGLENA 
GRACILIS ...................................................................................................... 76 
3.1 Insight into Euglena ........................................................................................... 77 
3.2 Fluorescence-based methodology II to probe mannosyltransferase activities 
in Euglena gracilis ......................................................................................................... 79 
3.2.1 Microsomal membranes as a source of glycosyltransferases ........................... 80 
3.2.2 Fluorescence assays to probe mannosyltransferase activities .......................... 81 
3.2.3 Purification of fluorescent products by HPLC ................................................. 82 
3.2.4 Identification of fluorescent products by LC-MS ............................................ 84 
3.2.5 Linkage analysis through exo-mannosidase digestions .................................... 85 
3.2.6 Confirmation of newly formed linkages in fluorescent mannoside products by 
LC-MS 88 
3.2.7 Investigation of number and nature of isomeric structures in fluorescent 
products by IM-MS ......................................................................................................... 90 
3.2.8 Summary of fluorescence-based methodology II used to investigate 
mannosyltransferase activities in Euglena gracilis ......................................................... 91 
3.3 Exploration of other glycosyltransferases in Euglena gracilis ....................... 94 
3.3.1 Fluorescence assays to probe glycosyltransferase activities ............................ 95 
3.3.2 Purification of fluorescent products by HPLC ................................................. 99 
ix 
 
3.3.3 IM-MS analyses on number of isomeric structures present in trisaccharide 
fluorescent product obtained from UDP-Glc incubation .............................................. 100 
3.3.4 Identification of fluorescent products obtained from incubation of UDP-Glc by 
LC-MS 101 
3.3.5 Identification of fluorescent products obtained from incubation with UDP-
GlcNAc by LC-MS ....................................................................................................... 104 
3.3.6 Investigation of newly formed linkages in fluorescent products through 
enzymatic and chemical degradations .......................................................................... 106 
3.3.7 Characterisation and confirmation of fluorescent product by NMR 
spectroscopy .................................................................................................................. 108 
3.3.8 Summary of fluorescence-based methodology II used to investigate 
glycosyltransferase activities in Euglena gracilis......................................................... 111 
3.4 Conclusion and future work ........................................................................... 114 
4 SYNTHESIS OF TRIAZOLE-LINKED LINEAR AND CYCLIC OLIGOMERS 
TO OBSTRUCT TRYPANOSOMA CRUZI MACROPHAGE INFECTION .............. 120 
4.1 Introduction ...................................................................................................... 121 
4.2 Synthesis of azido-alkyne galactose-containing monomer ........................... 126 
4.3 Cyclisation and oligomerisation through CuAAC reactions based on azido-
alkyne-containing galactose monomer ...................................................................... 127 
4.4 Fluorescent labelling of 1,4-triazole linked linear oligomers ....................... 133 
4.5 Uncatalysed 1,3-dipolar cycloaddition of azido-alkyne-containing galactose 
monomer ...................................................................................................................... 135 
4.6 Cyclic triazole-linked oligomers as acceptor substrates for Trypanosoma 
cruzi trans-sialidase (TcTS) ........................................................................................ 137 
4.7 Preliminary biological evaluation of triazole-linked oligomers ................... 139 
4.8 Conclusion and future work ........................................................................... 141 
5 MATERIALS AND METHODS ............................................................. 143 
x 
 
5.1 Chemical methods ............................................................................................ 144 
5.1.1 General experimental section ......................................................................... 144 
5.2 Chemical synthesis of non-fluorescent and fluorescent α-D-
mannopyranoside derivatives to utilise in fluorescence-based methodology I...... 148 
5.2.1 Chemical synthesis of non-fluorescent azidocoumarinyl α-D-mannopyranoside 
derivatives ..................................................................................................................... 148 
5.2.2 Chemical synthesis of fluorescent coumarinyl α-D-mannopyranoside 
derivative under strain-promoted click condition ......................................................... 152 
5.3 Chemical synthesis of non-fluorescent and fluorescent α-D-
mannopyranoside derivatives to utilise in fluorescence-based methodology II .... 154 
5.3.1 Chemical synthesis of non-fluorescent 5-hexynyl α-D-mannopyranoside 
derivatives ..................................................................................................................... 154 
5.3.2 Chemical synthesis of fluorescent coumarinyl α-D-mannopyranoside 
derivatives under Cu(I)-catalysed click conditions....................................................... 158 
5.4 Chemical synthesis of azido-alkyne galactose-containing monomer........... 161 
5.5 Cu(I)-catalysed oligomerisation of azido-alkyne galactose-containing 
monomer ...................................................................................................................... 164 
5.5.1 General procedure for catalysed cyclisation and oligomerisation ................. 164 
5.6 Uncatalysed oligomerisation of azido-alkyne galactose-containing monomer167 
5.6.1 General procedure for uncatalysed cyclisation and oligomerisation ............. 167 
5.7 Biological methods ........................................................................................... 168 
5.7.1 General experimental section ......................................................................... 168 
5.8 Mycobacterium smegmatis ............................................................................... 172 
5.8.1 Fluorescence-based assays to probe mannosyltransferase activities in 
Mycobacterium smegmatis............................................................................................ 172 
5.9 Trypanosoma brucei ......................................................................................... 173 
xi 
 
5.9.1 Fluorescence-based assays to probe galactosyltransferase activities in 
Trypanosoma brucei ..................................................................................................... 173 
5.10 Euglena gracilis ................................................................................................ 174 
5.10.1 Preparation of Euglena gracilis cells ............................................................. 174 
5.10.2 Isolation of microsomal membranes from Euglena gracilis161 ...................... 175 
5.10.3 Fluorescence-based assays to probe glycosyltransferase activities in Euglena 
gracilis 175 
5.10.4 Generation of product carrying N-acetylglucosamine-6-Phosphate motif for 
structural characterisation ............................................................................................. 176 
5.11 Trypanosoma cruzi ............................................................................................ 177 
5.11.1 Trans-sialidase-mediated sialylation of triazole-linked pseudo-
galactooligomers ........................................................................................................... 177 
5.11.2 Macrophage invasion assays .......................................................................... 177 
6 APPENDICES..................................................................................... 179 
7 REFERENCES ................................................................................... 187 
 
  
xii 
 
List of Figures 
Figure 1.1 Structural variations of GPI anchors in protozoan, yeast and mammalian 
systems.   ........................................................................................................................... 3 
Figure 1.2 Diagrammatic schemes of GPI anchor biosynthesis in Trypanosoma brucei.  
........................................................................................................................................... 5 
Figure 1.3 Representative examples of the main components of the mycobacterial cell 
surface; structural similarities and differences between LAM in Mycobacterium 
tuberculosis and Mycobacterium smegmatis.   ................................................................. 6 
Figure 1.4 Diagrammatic scheme of LAM biosynthesis in non-pathogenic 
Mycobacterium smegmatis.  ............................................................................................. 7 
Figure 1.5 Representative biosynthetic pathway of N-linked glycosylation at the ER 
membrane in eukaryotic cells.   ........................................................................................ 9 
Figure 1.6 Structural variations of lipid-linked N-glycan precursors in eukaryotic 
system.   .......................................................................................................................... 10 
Figure 1.7 Processing and maturation of oligosaccharide moiety of the N-linked 
glycoprotein at the ER and Golgi apparatus membranes.   ............................................. 11 
Figure 1.8 Structural variants of N-linked glycoproteins.   ............................................ 12 
Figure 1.9 Diagrammatic representation of N-linked glycoprotein phosphorylation. ... 13 
Figure 1.10 Diagrammatic representation of phosphorylation of a newly synthesised N-
linked lysosomal glycoprotein and it subsequent transfer to the lysosome.   ................. 14 
Figure 1.11 Structural variation of the mucin type O-glycans.   .................................... 16 
Figure 1.12 Diagrammatic representation of scintillation proximity assay utilising 
radiolabelled donor and impregnated bead to detect α-1,3-fucosyltransferase activity.  21 
Figure 1.13 Chemical structures of widely used fluorophores.   ................................... 22 
Figure 1.14 Schematic representation of fluorescence-based ligand-displacement assay 
for inhibitory screening.   ................................................................................................ 23 
Figure 1.15 Chemical structures of selected fluorescently-labelled sugar nucleotides 
and acceptor substrates used in the literature GT assays.   ............................................. 24 
xiii 
 
Figure 1.16 Representative example of enzymatic reactions of fluorescent GM1 and 
lactose acceptor substrates and their products derived from the glycolipid metabolism 
detected by CE-LIF. ........................................................................................................ 26 
Figure 2.1 General outline of fluorescence-based methodology to detect enzymatic 
activities of membrane-bound glycosyltransferases. ...................................................... 30 
Figure 2.2 Schematic representation of structures of glycoconjugates from 
Trypanosoma brucei and Mycobacterium smegmatis and synthetic fluorescent and non-
fluorescent glycoside acceptors to be used in detection of glycosyltransferase activities.34 
Figure 2.3 Authentic and synthetic acceptor substrate analogues of D-GlcNα-1,6-D-
myo-inositol-1-PO4-sn-1,2-diacylglycerol utilised in the literature research.   .............. 35 
Figure 2.4 Structures of non-fluorescent and fluorescent acceptor substrates designed 
to be used in methodology I and II to probe activities of membrane-bound 
glycosyltransferases.   ..................................................................................................... 36 
Figure 2.5 Coumarin-derived fluorophores with the highest quantum yield described in 
the literature.   ................................................................................................................. 43 
Figure 2.6 Structural differences of fluorescently labelled coumarinyl α-D-
mannopyranoside derivatives can affect their photophysical properties.   ..................... 43 
Figure 2.7 Fluorescent properties of coumarinyl α-D-mannopyranoside derivatives.   . 44 
Figure 2.8 The effect in change of pH level on the fluorescent properties of coumarinyl 
α-D-mannopyranoside derivatives.   ............................................................................... 45 
Figure 2.9 Comparison of TLC detection range of fluorescently labelled coumarinyl α-
D-mannopyranoside derivatives.   ................................................................................... 47 
Figure 2.10 The detection range of fluorescently labelled coumarinyl α-D-
mannopyranoside derivatives in solution.  ..................................................................... 47 
Figure 2.11 Diagrammatic representation of lipoarabinomannan biosynthesis in 
Mycobacterium smegmatis.  ........................................................................................... 50 
Figure 2.12 Structure of acceptor substrates used in the literature cell-free radiolabelled 
assays.   ........................................................................................................................... 51 
Figure 2.13 Structures of non-fluorescent and fluorescent compounds used to 
benchmark fluorescence-based methodology I and II against literature radiolabelled 
assay.   ............................................................................................................................. 52 
xiv 
 
Figure 2.14 TLC analyses of enzymatic assays of non-fluorescent and fluorescent 
mannoside acceptors to detect mannosyltransferase activities in Mycobacterium 
smegmatis membranes using fluorescence-based methodology I.   ............................... 54 
Figure 2.15 TLC analyses of enzymatic assays of non-fluorescent and fluorescent 
mannoside acceptors to detect mannosyltransferase activities in Mycobacterium 
smegmatis microsomal membranes using fluorescence-based methodology II.   .......... 55 
Figure 2.16 LC-MS analyses of reaction mixtures obtained from incubation of non-
fluorescent and fluorescent acceptors with GDP-Man in the presence of Mycobacterium 
smegmatis microsomal membranes.   ............................................................................. 57 
Figure 2.17 TLC analyses of exo-mannosidase digestions of fluorescent mannoside 
products with exo-mannosidase.   ................................................................................... 59 
Figure 2.18 Schematic representation of α-1,6-mannosyltransferase reaction with non-
fluorescent and fluorescent acceptor substrates using fluorescence-based methodology 
II.   ................................................................................................................................... 60 
Figure 2.19 Diagrammatic representation of GPI anchor biosynthesis in Trypanosoma 
brucei.   ........................................................................................................................... 62 
Figure 2.20 Structures of acceptor substrates used in the literature cell-free 
radiolabelled assays.   ..................................................................................................... 63 
Figure 2.21 Structures of non-fluorescent and fluorescent compounds used to 
benchmark fluorescence-based methodology II against radiolabelled literature assay.   65 
Figure 2.22 TLC analyses of enzymatic assays of non-fluorescent and fluorescent 
acceptors used in detection of galactosyltransferase activities in Trypanosoma brucei 
membranes utilising fluorescent methodology II.   ........................................................ 66 
Figure 2.23 TLC analyses of enzymatic assays of fluorescent mannoside acceptor to 
improve galactosyltransferase activities in Trypanosoma brucei microsomal membranes 
utilising fluorescent methodology II.   ............................................................................ 67 
Figure 2.24 UPLC analyses of reaction mixture obtained from incubation of 
fluorescent acceptor with UDP-Gal in the presence of Trypanosoma brucei microsomal 
membranes.  . .................................................................................................................. 68 
Figure 2.25 Analyses of exo-glycosidase digestion of fluorescent products with α-
galactosidase from green coffee beans and β-galactosidase from Escherichia coli.  (A) 
The TLC plate after exo-galactosidase digestion.  ......................................................... 69 
xv 
 
Figure 2.26 Ion mobility spectrum to represent isomeric structures present in 
trisaccharide fluorescent products obtained from incubation of UDP-Gal with 
Trypanosoma brucei membranes.   ................................................................................. 70 
Figure 2.27 Diagrammatic representation of fluorescent acceptor mimicked sites on the 
GPI anchor and resulted fluorescent products.   ............................................................. 71 
Figure 2.28 Structural comparison between acceptors used in the literature 
radiolabelled assays and in the fluorescence-based methodology. ................................. 74 
Figure 3.1 The Euglena gracilis cell.   ........................................................................... 77 
Figure 3.2 Diagrammatic representation of conserved N-glycan and GPI anchor 
biosynthesis to illustrate limited information available on glycosyltransferases present 
in Euglena gracilis.   ....................................................................................................... 79 
Figure 3.3 Schematic and chemical structures of fluorescent acceptors used in 
fluorescence-based methodology II to probe mannosyltransferases activities in Euglena 
gracilis microsomal membranes.   .................................................................................. 80 
Figure 3.4 TLC analyses of fluorescence-based assays to assess mannosyltransferase 
activities in Euglena gracilis microsomal membranes.   ................................................ 81 
Figure 3.5 HPLC analyses of reaction mixtures obtained from incubation of fluorescent 
acceptors with GDP-Man in the presence of Euglena gracilis microsomal membranes.  83 
Figure 3.6 Structural identification of fluorescent products obtained from enzymatic 
reactions with GDP-Man and Euglena gracilis microsomal membranes by LC-MS.   . 84 
Figure 3.7 TLC analyses to assess stereoselectivity and regioselectivity of disaccharide 
fluorescent products by exo-glycosidase digestions.   .................................................... 86 
Figure 3.8 TLC analyses to assess stereoselectivity and regioselectivity of trisaccharide 
fluorescent products by exo-glycosidase digestions.   .................................................... 87 
Figure 3.9 Formation of two fluorescent disaccharide isomeric compounds confirmed 
by LC-MS analysis.   ...................................................................................................... 88 
Figure 3.10 Presence of one fluorescent trisaccharide compound confirmed by LC-MS 
analysis.  . ........................................................................................................................ 89 
Figure 3.11 Drift time IM-MS spectra to represent number and nature of isomeric 
structures present in fluorescent mannoside products obtained from incubation with 
GDP-Man and Euglena gracilis microsomal membranes.   ........................................... 91 
xvi 
 
Figure 3.12 Schematic enzymatic reaction of monosaccharide acceptor and structural 
relationship between its disaccharide products and authentic N-glycan and GPI anchor 
intermediates.   ................................................................................................................ 92 
Figure 3.13 Schematic enzymatic reaction of disaccharide acceptor and structural 
relationship between its disaccharide products and authentic N-glycan and GPI anchor 
intermediates.   ................................................................................................................ 93 
Figure 3.14 Structural variations of N-linked glycoproteins in plants, mammalian and 
yeast systems. .................................................................................................................. 94 
Figure 3.15 Structures of fluorescent acceptors used in fluorescence-based 
methodology II to probe mannosyltransferases activities present in Euglena gracilis 
microsomal membranes.   ............................................................................................... 96 
Figure 3.16 TLC analyses of enzymatic assays involving incubation of monosaccharide 
fluorescent acceptor substrate with number of sugar nucleotides in the presence of 
Euglena gracilis microsomal membranes.   .................................................................... 97 
Figure 3.17 TLC analyses of enzymatic assays involving incubation of disaccharide 
fluorescent acceptor substrate with number of sugar nucleotides in the presence of 
Euglena gracilis microsomal membranes.   .................................................................... 98 
Figure 3.18 HPLC analyses of reaction mixtures obtained from incubation of 
fluorescent acceptors with UDP-Glc and UDP-GlcNAc in the presence of Euglena 
gracilis microsomal membranes.   .................................................................................. 99 
Figure 3.19 .  UPLC and ion mobility analyses of isomeric structures present in 
glucosylated product obtained from incubation of UDP-Glc with Euglena gracilis 
microsomal membranes.  . ............................................................................................ 101 
Figure 3.20 LC-MS analyses to investigate the nature of glucosylated products 
obtained from enzymatic biotransformation with UDP-Glc in the presence of Euglena 
gracilis microsomal membranes.   ................................................................................ 102 
Figure 3.21 LC-MS analyses to investigate the structure of fluorescent products 
obtained from enzymatic biotransformation with UDP-Glc in the presence of Euglena 
gracilis microsomal membranes.   ................................................................................ 103 
Figure 3.22 LC-MS analyses to investigate the nature of fluorescent products obtained 
from enzymatic biotransformation with UDP-GlcNAc in the presence of Euglena 
gracilis microsomal membranes.   ................................................................................ 105 
Figure 3.23 TLC analyses to investigate presence of terminal phosphate in fluorescent 
products through application of enzymatic hydrolysis with alkaline phosphatase.   .... 106 
xvii 
 
Figure 3.24 Diagrammatic representation of sequential chemical and enzymatic 
degradation of fluorescent trisaccharide and tetrasaccharide products containing 
phosphodiester bond.  . ................................................................................................. 107 
Figure 3.25 TLC analyses to investigate the presence of phosphodiester bond in 
fluorescent products through application of chemical degradation and enzymatic 
hydrolysis.   ................................................................................................................... 108 
Figure 3.26 Characterisation of fluorescent phosphodiester-linked product by the NMR 
spectroscopy.   ............................................................................................................... 109 
Figure 3.27 Characterisation of fluorescent phosphodiester-linked product by the NMR 
spectroscopy.   ............................................................................................................... 110 
Figure 3.28 Proposed structure and assignment of fluorescent phosphodiester-linked 
compound for NMR analysis. ....................................................................................... 111 
Figure 3.29 Schematic representation of enzymatic activities detected in Euglena 
gracilis microsomal membranes.   ................................................................................ 112 
Figure 3.30 Diagrammatic representation of mimicked N-glycan sites by synthetic 
fluorescent acceptors and their resulting products in Euglena gracilis.   ..................... 114 
Figure 3.31 Chemical structures of authentic fluorescent acceptors to aid with detection 
of mannosyltransferase activities in Euglena gracilis microsomal membranes. .......... 116 
Figure 4.1 Diagrammatic representation of Trypanosoma cruzi invasion and 
differentiation inside the vector and mammalian host cells.   ....................................... 122 
Figure 4.2 Representative transfer of sialic acid from the host glycoconjugate to the 
parasite cell surface mucin glycoprotein catalysed by Trypanosoma cruzi trans-
sialidase.   ...................................................................................................................... 123 
Figure 4.3 Representative examples of potent and moderate TcTs inhibitors.   .......... 124 
Figure 4.4 Schematic representation of cyclooligomerisation approach to the synthesis 
of cyclic pseudo-oligosaccharides.   ............................................................................. 125 
Figure 4.5 Schematic representation of cell surface-presented Trypanosoma cruzi 
trans-sialidase and potential for its blocking by 1,2,3-triazole-linked linear and cyclic 
pseudo-galactooligomers resulting in potential prevention of host cells invasion. ...... 126 
Figure 4.6 Reverse phase HPLC and normal phase TLC analyses of cyclic and linear 
products obtained from azido-alkyne 1,3-dipolar cycloaddition reactions of galactose 
monomer.   .................................................................................................................... 128 
xviii 
 
Figure 4.7 Linear oligomerisation products from the reaction of azido-alkyne-
containing galactose under CuAAC conditions.   ......................................................... 130 
Figure 4.8 Characterisation of cyclic and linear 1,4-triazole-linked galactose dimers by 
NMR spectroscopy.  ..................................................................................................... 132 
Figure 4.9 Normal phase TLC image and reverse phase HPLC chromatogram of 
fluorescently labelled 1,4-triazol-linked linear compounds obtained from azido-alkyne 
1,3-dipolar cycloaddition reactions of mixed 1,4-triazole-linked linear compounds in 
the presence of 3-azido-7-hydroxy-coumarin.   ............................................................ 133 
Figure 4.10 Fluorescent linear oligomerisation products from the reaction of azido-
alkyne-containing galactose under CuAAC conditions.   ............................................. 134 
Figure 4.11 Reverse phase HPLC and normal phase TLC analyses of cyclic and linear 
products obtained from azido-alkyne 1,3-dipolar cycloaddition reactions of galactose 
monomer.   .................................................................................................................... 136 
Figure 4.12 TLC analyses of enzymatic transformations of 1,4-triazole-linked cyclic 
monomer 4.08, 1,5-triazole-linked cyclic monomer 4.26, 1,4-triazole-linked cyclic 
dimer 4.09 and 1,4 triazole-linked cyclic trimer 4.10 into mono-, di- and tri-sialylated 
cyclic compounds in the presence of TcTS and a fetuin donor.   ................................. 138 
Figure 4.13 Inhibition of T. cruzi invasion of bovine macrophages in the presence of 
1,4/1,5-triazole-linked cyclic dimers (C2), trimer (C3), tetramer (C4), pentamer (C5), 
hexamer (C6), heptamer (C7) and a series of mixed 1,4/1,5-triazole-linked linear 
oligomers.  .................................................................................................................... 140 
Figure 4.14 Representative images illustrating amastigote-form parasite numbers 
present inside macrophages infected with T. cruzi.   .................................................... 141 
Figure 6.1 LC-MS data of peak 1 of fluorescent disaccharide (3.03) product obtained 
from incubation of monosaccharide acceptor substrate with UDP-Glc in the presence of 
Euglena gracilis microsomal membranes. .................................................................... 179 
Figure 6.2 LC-MS data of peak two of fluorescent disaccharide (3.03) product obtained 
form incubation of monosaccharide acceptor substrate with UDP-Glc in the presence of 
Euglena gracilis microsomal membranes. .................................................................... 180 
Figure 6.4 The 
1
H NMR spectra of fluorescent phosphodiester-linked product. ........ 182 
Figure 6.5 The 
31
P NMR spectra of fluorescent phosphodiester-linked product. ........ 182 
Figure 6.6 The HRMS spectrum of the series of 1,4-triazole-linked linear products 
obtained from CuAAC oligomerisation of galactose monomer. .................................. 186 
xix 
 
List of Tables 
Table 2.1 Outline schemes of fluorescence-based methodologies for pre- and post-
enzymatic transformation labelling in detecting enzymatic activities of membrane-
bound glycosyltransferases.   .......................................................................................... 33 
Table 2.2 Photophysical properties of fluorescently labelled coumarinyl α-D-
mannopyranoside derivatives.  ....................................................................................... 44 
Table 3.1 Percentage conversion of fluorescent products obtained from enzymatic 
reactions with Euglena gracilis microsomal membranes.   ............................................ 83 
Table 3.2 Percentage conversion of fluorescent products obtained from enzymatic 
reactions with UDP-Glc and UDP-GlcNAc in the presence of Euglena gracilis 
microsomal membranes.   ............................................................................................. 100 
Table 3.3 Euglena gracilis percent identity of mannosyltransferase to known protein 
sequences from other organisms.   ................................................................................ 115 
Table 4.1 Yields of 1,4-triazole-linked cyclic and linear products from CuAAC 
reactions of galactose monomer.   ................................................................................. 129 
Table 4.2 HRMS data of 1,4-triazole-linked cyclic products and linear oligomers. .... 130 
Table 4.3 HRMS data of fluorescent 1,4-triazole-linked linear products.   ................. 134 
Table 4.4 MALDI-TOF data of 1,4- and 1,5-triazole-linked cyclic oligomers.   ........ 136 
Table 4.5 HRMS data for products of enzymatic sialylation of triazole-linked cyclic 
oligomers.  .................................................................................................................... 138 
Table 5.1 Solvents mixtures used for TLC elution.   ................................................... 168 
Table 6.1 MS and MS2 data from LC-MS analysis of glucosylated fluorescent products 
obtained from 2.12 and 2.13.   ...................................................................................... 181 
Table 6.2 MS and MS2 data from LS-MS analysis of products obtained from 2.12  
with UDP-Glc.   ............................................................................................................ 181 
Table 6.3 MS and MS2 data from LS-MS analysis of products obtained from 2.13 with 
UDP-GlcNAc.   ............................................................................................................. 181 
Table 6.4 Euglena gracilis percent identity, similarity and gaps of EgAlg3 to known 
protein sequences.   ....................................................................................................... 183 
xx 
 
Table 6.5 Euglena gracilis percent identity, similarity and gaps of EgAlg9 to known 
protein sequences.   ....................................................................................................... 184 
Table 6.6 Euglena gracilis percent identity, similarity and gaps of GlcNAc-P-Tase to 
known protein sequences.   ........................................................................................... 186 
 
  
xxi 
 
List of Schemes 
Scheme 1.1 Mechanisms for inverting and retaining glycosyltransferases.   ................. 19 
Scheme 2.1 Azido coumarin-based fluorophore becomes fluorescent upon reaction 
with strain or terminal alkyne to form a triazole ring under click conditions.  .............. 31 
Scheme 2.2 Synthetic route to 2-(3-azido-coumarin-7-yloxy)ethyl α-D-
mannopyranoside.   ......................................................................................................... 38 
Scheme 2.3 Synthetic route to fluorescent coumarinyl α-D-mannopyranoside derivative 
through strain-promoted click conditions.   .................................................................... 39 
Scheme 2.4 Synthetic route to hexyn-5-yl α-D-mannopyranoside and hexyn-5-yl α-D-
mannopyranosyl-1,6-O-α-D-mannopyranoside.   ........................................................... 40 
Scheme 2.5 Synthetic routes to fluorescent coumarinyl α-D-mannopyranoside 
derivatives through Cu(I)-catalysed click conditions.   .................................................. 41 
Scheme 2.6 Reaction schemes of azido-alkyne compounds leading to formation of 5,5-
bistriazole by-products under Cu(I)-catalysed click conditions as described in the 
literature.   ....................................................................................................................... 42 
Scheme 2.7 Enzymatic transformations of synthetic acceptor substrate by 
galactosyltransferases responsible for branching of GPI anchors as detected by 
literature radiolabelled assay.   ........................................................................................ 64 
Scheme 4.1 Synthetic route to azido-alkyne-containing galactose monomer.   ........... 127 
Scheme 4.2 Cyclisation and oligomerisation of azido-alkyne-containing galactose 
through CuAAC.   ......................................................................................................... 129 
Scheme 4.3 Spontaneous cyclisation and oligomerisation of azido-alkyne-containing 
galactose leading to a mixture of compounds incorporating both 1,4-linked and 1,5-
linked 1,2,3-triazole residues. ....................................................................................... 135 
Scheme 4.4 Structures of proposed sialylated products obtained from enzymatic 
transformation of compound 4.10.   .............................................................................. 139 
  
xxii 
 
Abbreviations 
[α]D optical rotation 
°C degree Celsius 
Å Ångstrom 
Ac acyl  
AcOH acetic acid 
AG arabinogalactan 
AgOTf silver triflate 
AGP arabinogalactan protein 
Alg asparagine-linked glycosyltransferases 
AP alkaline phosphatase 
APTS 8-aminopyrene-1,3,6-trisulfonic acid  
aq aqueous 
Ar aromatic  
Asn asparagine 
At Arabidopsis thaliana 
ATP adenosine triphosphate 
b.p. boiling point 
BMMO macrophages derived from bone marrow 
BODIPY 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene 
BP by-product 
BSA bovine serum albumin 
BzCl benzoyl chloride 
c concentration 
CAD corona charged aerosol detector 
CDGS carbohydrate deficiency glycoprotein syndrome 
CE-LIF capillary electrophoresis-laser induced fluorescence 
CH2Cl2 dichloromethane 
CH3CN acetonitrile 
CHCl3 chloroform 
COSY correlation spectroscopy 
CuAAC Cu(I)-catalysed azido-alkyne cycloaddition  
d doublet 
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene 
dd doublet of doublets 
DMAP 4-dimethylaminopyridine 
DMF N,N-dimethylformamide 
Dol-PP dolichylpyrophosphate 
DP degradation product 
DTT dithiothreitol 
Emmax emission maximum 
ER endoplasmic reticulum 
ESI electro spray ionisation 
Et3N triethylamine 
xxiii 
 
EtNPO4 phosphoethanolamine 
EtOAc ethyl acetate 
EtOH ethanol 
Exmax excitation maximum 
FRET Förster (fluorescence) resonance energy transfer 
FTIR Fourier transform infrared  
Fuc L-fucose 
FucT fucosyltransferase 
Gal D-galactose 
Galf D-galactofuranose 
GalNAc N-acetyl-D-galactosamine 
GalNAcT N-acetylgalactosaminyltransferase 
Galp D-galactopyranose 
GalT galactosyltransferase 
GalT galactosyltransferase 
GclNAc N-acetyl-D-glucosamine 
GC-MS gas chromatography–mass spectrometry  
GDP guanosine diphosphate 
Glc D-glucose 
GlcA D-glucuronic acid 
GlcN D-glucosamine 
GlcNAc-PI N-acetylglucosamine-phosphatidyl-myo-inositol 
GlcNAc-P-Tase N-acetylglucosamine-1-phosphate transferase  
GlcNAcT N-acetylglucosaminyltransferase 
GlcT glucosyltransferase 
GPC gel permeation chromatography 
GPI anchor glycosylphosphatidylinositol anchor 
GPI-T glycosylphosphatidylinositol transamidase 
GT glycosyltransferase 
H BP hydrolysed by-product 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HMBC heteronuclear multiple bond correlation 
HPLC high performance liquid chromatography 
HPTLC high performance thin layer chromatography 
HRMS high resolution mass spectrometry 
HSQC heteronuclear single quantum coherence 
HTS high throughput screening 
Hyp hydroxyproline 
Hz Hertz 
IM-MS ion-mobility–mass spectrometry 
iPrOH isopropanol 
IR infrared 
J coupling constant 
K Kelvin 
kDa kiloDalton 
KO
t
Bu Potasium t-butoxide 
xxiv 
 
kV kiloVolts 
LAM lipoarabinomannan 
LC liquid chromatography 
LC-MS liquid chromatography–mass spectrometry  
LDA lithium diisopropylamide 
LM lipomannan 
m  multiplet 
m/z mass to charge ratio 
M6P mannose-6-phosphate 
MALDI-TOF matrix-assisted laser desorption ionization time of flight 
Man D-mannose 
ManH mannosidase 
ManT mannosyltransferase 
MeOH methanol 
MHz megaHertz 
MOPS 3-(N-morpholino)propanesulfonic acid 
MPR mannose-6-phosphate receptor 
ms milliseconds 
mU milliunit 
N normal 
NaAsc sodium ascorbate 
NaOMe sodium methoxide 
OT oligosaccharyl transferase 
PI phosphatidyl-myo-inositol 
PIM phosphatidyl-myo-inositol mannoside 
pKa acid dissociation constant 
ppGlcNAcT UDP-GlcNAc:polypeptide N-acetylglucosaminyltransferase 
ppm parts per million 
Py pyridine 
r.p.m rotation per minute 
Rf retention factor 
Rha L-rhamnose 
RP reverse phase 
Sia N-acetyl-neuraminic acid 
TB tuberculosis 
TcTS Trypanosoma cruzi trans-sialidase 
tD drift time 
TFA trifluoroacetic acid  
THF tetrahydrofuran 
TLC thin layer chromatography 
TMS tetramethylsilane 
TMSOTf trimethylsilyl trifluoromethanesulfonate 
TrCl trityl chloride 
Tris tris(hydroxymethyl)aminomethane 
U unit 
UDP uridine diphosphate 
xxv 
 
UPLC ultra performance liquid chromatography 
UV ultraviolet 
VSG variant surface glycoprotein 
Xyl D-xylose 
δ chemical shift 
ε extinction coefficient  
λem emission wavelength 
λex excitation wavelength 
ϕf quantum yield  
 
 
 
1 
 
1 Introduction 
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1.1 Essentials of glycoconjugates  
Glycoconjugates are vital components of prokaryotic and eukaryotic cell surface.  They 
consist of a variety of complex carbohydrate structures that are covalently linked to 
non-sugar moieties, such as proteins, peptides, and lipids.  The carbohydrate moiety of 
the glycoconjugate can incorporate a variety of monosaccharides, which can be 
arranged through different linkages, chain length and branching points, and can have 
different sequences and covalent attachment of terminal modifying groups.
1, 2
  Due to 
these complexities and variability of the terminal carbohydrate sequences, 
glycoconjugates can participate in a variety of biological functions.  In bacteria and 
parasites, glycoconjugates are constituents of the cell wall where they play an important 
role in protection against the immune system of the host, and aid with infectivity inside 
the vector and host organisms.
3, 4
  In animals and plants, glycoconjugates that occupy 
the intercellular spaces determine the cell adhesion and involved in signal transduction,
5
 
cell-cell or bacterial-host interactions
6, 7
 as well as cell development and fertility.
8, 9
  
However, the central function of glycosylation is the involvement of carbohydrate 
moiety in correct folding of polypeptides
10
 and consequent maintenance of protein 
solubility as well as protection against the proteases inside the cell.
11, 12
   
The assembly of these complex structures takes place in the endoplasmic reticulum 
(ER) and Golgi apparatus where a series of specific membrane-bound 
glycosyltransferases transfer sugar moieties from soluble sugar nucleotides or lipid 
linked activated sugars to variety of oligosaccharide, lipid or peptide acceptors with the 
correct stereo- and regio-selectivity.  The structures and biosynthesis of glycoconjugates 
have been extensively studied using radiolabelled methodologies; however, we are still 
far from the characterising and understanding construction of most glycoconjugates.   
 
1.2 The structures and biosynthesis of glycoconjugates of interest  
In this study, we looked at the detection of membrane-bound glycosyltransferase 
activities involved in the biosynthesis of GPI anchor in Trypanosoma brucei, 
lipoarabinomannan in Mycobacterium smegmatis and N-linked glycoproteins in 
Euglena gracilis.  We also looked at the mimetic of O-linked glycoproteins in 
3 
 
Trypanosoma cruzi.  Therefore, a description on what is known about these 
glycoconjugate structures and their biosynthesis is described below. 
 
1.2.1 Glycosylphosphatidylinositol anchors 
Glycosylphosphatidylinositol (GPI) anchors are present in all eukaryotic cells and are 
widely distributed in protozoa, plants, yeast, fungi, insects and mammals (Fig. 1.10).
13
   
Their main function is the attachment and transport of proteins, glycoproteins and 
glycolipids to the plasma membrane.
14
  GPI anchored components can then play a vital 
role in a variety of biological functions, for example in immune responses, signal 
transduction and cancer cell invasion, as well as pathophysiology of the parasites.
3, 15
  
The importance of GPI anchored proteins during mouse embryonic developmental 
stages was apparent from lethality in GPI deficient mice.
16
  
 
Figure 1.1 Structural variations of GPI anchors in protozoan, yeast and mammalian systems. 
The core structure of GPI anchors, EtNPO4-6-Man-α-1,2-Man-α-1,6-Man-α-1,4-GlcN-
α-1,6-myo-inositol-P-lipid, is conserved throughout all eukaryotic cells and the 
structural complexity originates from variations on either side-chains or/and the lipid 
moieties (Fig 1.1).  The side chain modifications include decoration of conserved core 
structure with galactose residues in Trypanosoma brucei, addition of a fourth mannose 
branching in yeast and additional phosphoethanolamine residues added to the first and 
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second mannose in mammals.
17
  The functional significance of these side modifications 
is largely unknown; although, the addition of galactose residues in Trypanosoma brucei 
was assigned as a requirement to fill the space between proteins in order to preserve 
their distribution and functional integrity.
18
   
The intact GPI precursors were first identified in Trypanosoma brucei and were used to 
develop a first cell-free system to assist in delineating the biosynthetic pathway for GPI 
biosynthesis.
19
  This method was then successfully adopted to define biosynthetic 
pathways in yeast
20
 and mammalian cells.
21
  The biosynthesis of core GPI anchors 
begins on the cytoplasmic side of the ER with the transfer of GlcNAc residue from 
UDP-GlcNAc to a phosphatidyl-myo-inositol (PI) precursor to give GlcNAc-PI (Fig. 
1.2).  The resulting GlcNAc-PI precursor is then deacetylated to form glucosamine 
(GlcN)-PI, which is flipped through the lipid bilayer to the lumenal side of the ER.  The 
biosynthesis of GPI precursor proceeds on the lumenal side of the ER by addition of 
three mannose residues from lipid-activated sugars (Dol-PP-Man) to GlcN-PI mediated 
by α-1,4-ManT (MT-I), α-1,6-ManT (MT-II) and α-1,2-ManT (MT-III) to generate 
Man3-GlcN-PI.  The significant difference between mammalian and Trypanosoma 
brucei biosynthesis at this point is the relative order of acylation of inositol and 
mannosylation.  In mammalian systems the attachment of acyl group to the inositol of 
the GlcN-PI precursor is followed by mannosylation while in Trypanosoma brucei 
mannosylation of GlcN-PI precedes the acylation of inositol.  Furthermore, in 
mammalian systems one ethanolamine phosphate (EtNP) is added to the first mannose 
residue of core GPI precursor, while it is absent in Trypanosoma brucei.  These 
apparent differences in the substrate specificities (GlcN-PI vs GlcN-(acyl)-PI in MT-I 
and Man2-GlcN-PI vs EtNP-Man2-GlcN-(acyl)-PI in MT-III) made these enzymes 
attractive targets to design inhibitors of GPI anchor biosynthesis in Trypanosoma 
brucei.
22, 23
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Figure 1.2 Diagrammatic schemes of GPI anchor biosynthesis in Trypanosoma brucei.  The biosynthesis initiates 
with transfer of GlcNAc to PI followed by deacetylation of GlcNAc and transfer of GlcN-PI to the lumenal side of 
the ER.  In the lumenal side of the ER the GPI precursor acylated, mannosylated with three mannose residues and 
transferred to the nascent protein.  
Attachment of GPI precursor to the nascent protein takes place on the lumenal side of 
the ER via a transamidation reaction catalysed by GPI transamidase (GPI-T).  The 
polypeptide chain requires a specific C-terminal signal sequence for the attachment to 
GPI precursor by GPI-T.  During its activation, GPI-T identifies and cleaves the C-
terminal signal sequence leading to formation of a new amide bond between the 
carbonyl group of the polypeptide chain and the amine group of the GPI precursor.
24
  
After the GPI has been attached to the protein, the glycoconjugate is transported to the 
Golgi apparatus where side chain modification of the core structure and lipid 
remodelling takes place.  The completed GPI anchored proteins are then transported 
from the Golgi to the plasma membrane where their specific cell surface location 
depends on the function of the protein concerned.  
Despite the importance of GPI anchors in plants,
25
 little work has been done to elaborate 
their structural composition or biosynthetic pathway.  In fact, to date the only plant GPI 
structure so far determined is from Pyrus communis.
26
  This GPI anchor has the 
conserved core structure, which is consistent with those found in protozoa, mammals 
and yeast; however, it is modified with β-1,4-galactosyl substitution of the 6-linked 
mannose residue.  The GPI biosynthetic pathway in plants has not been studied 
experimentally; it has only been proposed on the basis of a structural study from Pyrus 
communis and bioinformatics analysis, which identified orthologous genes to 
mammalian and yeast GPI biosynthetic systems.
26
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1.2.2 Mycobacterial lipoarabinomannan  
The cell surface of pathogenic Mycobacterium tuberculosis and non-pathogenic 
Mycobacterium smegmatis possess a series of amphipathic glycolipids, such as 
lipoarabinomannan (LAM), lipomannan (LM) and phosphatidyl-myo-inositol 
mannoside (PIM), which are non-covalently attached to the cell membrane through a 
phosphatidyl-myo-inositol (PI) anchor (Fig. 1.3).   
 
Figure 1.3 Representative examples of the main components of the mycobacterial cell surface; structural 
similarities and differences between LAM in Mycobacterium tuberculosis and Mycobacterium smegmatis. 
The mannosylated PIM structures contain between two and six mannose residues in α-
1,6 and α-1,2 linkages and can be acylated by transfer of fatty acid to one of the core 
mannose residues, resulting in final AcPIM6 species.  The LM structure is composed of 
a longer α-1,6-linked mannan backbone, which is elaborated with α-1,2-linked mannose 
residues forming short side chains.  The backbone of the LAM is then extended with α-
1,5-linked arabinofuranose residues modified with α-1,3-linked branching chains.  The 
terminal α-1,2-linked arabinofuranose residues are then modified with a specific 
capping motif, which is species dependent.  In slow-growing Mycobacterium 
tuberculosis, the capping motif was assigned to small mannooligosaccharides 
(ManLAM), while in fast-growing Mycobacterium smegmatis to phospho-inositol 
(PILAM) (Fig. 1.3).
27
  The ManLAM of Mycobacterium tuberculosis plays an 
important role in regulating the host immune response by interaction with different 
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receptors which contributes to the survival of the slow-growing pathogenic bacterium in 
the host.
28
  The current model of LAM biosynthesis follows a linear pathway from 
PI→PIM→LM→LAM with some diversion in the biosynthesis of AcPIM6 (Fig. 1.4).
4
   
 
Figure 1.4 Diagrammatic scheme of LAM biosynthesis in non-pathogenic Mycobacterium smegmatis.  The 
biosynthesis begins on the cytoplasmic face of the plasma membrane by mannosylation of inositol with two mannose 
residues to form PIM2 which is then further acylated and mannosylated to yield AcPIM3.  The AcPIM3 is transported 
to the outer face of the plasma membrane where it is mannosylated to AcPIM4 which either leads to formation of 
AcPIM6 or proceed further to the biosynthesis of LM and LAM.  
LAM biosynthesis initiates with the transfer of a mannose residue to the 2-position of 
the myo-inositol ring of PI, which is catalysed by a ManT, termed PimA, yielding a 
PIM1.  This enzyme has been well characterised using biochemical experiments and its 
crystal structure was solved in the presence of acceptor and donor, which gave an 
understanding of the enzymes catalytic mechanism.
29, 30
  The myo-inositol is then 
mannosylated by a ManT, termed PimB’ to give PIM2, which is acylated by 
acyltransferase (Rv2611c) to form AcPIM2.
31
  The latter is then mannosylated to 
AcPIM3 and AcPIM4, where AcPIM4 is believed to be a branching point intermediate 
leading to either formation of AcPIM6 or further elongation to LM and LAM.  The 
transition of AcPIM3 has been determined to occur from mannosyltransferases located 
on the cytoplasmic face of the plasma membrane, which utilise soluble GDP-Man sugar 
nucleotide to the glycosyltransferases that utilise lipid-linked-activated (polyprenol 
phosphate (PP)) sugars located on the luminal side of the ER.  This was supported by 
inhibiting the biosynthesis of AcPIM4 with amphomycin, which is a selective inhibitor 
of polyprenyl-phosphate-ManT.
32
  The enzyme involved in formation of AcPIM5 and 
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AcPIM6 is α-1,2-ManT, termed PimE; however, it is still not clear if it is solely 
responsible for the biosynthesis of both intermediates.   
The biosynthesis of LM involves two recently identified α-1,6-ManT, termed MptB and 
MptA.  The first α-1,6-ManT (MptB) enzyme is involved in the initial stage of AcPIM4 
elongation, while the second α-1,6-ManT (MptA) is involved in further elongation of 
LM precursor to produce mature LM.
33
  Deletion of genes encoding for MptB and 
MptA enzymes in Corynebacterium glutamicum, a species that shares similar 
orthologues involved in cell wall assembly with Mycobacterium tuberculosis and 
Mycobacterium smegmatis, resulted in the absence of LM and LAM structures when 
compared to the wild type.
34, 35
  The core LM structure is branched by α-1,2-ManT 
enzyme (Rv2181) resulting in characteristic α-1,2-linked branches.  The initial 
decoration of mannose core structures of mature LM with arabinose residues involves as 
yet uncharacterised arabinofuranosyltransferase (AraT) enzyme.  Decorated LAM is 
then further extended by α-1,5-AraT (EmbC)36 and at this point formation of branching 
is assigned to α-1,3-AraT (Rv2673).37  The branched LAM is then extended by 
unidentified α-1,5-AraT and finally β-1,2-AraT introduces terminal tetra and hexa-
arabinofuranoside structures.
38
 
 
1.2.3 Eukaryotic N-linked glycoproteins 
The majority of the genetic and biochemical characterisation of N-glycosylation has 
been established in eukaryotic cells and the biosynthetic pathway can be divided into 
three major stages.  The first stage involves assembly of the lipid-linked oligosaccharide 
and occurs at the ER; the second stage involves transfer of newly synthesised 
oligosaccharide from the lipid-linked precursor to the asparagine residue of proteins, 
finally, the third stage involves further modification of oligosaccharide on the protein 
and takes place in Golgi apparatus (Fig. 1.5).
39
  The first two stages are remarkably 
conserved in all eukaryotic cells ranging from unicellular organisms, such as yeast to 
the multicellular, such as animal, plant and humans.
40
  In contrast, the third stage is cell, 
tissue and organism specific.   
During the first stage, the assembly of the lipid-linked oligosaccharide requires a series 
of membrane-bound glycosyltransferases that belong to the Alg family (asparagine-
linked glycosyltransferases).  The ordered addition of sugar residues to the growing 
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intermediate is maintained through remarkable substrate specificity of these enzymes.  It 
all begins with the synthesis of dolichylpyrophosphate (Dol-P-P) carrier at the 
cytoplasmic face of the ER membrane.  Once the assembly of this carrier is complete, 
the first step of N-glycosylation begins with transfer of N-acetylglucosamine residue 
from UDP-GlcNAc to the Dol-P-P carrier giving rise to GlcNAc-P-P-Dol.  N-
Acetylglucosaminyl phosphate transferase (Alg7) involved in this catalysis is very 
sensitive to inhibition by tunicamycin, which is naturally occur in several bacteria 
including Streptomyces clavuligerus, and it was originally developed as an antiviral 
substance.
41, 42
  The next step involves transfer of a second GlcNAc residue to GlcNAc-
P-P-Dol followed by sequential addition of five mannose residues to give 
Man5GlcNAc2-P-P-Dol.  After completion, the Man5GlcNAc2-P-P-Dol intermediate is 
translocated to the lumenal side of the ER by a process which is believed to involve 
proteins, termed flippases; however, the overall process is still unclear.
43
   
 
Figure 1.5 Representative biosynthetic pathway of N-linked glycosylation at the ER membrane in eukaryotic 
cells.39 
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On the lumenal side of the ER the Man5GlcNAc2-P-P-Dol intermediate is elongated 
with four mannose residues to give Man9GlcNAc2-P-P-Dol.  These mannosylations are 
catalysed by Alg3, Alg12 and Alg9, where Alg3 and Alg12 transfers an α-1,3- and α-1,6-
linked mannose residues respectively, and Alg9 two α-1,2-linked mannose residues.44, 45  
Addition of the remaining three glucose residues is catalysed by glucosyltransferases 
(GlcT) Alg6, Alg8 and Alg10, which complete the biosynthesis of lipid-linked 
Glc3Man9GlcNAc2-P-P-Dol precursor (Fig 1.5).  It is worth mentioning that all 
glycosyltransferases involved in the biosynthesis of lipid-linked precursor on the 
cytosolic side of the ER utilise soluble sugar nucleotides, such as UDP-GlcNAc and 
GDP-Man.  In contrast, all glycosyltransferases on the lumenal side of the ER utilise 
lipid-activated sugar nucleotides such as Dol-P-Man and Dol-P-Glc as donors that are 
synthesised on the cytosolic side of the ER and translocated to the lumenal side.   
As mentioned above, the structure of lipid-linked Glc3Man9GlcNAc2-P-P-Dol precursor 
is conserved; nevertheless, several species of parasitic protozoa such as Trypanosoma 
brucei (Man9-8-7GlcNAc2-P-P-Dol) and Leishmania (Man7-6GlcNAc2-P-P-Dol) are 
known to synthesise truncated forms of lipid-linked oligosaccharide.
46
  This is due to 
the inability of trypanosomatids to synthesise Dol-P-Glc sugars as well as the lack of 
certain ManT and GlcT in these parasitic protozoa (Fig. 1.6).
47
   
 
Figure 1.6 Structural variations of lipid-linked N-glycan precursors in eukaryotic system. 
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During the second stage of N-glycosylation, newly synthesised Glc3Man9GlcNAc2-P-P-
Dol precursor is transferred en bloc from a dolichol-P-P carrier to the asparagine residue 
of the nascent polypeptide chain on the lumenal side of the ER.  This enzymatic reaction 
is catalysed by the integral membrane oligosaccharyl transferase (OT) (Fig. 1.7).
48
  
Glycosylation of asparagine occurs within an Asn-X-Thr/Ser sequence, where X can be 
any amino acid residue except proline; in particular OT has a slight preference for 
threonine.  After glycosylation, the protein undergoes an elaborate quality control that 
monitors the protein folding in the ER (Fig. 1.7).  The quality control is performed by 
two lectins, such as membrane-bound calnexin and its soluble homolog calreticulin.
49
  
The process of quality control begins with removal of two glucose residues by the 
action of glucosidases I and II to give GlcMan9GlcNAc2-Asn-Protein.  This precursor is 
then recognised by the two lectins that prevent protein aggregation and misfolding.  
Once the protein is properly folded, the removal of remaining glucose residues by 
glucosidase II liberates the Man9GlcNAc2-Asn-Protein from calnexin and calreticulin.  
However, if protein fails to fold, which can be due to several factors, such as 
spontaneous errors during transcription, genetic mutations, toxic compounds or a 
cellular stress, it is undergoes the ER-associated degradation process that employs 
proteasomes.
50
 
 
Figure 1.7 Processing and maturation of oligosaccharide moiety of the N-linked glycoprotein at the ER and 
Golgi apparatus membranes.40 
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The third stage occurs mainly in higher eukaryotic cells, as in mammals and plants.  In 
contrast, in yeast the number of mannose residues is not reduced but rather extended 
with more than 100 mannose residues onto a single glycosylation site forming an outer 
chain.
51
  In the case of higher eukaryotic cells, the correctly folded Man8GlcNAc2-Asn-
Protein is transported to the Golgi where it undergoes a series of hydrolytic reactions, 
known as processing and trimming (Fig. 1.7).
52
  This process starts by the addition of a 
GlcNAc residue to the Man-α-1,3-Man arm of the Man5GlcNAc2-Asn-Protein, 
catalysed by β-1,2-N-acetylglucosaminyl transferase I (GlcNAc-T I).  Subsequent 
removal of two mannose residues catalysed by mannosidases II produce a substrate for 
β-1,2-GlcNAc-T II, which transfers GlcNAc residue to the Man-α-1,6-Man arm of the 
Man3GlcNAc3-Asn-Protein.  These two steps are an evolutionary requirement for the 
next steps that involve building antennae by adding various numbers of Gal, sialic acid 
and fucose (xylose in plants).  It is worth mentioning again that these last enzymatic 
reactions, which produce the final N-glycan structures, involve glycosidases and 
glycosyltransferases with high substrate specificities that use soluble sugar nucleotides 
donor substrates.
53
  Deduction of N-linked oligosaccharide final structures from a 
variety of animal and plant sources using NMR spectroscopy allowed characterisation 
of N-linked glycans and their classification into three main categories that were defined 
as high-mannose, hybrid and complex (Fig. 1.8).
54
   
 
Figure 1.8 Structural variants of N-linked glycoproteins.  The core structure shared between all types of N-linked 
glycoproteins is indicated by a red box. 
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All three types of N-linked glycoproteins share a common Man3GlcNAc2-Asn core 
structure and differ in the outer branching (Fig. 1.8).
55
  The high-mannose N-glycans 
typically have two to six additional mannose residues attached to the common core 
structure, whereas complex-type contain several outer branches (bi-, tri-, and tetra-
antennary) that typically ends with a sialyl lactosamine sequence.  The complex-type N-
glycans also could have N-acetylglucosamine residue attached to the core mannose 
residue and a fucose residue to the innermost N-acetylglucosamine residue.  The hybrid-
type N-glycans share both features of high-mannose and complex-type oligosaccharides 
(N-acetylglucosamine residue attached to the core mannose residue).  Furthermore, 
some N-linked glycoproteins can undergo further post-translational modifications, 
including phosphorylation of mannose residue, sulfation of mannose and N-
acetylhexosamine residues and O-acetylation of sialic acid residue.   
 
Figure 1.9 Diagrammatic representation of N-linked glycoprotein phosphorylation. 
One example of post-translational modification is phosphorylation of mannose residues 
of the N-glycan attached to the lysosomal hydrolases, which are destined to be 
transported to the lysosomes where these enzymes are involved in the degradation of 
many different substrates accumulated inside the cell.
56
  Like all N-glycosylated 
proteins, lysosomal hydrolases are synthesised and N-glycosylated in the ER.  When 
they move along the secretory pathways in the Golgi, these proteins are selectively 
recognised by UDP-N-acetylglucosamine 1-phosphotransferase (GlcNAc-1-P-Tase) 
(Fig. 1.9).
57, 58
  This enzyme initiates the transfer of GlcNAc-1-P from the UDP-
GlcNAc to C-6-hydroxyl group of selected high-mannose type residues of the 
lysosomal hydrolases.
59
  The enzyme is capable of transferring GlcNAc-1-P to three 
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different mannose residues and can accept substrates that already carry one 
phosphorylated mannose residue in high-mannose oligosaccharides.
60
  The next step 
involves the removal of terminal GlcNAc residue by N-acetylglucosamine-1-
phosphodiester α-N-acetyl-glucosaminidase (uncovering enzyme) in order to expose 
mannose-6-phosphate (M6P) (Fig. 1.9).
61
  The M6P residue of the glycoprotein serves 
as a recognition site for cation-dependent and cation-independent mannose-phosphate 
receptors (MPR) in order to transport labelled hydrolases into the lysosomes (Fig. 
1.10).
62
  The MPRs are transmembrane glycoproteins localised in the trans-Golgi 
compartment, where they bind to M6P residue of the proteins at pH 6.5-6.7 and release 
the lysosomal hydrolases at pH 6 inside late endosomes.  Interestingly, some lysosomal 
hydrolases can escape binding to the MPR in the trans-Golgi compartment and end up 
secreted into the extracellular fluid.  The MPRs then travel to the plasma membrane to 
retrieve the escaped lysosomal hydrolases and return them back to the lysosome.
63
   
 
Figure 1.10 Diagrammatic representation of phosphorylation of a newly synthesised N-linked lysosomal 
glycoprotein and it subsequent transfer to the lysosome.63   
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1.2.4 Eukaryotic O-linked glycoproteins  
O-Glycosylation is the second major type of post-translational modification of proteins.  
During this modification a single sugar residue is covalently attached to an amino acid 
containing hydroxyl group, followed by stepwise elongation of carbohydrate moiety to 
form a rather compact structure.  Furthermore, any amino acid that contains hydroxyl 
groups such as serine, threonine, tyrosine, hydroxyproline and hydroxylysine can be 
implicated in the process of glycosylation compared to N-glycosylation, where the only 
amino acid which can be glycosylated is asparagine.  This type of modification occurs 
with either α- or β-anomeric configuration at the carbohydrate protein site compared to 
only β-anomeric configuration present in N-glycoproteins.  The O-linked glycans are 
less easy to characterise due to their diversity.  However, depending on the nature of the 
glycosidic bond between a single sugar residue and the protein there are several types of 
O-glycosylation.  In mammals, the O-linked N-acetylgalactosamine (GalNAc) to serine 
or threonine residues is known as mucin-type glycosylation;
64
 in protozoa, the O-linked 
N-acetylglucosamine to serine or threonine residues is also known as mucin type 
glycosylation
65
 and in plants the O-linked galactose to hydroxyproline is known as 
arabinogalactan (AGP) proteins.
25
  In addition, many other sugars such mannose, 
fucose, glucose, and xylose are known to be O-linked to proteins.
66
   
Mucin type O-glycosylation is initiated by the transfer of single GalNAc residue to the 
serine or threonine amino acid of protein catalysed by UDP-GalNAc:polypeptide N-
acetylgalactosaminyltransferases (GalNAcT).
67
  In the past, the search for the specific 
consensus sequence for this type of glycosylation has been unsuccessful, thus 
concluding that the enzyme responsible for this transfer had a broad specificity.  Only 
recently, it has been realised that there are more than one enzyme involved in the first 
step of O-glycosylation in mucins.  At the moment, there is evidences for about 20 
isoforms of GalNAcT present in humans,
68
 which makes mucin-type O-glycosylation 
unique compared to N-glycosylation, which is controlled by only one protein complex 
(OT) (Fig. 1.11 A).  Within this family of isoforms, there is hierarchy of action, where 
certain members act as initiating transferases and add GalNAc residue to unmodified 
polypeptide, while others favour previously glycosylated proteins adding the GalNAc 
residue adjacent to previous site of glycosylation.
69
  This hierarchy of enzymatic 
activities allows the build-up of rod-like structures of mucin.  Indeed, after the initial 
addition of GalNAc residue, the chain is extended in a stepwise fashion to generate the 
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vast majority of glycan structures (Fig. 1.11 A).  Core 1 is the most common 
modification which is known as Tn antigenic structure.
70
  This structure is formed by 
the action of core 1 galactosyltransferase (Gal-T), that transfer galactose residue to the 
existing GalNAc-α-1-O-serine or threonine moiety to form a β-1,3-linkage.  Conversely, 
core 3 is generated by β-1,3-GlcNAcT, this time by addition of GlcNAc residue to the 
existing GalNAc-α-1-O-serine or threonine moiety.71  Core 1 and 3 structures can be 
further modified to form core 2 and 4 by β-1,6-GlcNAc-T action.  These core structures 
are further extended with other sugars such as Gal, GlcNAc, Fuc and sialic acid, 
creating linear or branched short chain structures.  The O-glycan structure in mammals 
is usually terminated with the negatively charged sialic acid that constitutes a target for 
various lectins and antibodies.
72
 
 
Figure 1.11 Structural variation of the mucin type O-glycans.  (A) Biosynthesis of mucin type O-glycans in 
mammals.  (B) Representative examples of mucin type O-glycans in Trypanosoma cruzi.64, 65   
Serine and threonine O-glycosylation through α-N-acetylglucosamine-linkages in 
protozoa is also known as a mucin type O-glycosylation (Fig. 1.11 B).  This type of 
modification is mainly found on the mucin proteins located on the cell-surface of 
pathogens, such as Trypanosoma cruzi.
65
  Trypanosoma cruzi is an intracellular parasite 
and it is the etiologic agent of Chagas’ disease.  Protein glycosylation in this parasite at 
different developmental stages is the important post-translational modification that 
causes host-parasite interactions and determines the outcome of infection.  The protein 
domain of Trypanosoma cruzi mucin (Tc-mucin) is rich in threonine and serine with O-
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glycosylation occurring more frequently on the threonine residue.
73
  The first step of O-
glycosylation is initiated in the Golgi apparatus by the UDP-GlcNAc:polypeptide N-
acetylglucosaminyltransferase (ppGlcNAcT), which catalyse transfer of GlcNAc 
residue to the threonine side chain leading to formation of GlcNAc-α-1-O-threonine 
linkages.
74
  These residues are further extended by addition of galactopyranose (Galp) 
and galactofuranose (Galf) monosaccharides through the action of  β-1,6; β-1,4; β-1,3; 
β-1,2-Galp-transferases and β-1,4; β-1,2-Galf-transferases (Fig.1.11 B).  Terminal β-
linked galactose residues serve as substrates for the parasite-specific trans-sialidases 
that transfer sialic acid from exogenous host donor to the parasite acceptor (see Chapter 
4).
75
 
 
1.3 Glycosyltransferases involved in the biosynthesis of 
glycoconjugates 
GTs are a large family of enzymes, which can be found in the CAZy database (EC 
2.4.x.y, CAZy).
76
  They consist of around 200,000 GTs designated by sequence 
homology into 97 families.  GTs catalyse the transfer of a sugar moiety from either a 
soluble or a lipid-linked activated sugar to acceptor substrates, such as oligosaccharides, 
peptides, lipids or small molecules.  This leads to formation of glycosidic bonds, 
thereby creating a diverse range of saccharides and glycoconjugates in nature.  
According to the stereochemistry of the substrate and product glycosyltransferases can 
be classified as either inverting or retaining enzymes.
77
  Inverting GTs transfer sugar 
residues from the sugar nucleotide with inversion of stereochemistry of the anomeric 
centre e.g. UDP-α-Glc to β-glycoside.  In contrast, retaining GTs retain the same 
stereochemistry around the anomeric centre e.g. UDP-α-Glc to α-glycoside. 
The mechanism for the inverting GTs is well understood and follows a direct 
displacement via an SN2-like mechanism (Scheme 1.1 A).  During the enzymatic 
reaction, a side chain in the active site acts as a base catalyst and deprotonates the 
nucleophilic acceptor substrate, which in its turn attacks at C-1 position of the 
nucleotide donor substrate.  The C-1 atom of the donor substrate forms an 
oxocarbenium-ion-like transition state leading to formation of the glycosidic bond 
between the donor and acceptor with the inversion of the stereochemistry at the 
anomeric carbon.   
18 
 
In contrast, the catalytic mechanism used by retaining GTs is still debatable.  The 
current literature describes two hypothetical mechanisms first is a double-displacement 
mechanism and second is a SNi-like or “internal return” mechanism.  During a double-
displacement mechanism, a suitable base on the protein side chain attacks the donor 
substrate and forms a glycosyl-enzyme intermediate with inversion of the configuration 
at the anomeric carbon.  In the second displacement, the nucleotide phosphate leaving 
group acts as a base and deprotonates the hydroxyl group of the incoming acceptor 
substrate.  Subsequently, the acceptor substrate attacks the glycosyl-enzyme 
intermediate resulting in transfer of glycosyl moiety to the acceptor with inversion of 
configuration at the anomeric carbon (Scheme 1.1 B).  This method was based on the 
knowledge about mechanism of retaining glycosidases;
78
 however, despite numerous 
efforts no such glycosyl-enzyme intermediates have been trapped.  The second proposed 
“internal return” mechanism (Scheme 1.1 C) suggests a direct attack of the acceptor 
from the same side as the leaving group departures leading to formation of new 
glycosidic linkage on the same side of the sugar ring.  Currently, this mechanism was 
supported by mechanistic evidence utilising trehalose-6-phosphate synthases.
79 
GTs involved in the biosynthesis of a majority variety of glycoconjugates described 
above are membrane-bound enzymes located in the ER and Golgi apparatus.
80
  
Subcellular localisation of GTs has been experimentally confirmed by overexpressing 
them fused with green or red fluorescent proteins in the system of interest and then 
examining their intracellular distribution using confocal fluorescent scanning 
microscopy.
81
  The ER and Golgi apparatus GTs are type II transmembrane enzymes, 
with a short single transmembrane domain flanked by a short amino-terminal domain 
(cytosolic tail), stem region and a large C-terminal domain that possess a catalytic 
domain that points to the lumen of the ER and Golgi apparatus.  GTs are difficult to 
study when compared to soluble enzymes because of their microsomal membrane 
association, which presents a major challenge for the isolation of this type of enzymes 
from the membrane with retained enzymatic activities.  Often, the isolation leads to 
denaturation with subsequent loss of activity.  There are also additional difficulties to 
produce them in high yield in the recombinant form and to obtain crystal structures as 
they often exist as multi-domain proteins
48
 and can undergo substantial conformational 
changes.   
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Scheme 1.1 Mechanisms for inverting and retaining glycosyltransferases.  (A) Direct displacement SN2 
mechanism for inverting glycosyltransferases.  (B) Double displacement mechanism for retaining 
glycosyltransferases.  (C) Internal return mechanism. 
 
1.4 Methods to probe activities of glycosyltransferases 
In order to assess GT activities in both recombinant and cell-free systems a broad range 
of assay formats, such as radiolabelled, fluorescent, chromatographic, spectroscopic and 
immunological, were developed and employed to detect one or more product species 
from GT biotransformations.  Most assays require insertion of either a radiolabel or a 
fluorophore into a donor or acceptor substrates in order to detect GT enzymatic 
activities because during formation of glycosidic bond there is no obvious fluorescence 
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or absorbance change.  Presence of the label allows monitoring of enzymatic reactions 
through either depletion of donor or acceptor as well as separation and detection of 
products formed during these enzymatic reactions.  Furthermore, some excellent label-
free pH-sensitive and mass spectrometry-based assays have been developed and used to 
investigate GT substrate specificities.  Two excellent reviews by Palcic
82
 and Wagner
83
 
summarise all experimental formats currently used to detect GT and in this thesis 
section only radiolabelled and fluorescent methods are discussed.   
 
1.4.1 Radiolabelled methodologies to probe glycosyltransferase activities 
Radiolabelled assays are the most popular and generic methods to probe 
glycosyltransferase activities.  Indeed, they provide high sensitivity allowing detection 
of low level of enzymatic activities in natural sources.  For this reason, they have been 
used in a variety of different studies.
82
  Radiolabelled assays mainly utilise radiolabelled 
3
H- or 
14
C-labelled sugar nucleotides.  All mammalian radiolabelled donors are 
commercially available and some radiolabelled acceptors, such as lipids can also be 
found.  Generally, during the assay a radiolabelled donor and acceptor substrate are 
incubated with a recombinant enzyme of interest or a crude extract of microsomal 
membranes, which contain membrane-bound glycosyltransferases.  During the 
incubation, the radiolabelled monosaccharide is transferred from the activated donor to 
the acceptor leading to formation of radiolabelled products.  The typical assay can be set 
up either in the discontinuous or continuous fashion.  During the discontinuous assays 
the enzyme of interest is incubated with a specific acceptor and radiolabelled donor, and 
the whole reaction is quenched at the time where the formation of product is still linear.  
In contrast, in discontinuous assays aliquots are taken at set time intervals for the 
analysis and quantification of formed products.
84
  Subsequently, quantification of 
radiolabelled products can be performed by standard liquid scintillation counting.  
Purification of radiolabelled products from unreacted radiolabelled starting material is 
achieved by a variety of methods, which depend on the type of acceptor used.  In 
general, most carbohydrate acceptors are neutral and water soluble; therefore, a 
negatively charged unreacted radiolabelled donor can be removed by anion exchange 
column.  In this way, unreacted donor binds to the column and the soluble product 
elutes with water.  In contrast, enzymatic reactions that produce glycosides containing 
large hydrophobic aglycones can be easily purified by a single extraction with organic 
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phase
85
 or by application of reverse phase column cartridges.
86
  Obtained radiolabelled 
products are subjected to further analysis using thin layer chromatography (TLC), where 
products are identified by co-migration with known standards, as well as HPLC and 
mass spectrometry.  The chemical structure can be assigned using enzymatic or 
chemical degradation followed again by TLC analysis.
87, 88
 
The above radiolabelled methods are laborious and time consuming requiring extensive 
product separation and purification.  In order to address these issues scintillation 
proximity assays were developed and used to detect α-1,3-fucosyltransferase (FucT) 
activities responsible for the biosynthesis of sialyl Lewis X from human leukocytes.
89, 90
  
This method is based on the principle of scintillation proximity and utilises microscopic 
beads coated with a suitable acceptor that contain a scintillant inside the beads.  During 
these assays the microspheres impregnated with acceptors are incubated with the 
radiolabelled nucleotide donor and enzyme.  The transfer of the radiolabelled donor to 
the acceptor brings the radio-emitter in close proximity to the microsphere resulting in 
the emission of light detected by photometer (Fig. 1.12).   
 
Figure 1.12 Diagrammatic representation of scintillation proximity assay utilising radiolabelled donor and 
impregnated bead to detect α-1,3-fucosyltransferase activity.89  During the biotransformation fucosyltransferase 
transfer fucose residue to the acceptor coated on the SPA bead resulting in a scintillation proximity signal increase.  
SPA (scintillation proximity assay). 
 
1.4.2 Fluorescence-based methodologies to probe glycosyltransferase activities 
Fluorescence-based methodology provides high sensitivity, operational simplicity, and, 
most importantly, the fluorescence-based assays are free from radioactivity, so the 
outcome could be analysed with any modern analytical instrumentation.  In order to 
assess glycosyltransferase activities a fluorophore can be chemically attached to either a 
donor or an acceptor substrate depending on the prerequisite of a particular 
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investigation.  In almost all fluorescence-based assays the focus lies on a small family 
of fluorophores, such as BODIPY (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene), 
fluoresceins, rhodamines and umbelliferones (coumarin-based) (Fig. 1.13).
91
   
 
Figure 1.13 Chemical structures of widely used fluorophores. 
These are fairly large aromatic compounds that can influence either substrate 
association with membranes or substrate solubility, and all provide different fluorescent 
properties.
91
  BODIPY-based fluorophores possess unique photophysical properties, 
such as a small Stokes shift, high fluorescent quantum yield, sharp excitation and 
emission peaks and high molar extinction coefficient.
92
  Moreover, this fluorophore is 
not affected by solvent polarity and pH, compared to fluorescein- and coumarin-based 
fluorophores.  The common limitations of this fluorophore are its poor water solubility 
and lack of functional groups for conjugation; however, introduction of various 
substituents can be modulated to suit various applications.
93
  Fluorescein-based 
fluorophores possess good water solubility, high fluorescent yield and it has two groups, 
such as carboxyl and hydroxyl group, which can be used to attach acceptor or donor.  
Nevertheless, these types of fluorophores have several significant drawbacks, including, 
pH sensitive fluorescence and especially high rate of photobleaching that requires 
storage and all manipulations to be performed in the dark.  Rhodamine-based 
fluorophores have good photostability compared to the fluorescein-based fluorophores, 
a high extinction coefficient and high fluorescence quantum yield.  Although, 
conjugation of rhodamine-based fluorophores to protein known to precipitate from 
solution.  Coumarin-based fluorophores are the most interesting set of fluorophores 
because their photophysical properties (especially quantum yield) can be altered by 
adding different substituents on the coumarin scaffold.
94
  They are fairly small and easy 
to synthesise but they could also show pH sensitivity, due to the presence of hydroxyl 
group at the 7-position of coumarin rings but can be modified to avoid this limitations.  
Moreover, placing the azido group at the 3-position quenches the fluorescence 
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completely and it can be restored on formation of the triazole ring (see Chapter 2 
section 2.1). 
 
Fluorescence-based methodologies utilising sugar nucleotides and acceptors 
Naturally occurring sugar nucleotide donors are poor light emitters and therefore a 
variety of strategies have been developed to generate fluorescent donor analogues to 
target GTs activities (reviewed in Wagner’s publication83).  In these strategies, a 
fluorophore is always attached to the donor site that does not interfere with the active 
site of investigated enzymes.  One of these fluorescent-based methodologies utilises a 
ligand-displacement format because it provides a more practical and cheaper way to 
identify GT enzyme inhibitors where labelling of acceptors require substantial time and 
effort.  This assay simply monitors changes in fluorescence polarisation occurring when 
the fluorescent donor substrate analogues bind to active sites of GT enzymes and 
following their displacement by inhibitors introduced into the reaction mixture (Fig. 
1.14).  The general principle underlying these assays is that the fluorescence 
polarisation of the fluorescent label is lower when it is attached to a small molecule and 
higher when it is attached to a larger one.
95
   
 
Figure 1.14 Schematic representation of fluorescence-based ligand-displacement assay for inhibitory 
screening.96 
More specifically, this method has been used to identify inhibitors of O-GlcNAc 
transferase, which, as discussed in section 1.2.4, transfer N-acetylglucosamine from 
UDP-GlcNAc to serine and threonine residues of newly synthesised proteins.  For this 
assay fluorescent UDP-GlcNAc donor was generated by conjugation of fluorophore to 
the N-acetyl functional group of UDP-GlcNAc (Fig. 1.15 A(i)).
97
  This donor substrate 
was then screened in HTS assays against library of 64,416 commercial compounds 
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using a microplate reader to measure changes in fluorescent polarisation.  The output 
identified 102 compounds which acted as very strong inhibitors.  They identification 
prompted authors to look into effect of these compounds in cell cultures where 
reduction in O-GlcNAc transferase activity could assess the biological function of this 
enzyme in vivo; however, no further publication to illustrate this point has been 
produced.  
 
Figure 1.15 Chemical structures of selected fluorescently-labelled sugar nucleotides and acceptor substrates 
used in the literature GT assays.  (A) Fluorescently labelled sugar nucleotides;83 (B) Fluorescently labelled 
acceptor substrates.  
An alternative approach to the one described above looked at the installation of a 
fluorophore into the nucleotide part of the GDP-Man donor following utilisation of this 
modified sugar nucleotide to screen inhibitor candidates of mycobacterial α-1,6-ManT, 
such as PimA and PimB’ (section 1.2.2).  The enzymes involved in the biosynthesis of 
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LM represent prospective targets for novel chemotherapeutic agents.  In this study, a 
series of GDP-Man donor analogues, which incorporated aryl or heteroaryl substituents 
at position 8 on the guanine nucleobase were synthesised by Suzuki-Miyaura cross-
coupling chemistry (Fig. 1.15 A(ii)).
98
  The extension of the aromatic system with aryl 
or heteroaryl substituents resulted only in subtle differences in fluorescence 
characteristics of these compounds, having λem around 400 nm and similar Stokes shifts.  
In further research performed by Besra’s group, only the brominated derivative of GDP-
Man, used as a precursor for Suzuki-Miyaura cross-coupling reaction, has been co-
crystallised with PimB’ in order to assess structural and mutational analysis of the 
active site.
99
 
Fluorescent labelling of acceptors has been used in HTS screening to check for 
activities of engineered glycosyltransferases and identify mutants which possess the 
highest activities.  One of these studies described in the literature
100
 used fluorescently 
labelled acceptors to identify activities of engineered sialosides in intact Escherichia 
coli cells by fluorescence-activated cell sorting (FACS).  This technique is based on 
using flow cytometry to separate intact cells according to their size and fluorescence.
101
  
In this assay, a series of lactose and galactose acceptors fluorescently labelled with 
coumarin, fluoresceine and BODIPY fluorophores were synthesised (Fig. 1.15 B(i)) 
with prerequisite that these acceptors substrates can freely be transported in and out of 
cells.  Engineered cells were then incubated with fluorescent acceptors and, as the 
reaction took place, sialylated galactoside products were trapped inside the cell due to 
their size and charge, while unreacted acceptor substrates were washed away.  The 
washing step was important to get rid of any fluorescent background in order to 
facilitate detection of minimal enzymatic activities.  In the last step intact cells were 
subjected to the fluorescence-activated cell sorting.  Using this method, it was possible 
to screen libraries of ˃106 engineered mutants in less than two hours and to detect 
mutants with increased enzymatic activities compared to the wild type.  In addition, it 
was demonstrated that using fluorescence-activated cell sorting techniques two different 
fluorescent acceptors with different fluorophores attached could be used in parallel and 
their transfer reactions monitored simultaneously.   
Another fascinating study described in the literature was performed in Palcic’s group.102  
In this study, fluorescently labelled acceptor substrate analogues were utilised to analyse 
glycosphingolipids (glycolipid) metabolism on the single cell scale by capillary 
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electrophoresis (CE) with laser induced fluorescence (LIF) detection.
102
  To begin with, 
fatty acids of the ceramide lipid moiety of GM1 and lactose glycosphingolipid were 
replaced with a fluorophore, such as BODIPY and tetramethylrhodamine (Fig. 1.15 
B(ii)).  The fluorescent GM1 and lactose glycolipid were then modified in vitro 
employing recombinant sialyltransferases and commercially available glycosidases 
resulting in a variety of fluorescent glycolipid structures.  These fluorescently labelled 
glycolipids intermediates were used as standards in CE-LIF analysis.  Incubation of 
fluorescent lactose and GM1 glycolipids with cells culture and subsequent product 
separation using CE-LIF method revealed detection of glycosyltransferases as well as 
hydrolase activities involved in the metabolism of glycosphingolipids (Fig. 1.16 A and 
B). 
 
Figure 1.16 Representative example of enzymatic reactions of fluorescent GM1 and lactose acceptor substrates 
and their products derived from the glycolipid metabolism detected by CE-LIF. 
 
1.5 Requirement for the new fluorescence-based methodology 
Despite the sensitivity and applicability of radiolabelled assays, they can be complicated 
by a number of factors.  There is a limited availability of radiolabelled sugar 
nucleotides, especially in the case of complex glycosides that come from bacterial or 
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plant systems.  The separation of reaction mixtures using ion-exchange columns can 
also generate high background values due to donor decomposition leading to high 
scintillation count reading.  The requirement for specially designed and equipped labs, 
personnel trained in handling radiolabelled materials and long preparations of health 
hazard assessments and standard operating procedures extends the preparation and 
experimental times.  Radiolabelled sugar nucleotides that contain 
3
H or 
14
C have low or 
moderate specific activities, therefore requiring long processing times to obtain 
meaningful results; for example, it can take up to a week to develop a TLC plate using 
autoradiography.  Other limitations include health hazards associated with handling and 
waste disposal of radioactive material.   
Fluorescence-based methodologies described above allow screening of already 
identified and overexpressed glycosyltransferases involved in biosynthesis of 
glycoconjugates.  These assays illustrate that modification of acceptors or donor with a 
fluorophore does not impair activities of the glycosyltransferases, and these enzymes are 
still able to transfer sugar residue from sugar nucleotide to the acceptor analogues.  
Therefore, there is scope to develop a fluorescence-based methodology to probe 
activities of membrane-bound glycosyltransferases involved in the biosynthesis of 
various glycoconjugates.  The research has shown that donors modified on the 
nucleobase are good substrates and can be compatible with enzyme active site.  It is less 
likely that this strategy would be applied because modification of donor with a 
fluorophore would require additional chemical synthesis of donor as well as acceptor, 
which is not always trivial and easily applicable.  In contrast, it is more plausible to 
develop a new fluorescence-based methodology that incorporates a fluorophore on the 
acceptor and especially on the aglycone part of the molecule because it could aid with 
substrate presentation and recognition by membrane-bound enzymes and it would not 
interfere with the active site of detected enzymes.  Furthermore, this would give the 
desired experimental flexibility as well as provide opportunity to investigate the effect 
of aglycone hydrophobicity and bulkiness on enzymatic activities of investigated 
membrane-bound glycosyltransferases.   
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1.6 Project aims and objectives 
The initial aim of this project was to design several novel fluorescent based 
methodologies which can probe activities of membrane-bound glycosyltransferases 
responsible for the biosynthesis of multiple glycoconjugates from various biological 
systems with the purpose to replace traditional radiolabelled methods used in the 
laborattory environment.  The prerequisite of these methodologies would be sensitive, 
quick and simple in operation and to employ standard analytical techniques for product 
analyses.  
The second aim was to validate and benchmark designed fluorescence-based 
methodologies against the established radiolabelled assays used to detect 
glycosyltransferase activities involved in the biosynthesis of lipoarabinomannan in 
Mycobacterium smegmatis and GPI anchors in Trypanosoma brucei.  Furthermore, 
fluorescence-based methodologies should be able to illustrate diversities in targeting 
several membrane-bound glycosyltransferases from two different organisms so in the 
future it could be used for detection of various enzyme activities with little 
modifications.   
The third aim was to utilise the most promising fluorescence-based methodology to 
detect glycosyltransferases responsible for the biosynthesis of N-glycans and GPI 
anchors in Euglena gracilis in order to use it as a model organism. 
An additional aim of this project was to synthesise a series of Trypanosoma cruzi mucin 
glycan mimetic based on the linear and cyclic 1,4/1,5-triazole-linked oligomers utilising 
Cu(I)-catalysed click reactions of an azido-alkyne-functionalised galactose building 
block.  Subsequently, to test these linear and cyclic 1,4/1,5-triazole-linked oligomers for 
their ability to act as substrates for T. cruzi trans-sialidases with the scope to illustrate 
their potential ability to block T. cruzi macrophage invasion.  
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2 Development and validation of fluorescence-based 
methodologies to probe biosynthesis of glycoconjugates  
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2.1 Underlying aspects of fluorescence-based methodologies 
The primary aim of this study was to design and develop a universal fluorescence-based 
methodology that is capable of probing membrane-bound glycosyltransferases (GTs) 
involved in the biosynthesis of glycoconjugates in a variety of biological systems.  In 
general, we envisaged our fluorescence-based methodology would incorporate the 
chemical synthesis of a fluorescently labelled acceptor substrate capable of mimicking 
the authentic intermediates involved in the biosynthesis of a number of glycoconjugates.  
The labelled acceptor would then undergo enzymatic transformation in the presence of a 
sugar nucleotide and a crude microsomal membrane extract (ER/Golgi), with 
subsequent product visualisation by thin layer chromatography (TLC), product 
purification by high performance liquid chromatography (HPLC) and product analysis 
using a variety of analytical, spectroscopic, and enzymatic digestion methods (Fig. 2.1).   
 
Figure 2.1 General outline of fluorescence-based methodology to detect enzymatic activities of membrane-
bound glycosyltransferases. 
Three fluorescence-based approaches were initially considered.  Methodology I includes 
chemical syntheses of a non-fluorescent and fluorescent glycoside acceptor substrates 
with a hydrophobic linker that incorporates either a “turned off” or an activated 
coumarin-based fluorophore, such as 3-azido-7-hydroxycoumarin (Table 2.1 
Methodology I).  In the “turned off” state this label possesses no fluorescence due to a 
quenching effect from the electron rich α-nitrogen of azido group.  However, once it 
undergoes the azido-alkyne 1,3-dipolar cycloaddition under click conditions the 
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fluorescence of azido coumarin-based fluorophore is “turned on” or activated due to 
extension of the conjugation exhibited through the 1,2,3-triazole ring formation on the 
coumarin ring  (Scheme 2.1 A).
103, 104
   
 
Scheme 2.1 Azido coumarin-based fluorophore becomes fluorescent upon reaction with strain or terminal 
alkyne to form a triazole ring under click conditions.  (A) A general scheme to represent “turned off and on” 
fluorescent properties of 3-azido-7-hydroxycoumarin.  (B) Underlying chemical reactions of each methodology.  
Fluorophores are shown in green. 
The activation of the “turned off” azidocoumarin-based fluorophore could be performed 
either before or after enzymatic transformations.  In both cases, activation of an 
azidocoumarin-based fluorophore happens as result of azido-alkyne 1,3-dipolar 
cycloaddition reaction with a triple bond of the cyclooctyne under Cu(I)-free strain-
promoted click conditions (Scheme 2.1 B, Methodology I).
105
  Fluorophore activation 
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after the enzymatic transformations would be performed directly on the TLC plate in 
order to have means of visualising the progress of enzymatic reactions.  Presence of 
fluorophore allows tracking of fluorescent material throughout manipulations, quick 
access to information on the reaction progress by TLC methods and product separation 
and analysis.   
Methodology II and III include chemical syntheses of a non-fluorescent and fluorescent 
glucoside acceptor substrates with a hydrophobic linker that contains either a terminal 
alkyne group, required for the attachment of fluorescent label or an activated 
fluorophore.  The choice of fluorophore attached to the terminal alkyne functional group 
would depend entirely on the analytical method to be used in further analyses (Table 2.1 
Methodology II and III).  In methodology II we proposed to use a “turned off” 
azidocoumarin-based fluorophore that undergoes an azido-alkyne 1,3-dipolar 
cycloaddition with a terminal alkyne group under Cu(I)-catalysed click conditions 
(Scheme 2.1 B, Methodology II).
106
  The labelling of the terminal alkyne group with the 
azidocoumarin-based fluorophore before enzymatic transformations would give a set of 
fluorescent compounds that could be visualised on TLC plates without further 
modification and that could be taken forward for further purification and analysis.  The 
labelling of the terminal alkyne group with the azido coumarin-based fluorophore after 
enzymatic transformations would be done on the reaction mixture in solution to aid with 
product visualisation on the TLC plate (Table 2.1 Methodology II).   
In methodology III, we proposed to use a negatively charged 8-azidopyrene-1,3,6-
trisulfonic acid (AzPTS) that undergoes an azido-alkyne 1,3-dipolar cycloaddition with 
terminal alkyne group of the acceptor under Cu(I)-catalysed click conditions (Scheme 
2.1 B, Methodology III).  The azido group on the AzPTS dramatically quenches the 
fluorescence resulting in 24-fold reduction in the quantum yield compared to 8-
azidopyrene-1,3,6-trisulfonic acid (APTS), and on formation of the 1,2,3-triazole ring 
could be restored.
107
  The labelling of glycoside acceptor with AzPTS after enzymatic 
transformation would allow product separation and identification by the capillary 
electrophoresis with laser induced fluorescence detection (CE-LIF) (Table 2.1 
Methodology III).
108
  In past research in Field’s group, a related mode of labelling has 
been successfully used by Dr. Goetz to evaluate the synthetic pathways of 
polysaccharides present in plant cell walls.
109
  In these studies, labelling was achieved 
through reductive amination of reducing sugar terminus with 8-aminopyrene-1,3,6-
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trisulfonic acid (APTS).  The detection of APTS-labelled products proved to be highly 
sensitive, allowing detection on fluorescent products on femtomole scale.  Indeed, CE-
LIF techniques of separation and detection have been successfully used in other studies 
to probe fatty acid, phosphoinositide and sphingolipid metabolism.
110-112
  However, it 
should be noticed that this technique not the most robust and adaptable method. 
 
Methodology I Methodology II Methodology III 
Chemical synthesis of acceptors 
  
 
  
Enzymatic reaction 
 
TLC visualisation using 
Strain-promoted click reaction 
 
Cu(I)-catalysed click reaction 
  
TLC visualisation   
Capillary 
electrophoresis 
 
Product separation Product separation 
Product analyses  Product analyses  
 
Table 2.1 Outline schemes of fluorescence-based methodologies for pre- and post-enzymatic transformation 
labelling in detecting enzymatic activities of membrane-bound glycosyltransferases. 
 
 
 
Work flow 
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2.2 Design of non-fluorescent and fluorescent mannoside substrates 
for fluorescence-based methodologies 
Non-fluorescent and fluorescent monosaccharide and disaccharide acceptor substrates 
were designed to have mannose residue as well as α-1,6-mannosidic linkage similar to 
that present in authentic glycoconjugate structures, such as GPI anchors, N-glycans and 
lipomannans (Fig. 2.2).  Such monosaccharides and disaccharides could mimic the 
authentic intermediates involved in the biosynthesis of these glycoconjugates during 
biotransformation.  In essence allowing generic mannoside acceptors to be used in the 
detection of α-1,6-ManT activities in Mycobacterium smegmatis and α-1,3-GalT 
activities in Trypanosoma brucei required for initial validation and benchmarking of 
florescence-based methodologies against established radiolabelled assays as well as 
further investigation into biosynthesis of N-glycans and GPI anchors in Euglena 
gracilis.  
 
Figure 2.2 Schematic representation of structures of glycoconjugates from Trypanosoma brucei and 
Mycobacterium smegmatis and synthetic fluorescent and non-fluorescent glycoside acceptors to be used in 
detection of glycosyltransferase activities.  
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Previous research on the enzyme specificities of the Dol-P-Man:GlcNH2-PI α-1,4-
ManT, which is responsible for transfer of mannose residue to the GlcNH2-PI 
intermediate during the GPI anchor biosynthesis in Trypanosoma brucei, showed that 
the acceptor substrate required the presence of full diacylglycerol structure.
113
  In these 
investigations, synthetic GlcN-inositol-glycerol substrate that lacks two fatty-acid 
components, showed much less enzymatic efficiency compared to the natural substrate 
D-GlcN-α-1,6-D-myo-inositol (GlcN-PI) that contains 1,2-diacylglycerol fatty acid.  The 
removal of glycerol or glycerol phosphate moieties from the synthetic acceptor further 
reduced enzymatic activities and the removal of inositol resulted in hardly any activities 
(Fig. 2.3).  These data suggested that the presence of lipid moiety is important in 
substrate presentation and recognition by membrane bound enzymes.   
 
Figure 2.3 Authentic and synthetic acceptor substrate analogues of D-GlcNα-1,6-D-myo-inositol-1-PO4-sn-1,2-
diacylglycerol utilised in the literature research.113 
Other research on acceptor substrate specificities of the GlcNAc-phosphatidylinositol 
(GlcNAc-PI) de-N-acetylase enzyme present in T. brucei showed that a synthetic 
acceptor with a simple C18:0 alkyne chain in place of sn-1,2-dipalmitoylglycerol 
proved to be a better substrates.
114
  This suggests that the precise lipid structure and 
stereochemistry are not essential for substrate recognition in GlcNAc-PI de-N-acetylase.  
Furthermore, the alkyl chain can be replaced with steroidal moieties without decrease in 
the GlcNAc-PI de-N-acetylase activitiy.
115
  Evidently, if the lipid moiety provides 
enough hydrophobicity to associate with the lipid bilayer, the activity of this enzyme 
remained unperturbed.  
Based on these research data, all synthetic non-fluorescent and fluorescent acceptor 
substrates used in our florescence-based methodologies incorporated a hydrophobic 
aglycone (Fig. 2.4).  This gives the desired experimental flexibility as well as provided 
opportunity to investigate the effect of aglycone hydrophobicity and bulkiness on 
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enzymatic activities of investigated membrane-bound glycosyltransferases.  In 
methodology I, the aglycone of non-fluorescent acceptor incorporates a “turned off” 
fluorophore that on extension with cyclooctyne imposes slight bulkiness to the 
hydrophobic linker (Fig. 2.4 Methodology I).  In methodology II, the aglycone of the 
non-fluorescent acceptor substrate carries 5-hexynyl linker that can be extended through 
the attachment of fluorophore to increase the length and hydrophobicity (Fig. 2.4 
Methodology II).  Potentially, these modifications could affect membrane association 
and presentation of non-fluorescent and fluorescent acceptor substrates to the 
investigated membrane-bound enzyme.  In addition, the fluorophore in the hydrophobic 
linker imparts important spectroscopic properties which conveniently would assist with 
product detection. 
 
 
Figure 2.4 Structures of non-fluorescent and fluorescent acceptor substrates designed to be used in 
methodology I and II to probe activities of membrane-bound glycosyltransferases.  Fluorophores are shown in 
green. 
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2.3 Chemical synthesis of non-fluorescent and fluorescent α-D-
mannopyranoside derivatives for methodology I 
In order to establish scope and limitations of fluorescence-based methodology I, the 
non-fluorescent α-Man-EtC (2.04) and fluorescent α-Man-EtTC (2.05) compounds were 
synthesised. 
 
2.3.1 Chemical synthesis of non-fluorescent azidocoumarinyl α-D-
mannopyranoside derivatives 
The 2-(3-azido-coumarin-7-yloxy)ethyl α-D-mannopyranoside (α-Man-EtC (2.04)) was 
synthesised from 2-bromoethyl mannoside (2.02) and 3-azido-7-hydroxycoumarin in 
three steps (Scheme 2.2).  Know glycosyl bromide donor (2.01),
116
 was obtained by 
reaction of perbenzoylated mannose with HBr-AcOH in 97% yield.  The glycosyl 
bromide donor (2.01) was activated with AgOTf and reacted with 2-bromoethanol to 
give α-glycoside 2.02 in 83% yield.  The α-configuration of 2.02 was determined by 13C 
NMR spectroscopy of the anomeric carbon signal (δC-1 97.8 ppm, JC-H=171.0 Hz).
117
  3-
Azido-7-hydroxycoumarin was synthesised through cyclisation, hydrolysis and 
diazosation of corresponding 2,4-dihydroxybenzaldehyde and N-acetylglycine 
following a literature procedure in 12% overall yield.
118
  Compound 2.02 was then 
treated with K2CO3 (modified Williamson ether synthesis)
119
 in the presence of 3-azido-
7-hydroxycoumarin and 18-crown-6 to give 2.03 in a moderate 40% yield.  De-O-
benzoylation of 2.03 afforded target α-Man-EtC (2.04) in 71% yield. 
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Scheme 2.2 Synthetic route to 2-(3-azido-coumarin-7-yloxy)ethyl α-D-mannopyranoside.  Reagents and 
conditions: a) NaOAc, Ac2O, reflux; b) HCl/EtOH (v/v 1:1), reflux; c) NaNO2, NaN3, 0 °C; d) Bromoethanol, 
AgOTf, CH2Cl2; e) K2CO3, 18-crown-6, DMF; f) NaOMe, MeOH. 
 
2.3.2 Chemical synthesis of fluorescent coumarinyl α-D-mannopyranoside 
derivative under strain-promoted click conditions 
The hydrophobic aglycone of 2.04 incorporates a “turned off” 3-azido-7-
hydroxycoumarin attached to the carbohydrate moiety through the 2xCH2 linker.  The 
exposed azido group is used to generate fluorescent 2.05 under the strain-promoted 
click conditions,
105
 as depicted in Scheme 2.3.  The synthesis of cyclooctyne was 
performed according to the literature procedure,
120
 starting from commercially available 
cyclooctene, which was first dibrominated to form 1,2-dibromocyclooctane followed by 
two consecutive dehydrobrominations; first with KOt-Bu and then with lithium 
diisopropylamide (LDA) to afford the desired strained cyclic product.  The fluorescent 
α-Man-EtTC (2.05) was then synthesised using strain-promoted reaction with 
cyclooctyne in almost quantitative yield.  Product formation was evident from the 
appearance of new set of signals between 2.96 and 1.55 ppm in 
1
H NMR spectrum that 
corresponded to six CH2 groups of the triazole-fused cyclooctyne ring.  It should be 
noted that compound 2.04 possessed limited stability at room temperature. 
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Scheme 2.3 Synthetic route to fluorescent coumarinyl α-D-mannopyranoside derivative through strain-
promoted click conditions.  Reagents and conditions: a) Br2, CH2Cl2; b) KOtBu, THF; c) LDA, THF, -25 °C; d) 
cyclooctyne, MeOH, rt. 
 
2.4 Chemical synthesis of non-fluorescent and fluorescent α-D-
mannopyranoside derivatives for methodology II 
To establish fluorescence-based methodology II, two non-fluorescent compounds, such 
as monosaccharide H-α-Man (2.07) and disaccharide H-α-Manα-1,6-Man (2.10) as well 
as two fluorescent compounds: α-Man-HTC (2.12) and α-Man-1,6-α-Man-HTC (2.13) 
were synthesised.   
 
2.4.1 Chemical synthesis of non-fluorescent 5-hexynyl α-D-mannopyranoside 
derivatives 
A non-fluorescent monosaccharide H-α-Man (2.07) was synthesised in two steps 
starting from known glycosyl bromide
117
 2.01, as outlined in Scheme 2.4.  The 
glycosylation step was performed upon activation of 2.01 with halophilic promoter 
AgOTf
121
 followed by reaction with 5-hexyn-1-ol, which gave α-glycoside 2.06 in 85% 
yield.  The α-configuration of 2.06 followed from the characteristic anomeric carbon 
signal (δ 98.4 ppm, JC-H=171.9 Hz) in the 
13
C NMR spectrum. 
117
  De-O-benzoylation 
of 2.02 afforded target hexyn-5-yl α-D-mannopyranoside H-α-Man (2.07) in 92% yield.   
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Scheme 2.4 Synthetic route to hexyn-5-yl α-D-mannopyranoside and hexyn-5-yl α-D-mannopyranosyl-1,6-O-α-
D-mannopyranoside.  Reagents and conditions: a) 2.01, AgOTf, CH2Cl2, 5-hexyn-1-ol; b) NaOMe, MeOH; c) TrCl, 
DMAP, BzCl, Py; d) 2.01, AgOTf, CH2Cl2, 2.08; e) NaOMe, MeOH.  
Non-fluorescent disaccharide H-α-Manα-1,6-Man (2.10) compound was synthesised in 
three steps using α-glycoside 2.07 as a starting material (Scheme 2.4).  The 6-OH group 
of 2.07 was regioselectively protected with trityl group followed by per-O-benzoylation 
to afford 2.08, which was isolated in 92% yield.  AgOTf-promoted glycosylation of 
2.08 with glycosyl bromide 2.01 gave α-glycoside 2.09 in 45% yield.  De-O-
benzoylation of 2.09 afforded target H-α-Manα-1,6-Man (2.10) in 84% yield.  The α-
configuration of 2.10 was confirmed by the anomeric carbon signal (JC-H= 171 Hz) in 
the 
13
C NMR spectrum. 
 
2.4.2 Chemical synthesis of fluorescent coumarinyl α-D-mannopyranoside 
derivatives under Cu(I)-catalysed click conditions 
The alkyne functional group on the 5-hexyn-1-ol, H-α-Man (2.07) and H-α-Manα-1,6-
Man (2.10) was employed to attach a non-fluorescent 3-azido-7-hydroxycoumarin to 
generate fluorescent HTC (2.11), α-Man-HTC (2.12) and α-Man-1,6-α-Man-HTC (2.13) 
as outlined in Scheme 2.5. 
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Scheme 2.5 Synthetic routes to fluorescent coumarinyl α-D-mannopyranoside derivatives through Cu(I)-
catalysed click conditions.  Reagents and conditions: a) 3-azido-7-hydroxycoumarin, CuSO4/NaAsc, MeOH/H2O 
(1:1), rt. 
Fluorescent 1,4-triazole-linked HTC (2.11), α-Man-HTC (2.12) and α-Man-1,6-α-Man-
HTC (2.13) were synthesised using Cu(I)-catalysed click reactions of alkyne precursors 
with 3-azido-7-hydroxycoumarin, the synthesis of which is described in section 2.3.1.  
These reactions were generally complete after 2 h at room temperature, resulting in 
good yields (70-90%) (Scheme 2.5).  The 1,4-triazole ring formation was confirmed by 
the presence of singlets at δ 8.24 ppm for HTC (2.11), δ 8.17 ppm for α-Man-HTC 
(2.12) and δ 8.5 ppm for α-Man-1,6-α-Man-HTC (2.13) in 1H NMR spectra; peaks at 
around 122.3 and 124.2 ppm in 
13
C NMR spectra further confirmed formation of 
triazole rings.  The efficiency of all three reactions were affected by formation of by-
products with Rf values in each case slightly lower compared to Rf values of the desired 
products but identities of these by-products were not pursued.  The reported data in 
literature with related alkyne coumarin-based fluorophores
122
 and other azido-alkyne 
compounds
123
 also indicated formation of a by-product under Cu-(I)-catalysed click 
conditions.  This by-product was isolated and shown to have a 5,5-bistriazole structure, 
which can form as a major product under basic conditions (Scheme 2.6).
123, 124
  In our 
synthesis this is not be the case because the Rf value of bistriazole compound would 
differ by TLC significantly.    
 
42 
 
 
Scheme 2.6 Reaction schemes of azido-alkyne compounds leading to formation of 5,5-bistriazole by-products 
under Cu(I)-catalysed click conditions as described in the literature. 123, 124 
 
2.5 Spectroscopic studies of fluorescent coumarinyl α-D-
mannopyranoside derivatives 
The photophysical properties of α-Man-EtTC (2.05) and α-Man-1,6-α-Man-HTC (2.13) 
only were investigated in this study as these compounds have different substituents 
attached at the 3- and 7- positions of the coumarin scaffold and modifications at these 
sites have been shown to have a strong impact on photophysical properties.
94
  
Investigation of structure and optical properties of coumarin-based fluorophores showed 
that the extension of the π-system with an aromatic group at the 3-position and the 
electron donating group, such as an amino group, at 7-position resulted in compounds 
with the highest quantum yields (Fig. 2.5).
94
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Figure 2.5 Coumarin-derived fluorophores with the highest quantum yield described in the literature.94 
Photophysical properties of depicted compounds in ethanol 8A2 (λabs = 395 nm, λem = 478 nm, ϕf = 0.90), 7C4 (λabs = 
393 nm, λem = 480 nm, ϕf = 0.62), 5A9 (λabs = 373 nm, λem = 535 nm, ϕf = 0.18) and 7B1 (λabs = 397 nm, λem = 455 
nm, ϕf = 0.98) External standard 9,10-diphenylanthracene (ϕf = 0.95 in cyclooctene).  
In our case, both α-Man-EtTC (2.05) and α-Man-1,6-α-Man-HTC (2.13) compounds 
have electron donating groups at the 7-position and at the 3-position the π-system of α-
Man-EtTC (2.05) compound is extended through triazole ring connected to cycloctene 
and of α-Man-1,6-α-Man-HTC (2.13) compound is extended through the triazole ring 
connected to the alkyne (Fig. 2.6).  These structural differences could influence 
photophysical properties of these compounds.  In contrast, carbohydrate moieties, which 
are well separated from the fluorophore in 2.05 and 2.13 should imposes no influence 
on photophysical properties of the fluorophore.
125
  Fluorescent derivatives HTC (2.11) 
and α-Man-HTC (2.12) were omitted from this investigation due to the structural 
similarity with α-Man-1,6-α-Man-HTC (2.13). 
 
Figure 2.6 Structural differences of fluorescently labelled coumarinyl α-D-mannopyranoside derivatives can 
affect their photophysical properties.   
Spectral characterisation of 2.05 and 2.13 were performed in methanol due to limited 
aqueous solubility and water, respectively at concentration (10x10
-5
 M) at room 
temperature.  The structural differences associated with coumarin fluorophore as 
described above showed a direct influence on the photophysical properties of 2.05 and 
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2.13 that are reflected in the values obtained for the UV-vis absorbance, extinction 
coefficient, fluorescence excitation, emission and Stokes shift (Table 2.2).  The 
emission of 2.05 at 405 nm gives rise to a blue colour, whereas the emission of 2.13 at 
469 nm associates with the intense green colour in solutions (Fig. 2.7 A1 and A2).  The 
separation between excitation and emission peaks in 2.05 is greater compared to 2.13 
which results in a larger Stokes shift (Fig 2.7 B1 and B2).  Obtained values of extinction 
coefficients for both compounds could assist with the estimation of product 
concentration of purified samples in later fluorescence-based methodologies as required. 
 
Figure 2.7 Fluorescent properties of coumarinyl α-D-mannopyranoside derivatives.  (A) Visual fluorescence of 
coumarinyl α-D-mannopyranoside derivatives in solution (A1) 2.05 and (A2) 2.13;  (B) The excitation and emission 
spectra (B1) 2.05 (10 x10-5 M) in water and (B2) 2.13 (10 x10-5 M) in MeOH. 
 
 
 
Absorption 
λ  
(nm) 
Extinction 
coefficient 
 ε (M-1cm-1) 
Excitation  
λ Exmax  
(nm) 
Emission  
λ Emmax  
(nm) 
Stokes shift  
∆λ  
(nm) 
2.05 336 19300 335 405 70 
2.13 344 10302 347 469 122 
 
Table 2.2 Photophysical properties of fluorescently labelled coumarinyl α-D-mannopyranoside derivatives. 
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The presence of a free hydroxyl group at the 7-position of the coumarin ring makes the 
fluorophore pH sensitive and affects the fluorescence intensity as the pH level changes 
from neutral to basic.  The pH dependence of fluorescence in 2.05 and 2.13 were 
investigated by preparing solutions of known concentration using “universal” buffer 
(0.04 M H3BO3, H3PO4 and CH3COOH) in the range of pH from 2 to 11.  Subsequently, 
fluorescence intensities of each solution at different pH were measured and data 
analysed (Fig. 2.8 A).   
 
 
Figure 2.8 The effect in change of pH level on the fluorescent properties of coumarinyl α-D-mannopyranoside 
derivatives.  (A) The pH dependence on fluorescence intensities in the presence and absence of hydroxyl group at the 
7-position on the coumarin ring.  (Blue trace) 2.05 (20 x10-6 M) Emmax 405 nm and (Green trace) 2.13 (20 x10
-7 M) 
Emmax 469 nm.  (B) Excitation and emission spectra of 2.13 to represent the bathochromic shift.  Solutions of 2.13 
(20 x10-7 M) were prepared using universal buffer (a) pH 6; (b) pH 7; (c) pH 8.  (C) Equilibrium between neutral and 
anion tautomer forms of 2.13 that occur with change in pH level from neutral to basic. 
Fluorescence intensity of 2.13 slightly increases from pH 7 reaching its highest at pH 9 
(Fig. 2.8 A green trace).  This observation can be explained by the deprotonation of the 
hydroxyl group as the pH level changes from neutral to basic, leading to formation of 
new tautomer anion species that possesses a different excitation optimum resulting in 
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slight increase of fluorescent intensity at pH 9 (Fig. 2.8 C).
126
  In contrast, no significant 
changes in the fluorescence intensity of 2.05 were detected as pH level increased 
because it lacks free hydroxyl group on the coumarin scaffold (Fig. 2.8 A blue trace).  
The decrease in the fluorescent intensity at pH above 10 for both 2.05 and 2.13 could be 
due to lactone ring hydrolysis.  The fully deprotonated new tautomer anion species of 
2.13 causes the bathochromic shift of excitation wavelength from 347 nm at pH 2-6 to 
367 nm at pH 7 and to 387 nm at pH 8-10 (Fig. 2.8 B).  The emission wavelength 
remains at 469 nm despite the change in the excitation wavelength.   
In fluorescence-based methodology II the progress of enzymatic reaction would be 
visualised on the TLC plate; therefore the fluorescent intensity of 2.13 and its enzymatic 
products could be enhanced, as required, by spraying the TLC plate with basic solution 
prior visualisation.
112
 
 
2.6 Examination of detection limits of fluorescently labelled 
coumarinyl α-D-mannopyranoside derivatives  
2.6.1 TLC analyses 
The lowest amounts of fluorescent α-Man-EtTC (2.05) and α-Man-1,6-α-Man-HTC 
(2.13) compounds that could be detected on TLC plates using UV-light were 
determined in the series of experiments.   
The fluorescent method of detection was then compared to orcinol staining, which is a 
standard method of carbohydrate detection.
127
  For this purpose solutions of 2.05 and 
2.13 in a wide range of concentrations were prepared and 2 µL aliquots were loaded 
onto glass-backed TLC plates containing no fluorescent indicator.  Each TLC plate was 
eluted with an appropriate solvent system and then visualised with a mid-wave length 
UV light for fluorescence detection (Fig. 2.09 A1 and A2) and then stained with orcinol 
for standard carbohydrate detection (Fig. 2.09 B1 and B2).  The results indicated that 
the fluorescent method of detection for 2.05 and 2.13 is ca. 100 fold more sensitive than 
orcinol staining, allowing detection of fluorescent mannoside acceptors at the 25 ng or 
40 pmols level for 2.13 and 20 ng or 40 pmols for 2.05.  Values obtained with 
fluorescence method of detection are lower compare to the typical limits of detection 
using radiolabelling. 
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Figure 2.9 Comparison of TLC detection range of fluorescently labelled coumarinyl α-D-mannopyranoside 
derivatives.  (A) The TLC plate visualised with mid-wave length UV light (A1) 2.13 and (A2) 2.05. (B) The TLC 
plate developed with orcinol staining (B1) 2.13 and (B2) 2.05.  TLC conditions: 2 μL of 2 x10-2 M, 2 x10-3 M, 2 x10-4 
M, 2 x10-5 M aliquots in water for 2.13 and in MeOH for 2.05 were loaded onto the TLC and eluted with 
(CH2Cl2:MeOH:H2O (80:20:3)) for 2.13 and (CH2Cl2:MeOH (9:1)) for 2.05. 
 
2.6.2 Solution analyses 
In order to achieve quantification of fluorescently labelled glycoside products obtained 
from the enzymatic biotransformation the detection limits of α-Man-EtTC (2.05) and α-
Man-1,6-α-Man-HTC (2.13) were examined in solution (Fig 2.10).   
 
Figure 2.10 The detection range of fluorescently labelled coumarinyl α-D-mannopyranoside derivatives in 
solution.  ( ) Solution of 2.13 pH 9 (universal buffer), Exmax 344 nm, Emmax 469 nm;  ( ) Solution of 2.05 pH 6 
(universal buffer), Exmax 335 nm, Emmax 405 nm; 
As for results described in section 2.5 a range of concentrations of 2.05 and 2.13 were 
prepared at the pH level with the highest fluorescence intensity observed, for 2.13 at pH 
5% H2SO4 in 
EtOH 
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9 and for 2.05 at pH 6.  The fluorescence intensity was measured as the concentration of 
each compound decreased.  The analysis of results showed that concentrations as low as 
0.06 μM for 2.13 and 0.3 μM for 2.05 could be detected in solution. 
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2.7 Validation of fluorescence-based methodologies against 
established radiolabelled assay 
In order to develop fluorescence-based methodologies the initial validation and 
benchmarking against published protocols of radiolabelled assays utilised to investigate 
the biosynthesis of cell surface glycoconjugates in Mycobacterium smegmatis was 
performed.  In these studies we targeted α-1,6-ManT responsible for the biosynthesis of 
lipomannan in Mycobacterium smegmatis.  
 
2.7.1 Insight into studying biosynthesis of glycoconjugates in mycobacteria  
Pathogenic Mycobacterium tuberculosis is the causative agent of tuberculosis (TB).  
According to the World Health Organisation it infects about 9.0 million and kills 1.5 
million people worldwide every year.  Treatments for this disease with four front-line 
drugs, such as isoniazid, rifampicin, pyrazinamide and ethambutol, are often require 
administration of several drugs for a long period of time, which leads to the 
development of multiple drug-resistant and extremely drug-resistant mycobacterial 
strains, making the development of new drugs even more essential.
128
  Difficulties in 
treatment of TB arise from the unique structure of the mycobacterial cell wall, which is 
composed of peptidoglycans, arabinogalactans, long fatty acids (mycolic acids), 
glycolipids and lipoglycans that are tightly packed side by side and layered on top of the 
plasma membrane.  This hydrophobic complex layer around the cell wall provides 
mycobacterial species with a formidable permeability barrier to hydrophobic drugs and 
other harmful substances.
129
  Intervention with the biosynthesis of any of these 
components through understanding the specificity of the glycosyltransferases involved 
could lead to new antimicrobial drugs.  Lipoarabinomannan (LAM), lipomannan (LM) 
and phosphatidyl-myo-inositol mannoside (PIM) are major components of 
mycobacterial cell wall that have been extensively studied (see section 1.2.2).  The 
terminal capping motif of the LAM has shown to contribute to the survival of M. 
tuberculosis in the host through regulating the host immune responses by interaction 
with different host receptors in the course of TB.
28
  Compounds that prevent the 
formation and installation of these capping motives should have potential as anti TB 
agents. 
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2.7.2 Literature radiolabelled assay to probe α-1,6-mannosyltransferase activities 
responsible for the biosynthesis of LAM in mycobacterial species 
The proposed biosynthesis of mycobacterial LAM follows a linear pathway starting 
from a decoration of phosphatidyl-myo-inositol (PI) with four mannose residues to give 
phosphatidyl-myo-inositol mannoside (PIM4), which is then elaborated to linear α-1,6-
linked LM and further decorated with α-1,2-linked single mannose residue to form 
mature LM and finally the addition of arabinose moieties completes the biosynthesis of 
LAM (see Chapter 1 section 1.2.2).
130
  The biosynthesis of linear α-1,6-linked LM 
involves several α-1,6-mannosyltransferases.  The first two α-1,6-ManT enzymes 
(PimA and PimB) catalyse the transfer of mannose residue from the soluble GDP-Man 
donor to PI to form PIM2 intermediate.  While another two recently identified α-1,6-
ManT enzymes (MptB and MptA) involved in the elongation of linear α-1,6-linked LM 
and catalyses transfer of mannose residue from the lipid linked polyprenyl-phosphate-
mannose (P-P-Man) donor to PIM4 intermediate (Fig. 2.11).  Another set of 
mannosyltransferases that catalyse transfer of mannose residue from GDP-Man donor to 
a variety of polyprenol monophosphate donors are also present and can be inhibited by 
amphomycin in the presence of calcium ion through chelation with polyprenol 
monophosphate.
131
 
 
Figure 2.11 Diagrammatic representation of lipoarabinomannan biosynthesis in Mycobacterium smegmatis.  
The red box area indicates the site of authentic intermediate mimicked by the synthetic acceptors used in the literature 
radiolabelled assays. 
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In order to understand the biosynthesis of LAM, cell-free radiolabelled assays were 
developed by Dr. Brown and used in Professor Besra’s group to study the biosynthetic 
pathways and substrate specificities of these glycosyltransferases in mycobacterial 
species.
132, 133
  One of these radiolabelled assay that looked at the substrate activities of 
chemically synthesised substrates for ManT responsible for elongation of LM structure 
was used to benchmark our fluorescence-based methodologies.
87
  In their study, 
chemically synthesised compounds, such as octyl 6-O-α-D-manopyranosyl-α-D-
mannopyranoside (2.14) and octyl 6-O-α-D-manopyranosyl-1-thio-α-D-
mannopyranoside (2.15) (Fig. 2.12) were designed to mimic LM intermediates and to 
target α-1,6-ManT (MptB and MptA) involved in the elongation of α-1,6-linked LM.  
During these assays acceptor substrates were incubated with the radiolabelled GDP-
[
14
C]Man in the presence of M. smegmatis membranes.  [M. smegmatis is a fast growing 
non-pathogenic bacterium that has a similar cell wall composition to the M. tuberculosis 
and is used as a model organism.]   
 
 
Figure 2.12 Structure of acceptor substrates used in the literature cell-free radiolabelled assays.  (Top image) 
The diagrammatic representation of acceptor substrates.  The red box area indicates the site of authentic intermediate 
mimicked by the synthetic acceptors. 
The reported results demonstrated that both compounds acted as acceptor substrates for 
these enzymes, leading to formation of two radiolabelled mannoside products, as 
evaluated by HPTLC and autoradiography.  The nature of α-1,6-glycosidic linkage in 
these assays has been confirmed through exo-glycosidase digestion and permethylation 
analysis by GC-MS, which indicated formation of a major α-1,6-linked trisaccharide 
and minor α-1,6-linked tetrasaccharide radiolabelled products.  Therefore, in order to 
benchmark our fluorescence-based methodologies we were looking to obtain similar 
results.   
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2.7.3 Fluorescence-based methodologies to probe α-1,6-mannosyltransferase 
activities in Mycobacterium smegmatis 
The immediate question that we wanted to ask through the initial benchmarking against 
the above radiolabelled assays was which of our non-fluorescent and fluorescent 
mannoside compounds could act as acceptor substrates for α-1,6-mannosyltransferases 
present in M. smegmatis membranes?  Could we observe formation of the two products, 
as described in the cell-free radiolabelled assays and/or could our acceptors be more 
effective substrates and extended beyond a tetramer?  In what way does the length and 
hydrophobicity of aglycone affect the efficiency of α-1,6-ManT activities and finally 
could we detect α-1,2-ManT with our acceptor substrates?  In an attempt to answer 
these questions, two chemically synthesised non-fluorescent compounds α-Man-EtC 
(2.04) and H-α-Man-α-Man (2.10) and two fluorescent compounds α-Man-EtTC (2.05) 
and α-Man-1,6-α-Man-HTC (2.13) were chosen to be examined.  Each methodology 
included one fluorescent and one non fluorescent compound (Fig. 2.13).   
 
 
 
 
Figure 2.13 Structures of non-fluorescent and fluorescent compounds used to benchmark fluorescence-based 
methodology I and II against literature radiolabelled assay.  The red box area indicates the site of authentic 
intermediate mimicked by the synthetic acceptors. 
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Mycobacterial membranes, kindly donated by Professor Besra’s group, were obtained 
by growing M. smegmatis (strain mc
2
155) in media (Bacto Nutrient Broth) to mid-log 
phase (about 24 h).  The harvested cells were then lysed, centrifuged to remove larger 
cell particles and ultracentrifuged to obtain the required mycobacterial membranes.
87
  
Compounds 2.04, 2.05, 2.10 and 2.13 were incubated with GDP-Man in the presence of 
washed mycobacterial membranes under the same conditions used in the radiolabelled 
assays.  The progress of each enzymatic reaction for both methodology I and II, during 
18 h and 29 h of incubation at 37 °C, was monitored by TLC.  
 
2.7.4 TLC results from the fluorescence-based methodology I 
During enzymatic assays 20 μL aliquots at 20 min, 40 min, 60 min, 2 h, 4 h and 18 h 
were taken and stopped by addition of methanol-chloroform (1:1).  Reaction mixtures (2 
μL) of each time point, from the non-fluorescent α-Man-EtC (2.04) acceptor, were 
applied onto the TLC plate and eluted.  In order to visualise the progress of enzymatic 
reaction from the non-fluorescent acceptor substrate the TLC plate was sprayed with the 
solution of cyclooctyne in EtOAc (1:1) and visualised under UV light (Fig. 2.14 A).  
Reaction mixtures (2 μL) of each time point from the fluorescent α-Man-EtTC (2.05) 
acceptor were applied onto the TLC, eluted and visualised without further 
manipulations (Fig. 2.14 B).   
TLC analysis of enzymatic reactions with non-fluorescent and fluorescent acceptors 
showed no enzymatic transformations.  The TLC plate from the incubation of 2.05 
contained one faint fluorescent band with lower Rf value compared to the starting 
acceptor.  This fluorescent band was associated with formation of some degradation 
product (DP) which was formed after 18 h of incubation at 37 °C.  In the event of 
formation of disaccharide product the expected Rf value would be lower compare to the 
observed value of the degradation product when utilising this eluent system.  According 
to these results no further analysis of these reaction mixtures were performed. 
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Figure 2.14 TLC analyses of enzymatic assays of non-fluorescent and fluorescent mannoside acceptors to 
detect mannosyltransferase activities in Mycobacterium smegmatis membranes using fluorescence-based 
methodology I.  (A) The TLC plate features reaction mixtures of a non-fluorescent acceptor (2.04) after fluorescent 
labelling with cyclooctyne;  (B) The TLC plate features reaction mixtures of a fluorescent acceptor (2.05).  Assay 
conditions: acceptor substrate (0.5 mM); GDP-Man (1 mM); reaction buffer MOPS/KOH (50 mM, pH 7.9), MgCl2 
(10 mM), DTT (5 mM); M. smegmatis microsomal membranes (50 μL, 500 μg of total protein); Total reaction 
volume of 200 μL.  TLC plates were eluted with CH2Cl2:MeOH:H2O (6:4:1) and visualised using mid-wave length 
range UV light.  Reaction time points are shown below the corresponding TLC image and starting acceptors and DP 
(degradation product) are shown to the left of the TLC image. 
 
2.7.5 TLC results from the fluorescence-based methodology II 
During enzymatic assays 20 μL aliquots at 2 h, 4 h, 6 h, and 29 h were taken and 
stopped by addition of methanol-chloroform (1:1).  Subsequently, each reaction mixture 
incorporating non-fluorescent H-α-Man-α-1,6-Man (2.10) acceptor was made 
fluorescent in solution by addition of 3-azido-7-hydroxycoumarin, catalytic CuSO4 and 
sodium ascorbate (NaAsc).  The Click reactions continued overnight to ensure complete 
fluorescent labelling of starting compound and possible products.  In order to visualise 
the progress of enzymatic reaction 2 μL from each aliquot were spotted onto the TLC 
plate that were eluted and visualisation under the UV light (Fig. 2.15 A).  Enzymatic 
reactions that involved fluorescent α-Man-1,6-α-Man-HTC (2.13) acceptor were 
visualised on the TLC plate without further modifications (Fig. 2.15 B).  The 
fluorescent labelling of H-α-Man-α-1,6-Man (2.10) under Cu(I)-catalysed click 
conditions with coumarin-based fluorophore should generate fluorescent α-Man-1,6-α-
Man-HTC (2.13) and fluorescent products that would be expected to have the same 
structures as fluorescent products obtained from 2.13 (Fig. 2.15 C).   
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Figure 2.15 TLC analyses of enzymatic assays of non-fluorescent and fluorescent mannoside acceptors to 
detect mannosyltransferase activities in Mycobacterium smegmatis microsomal membranes using fluorescence-
based methodology II.  (A) The TLC plate features reaction mixtures of a non-fluorescent acceptor (2.10) after 
fluorescent labelling with 3-azido7-hydroxycoumarin;  (B) The TLC plate features reaction mixtures of a fluorescent 
acceptor (2.13);  Assay conditions: acceptor substrate (1 mM), GDP-Man (4 mM), reaction buffer MOPS/KOH (50 
mM, pH 7.9), MgCl2 (10 mM), DTT (5 mM); M. smegmatis microsomal membranes (250 μL, 4000 μg of total 
protein);  Total reaction volume of 1 mL.  (A) TLC plates were eluted with CHCl3:MeOH:H2O (10:6:1) visualised 
using mid-wave length range UV light.  Reaction time points are shown below the corresponding TLC image and 
starting acceptors and products are shown to the left of the TLC image.  (BP) by-product.  (C) Schematic 
representation of reaction mixture obtained from 2.10 leading to the same products as from 2.13 after fluorescent 
labelling occurred. 
TLC analysis of enzymatic reaction obtained from H-α-Man-α-1,6-Man (2.10) showed 
formation of two new fluorescent bands (Fig. 2.15 A).  The fluorescent band with the 
lowest Rf value began to form after 2h incubation with a gradual increase in intensity 
through to 29 h of incubation.  This fluorescent band was tentatively assigned as a 
trisaccharide (2.16) product with a possible transfer of one mannose residue to the non-
fluorescent H-α-Man-α-1,6-Man (2.10) acceptor.  The second fluorescent band between 
the acceptor and product had the same fluorescent intensity at each time point.  This 
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fluorescent band was attributed to the formation of by-product (BP) which has been 
observed previously when synthesising the fluorescent compounds using Cu(I)-
catalysed click conditions (see section 2.4.2).   
TLC analysis of the enzymatic reaction from α-Man-1,6-α-Man-HTC (2.13) acceptor 
also showed formation of two new fluorescent bands (Fig. 2.15 B).  The most intense 
band below the starting acceptor was tentatively assigned to formation of trisaccharide 
(2.16) product and the less intense band with the lower Rf value was assigned as 
tetrasaccharide (2.17) product.  The fluorescent band of trisaccharide products had the 
same Rf value on TLC plates obtained from both incubation of H-α-Man-α-1,6-Man 
(2.10) and α-Man-1,6-α-Man-HTC (2.13), indicating that the presence and absence of 
fluorescent aglycone in the acceptor did not influence which glycosyltransferases were 
targeted.  Fluorescent bands with higher Rf value compared to both acceptor substrates 
indicated a possible hydrolysis of H-α-Man-α-1,6-Man (2.10) and α-Man-1,6-α-Man-
HTC (2.13) (Fig. 2.15 A and B).  At this stage, structures of enzymatically 
mannosylated fluorescent products obtained from fluorescence-based methodology II 
needed to be established.   
 
2.7.6 Identification of fluorescent products by LC-MS 
In order to confirm formation of fluorescent mannoside products, reaction mixtures 
from H-α-Man-α-1,6-Man (2.10) after 18 h incubation and α-Man-1,6-α-Man-HTC 
(2.13) after 29 h incubation were submitted to the LC-MS analysis.  LC-MS method 
provides separation of fluorescent carbohydrate products using either normal phase 
(amino-modified stationary phase) or reverse phase (C18 stationary phase) methods and 
when coupled to the mass spectrometry it allows mass analysis of each separated 
compound.  The derivatisation of carbohydrate acceptor substrates with the fluorophore 
also allowed utilisation of UV-detection in LC methods, simplifying the identification 
of fluorescent products amongst other components of reaction mixture.  Normal phase 
LC was chosen in the first instance because it provided superior resolution of mixtures 
of carbohydrates that differ in monosaccharide composition and inter-glycosidic linkage 
types when compared to reverse phase LC methods.
134, 135
   
Normal phase LC coupled with UV-detection allowed separation of fluorescent 
products and revealed one peak at retention time 7.7 min (2.16) for the reaction mixture 
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involving H-α-Man-α-1,6-Man (2.10) and two peaks at retention time 7.2 min (2.16) 
and 8.0 min (2.17) for the reaction mixture involving α-Man-1,6-α-Man-HTC (2.13) 
(Fig. 2.16 A1 and A2).  Slight inconsistence in the retention time of 2.16 from 2.10 and 
2.13 could be due to the instrumental issue.   
The analysis of MS data of fluorescent (2.16) product confirmed addition of single 
mannose residue to H-α-Man-α-1,6-Man (2.10) and α-Man-1,6-α-Man-HTC (2.13), thus 
major signal observed in both MS spectrum had m/z of 788.18 and 788.25, respectively, 
corresponding to [M+H]
+
 of a trisaccharide molecular ion (Fig. 2.16 B1 and B2a).  The 
MS data for fluorescent (2.17) product confirmed addition of two mannose residue to α-
Man-1,6-α-Man-HTC (2.13) with m/z of 950.13 corresponding to [M+H]+ of a 
tetrasaccharide molecular ion (Fig. 2.16 B2b).  LS-MS data were in agreement with the 
preliminary TLC observations. 
 
Figure 2.16 LC-MS analyses of reaction mixtures obtained from incubation of non-fluorescent and fluorescent 
acceptors with GDP-Man in the presence of Mycobacterium smegmatis microsomal membranes.  (A) UV 
chromatogram (A1) reaction mixture from 2.10, (A2) reaction mixture from 2.13.  LC conditions: Kinetex LUNA 
NH2 (100 mm/2.0 mm/3μm), mobile phase: CH3CN-water (0.1% TFA) (10 to 90 %, 32 min, flow rate: 1 mL/min) 
UV detector at 347 nm.  (B) MS spectra (B1) 2.16 obtained from the non-fluorescent acceptor (2.10); (B2) 2.16 
obtained from the fluorescent acceptor (2.13); (B3) 2.17 obtained from the fluorescent acceptor (2.13). 
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2.7.7 Linkage analysis through exo-mannosidase digestions 
The newly formed linkages in fluorescent trisaccharide (2.16) and tetrasaccharide (2.17) 
products were assessed through the application of exo-mannosidase digestion with a 
hydrolase of well-defined α-1,6-specificity.  For this purpose, both enzymatic reactions 
were scaled up to obtain sufficient ampount of fluorescent products to be analysed.  The 
purification of 2.16 from H-α-Man-α-1,6-Man (2.10) and 2.16/2.17 from α-Man-1,6-α-
Man-HTC (2.13) was attempted by a normal phase HPLC method.  Disappointingly, the 
obtained fractions contained mixed products as some interactions of coumarin-based 
fluorophore with the amino column were observed, which resulted in tailing of peaks 
for all fluorescent compounds.  Semi-purified fraction containing mixed trisaccharide 
(2.16) and by-product (BP) from H-α-Man-α-1,6-Man (2.10) reaction (Fig. 2.17 A, lane 
1) was subjected to exo-mannosidase digestion with Xanthomonas manihotis α-1,6-
mannosidase and the progress of this reaction was monitored by TLC (Fig. 2.17 A, lane 
2).  TLC analysis indicated that α-1,6-mannosidase hydrolysed trisaccharide (2.16) and 
removed two mannose residues releasing fluorescent α-Man-HTC (2.12).  Interestingly, 
the by-product of Cu(I)-catalysed click reaction was also hydrolysed by α-1,6-
mannosidase; therefore, indicating that the structural deviations possibly lies in 
aglycone.   
HPLC purification of the reaction mixture from α-Man-1,6-α-Man-HTC (2.13) gave 
two mixed fractions.  First semi-purified fraction contained mixed trisaccharide (2.16) 
product, a faint amount of α-Man-1,6-α-Man-HTC (2.13) and product of hydrolysis α-
Man-HTC (2.12) (Fig. 2.17 B, lane 1).  Second semi-purified fraction contained 
tetrasaccharide (2.17) product, small amount of trisaccharide (2.16) as well as 2.13 and 
2.12 (Fig. 2.17 B, lane 3).  Both fractions were subjected to exo-mannosidase digestion 
with Xanthomonas manihotis α-1,6-mannosidase (Fig. 2.17 B, lane 2 and 4).  TLC 
analysis indicated that hydrolysis of trisaccharide (2.16) and tetrasaccharide (2.17) 
products with α-1,6-mannosidase resulted in formation of α-Man-HTC (2.12) (Fig. 2.17 
B, lane 2 and 4).  The obtained data indicates that both non-fluorescent H-α-Man-α-1,6-
Man (2.10) and fluorescent α-Man-1,6-α-Man-HTC (2.13) compounds can act as 
acceptor substrates for α-1,6 ManT present in M. smegmatis membranes.   
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Figure 2.17 TLC analyses of exo-mannosidase digestions of fluorescent mannoside products with exo-
mannosidase.  Exo-mannosidase hydrolysis of mixed products obtained (A) from H-α-Man-α-1,6-Man (2.10); (B) 
from α-Man-1,6-α-Man-HTC (2.13).  Enzyme used in this assay is Xanthomonas manihotis α-1,6-mannosidase (α-
1,6-ManH).  TLC plates were eluted with CHCl3:MeOH:H2O (10:8:1) and visualised using mid-wave length range 
UV light.  Starting acceptors and products are shown to the left and right of each TLC image; BP by-product 
originated from click reaction and H-BP hydrolysed by-product. 
 
2.7.8 Summary of fluorescence-based methodologies in Mycobacterium smegmatis 
The immediate answer that we were able to obtain from the first round of validation was 
that non-fluorescent α-Man-EtC (2.04) and fluorescent α-Man-EtTC (2.05) compounds 
used in fluorescence-based methodology I were not able to act as substrates for α-1,6-
ManTs present in M. smegmatis membranes.  This could be attributed to the poor 
association of both aglycones with mycobacterial membranes and as a result it affects 
acceptor presentation and recognition by mannosyltransferase enzymes.  Another 
possible consideration is that both compounds carry only one mannose residue which 
makes them unsuitable acceptors for the active site of these enzymes.  The radiolabelled 
assays
87
 only examined the synthetic disaccharides and no monosaccharides were 
mentioned in this publication.   
In contrast, the non-fluorescent H-α-Man-α-1,6-Man (2.10) and fluorescent α-Man-1,6-
α-Man-HTC (2.13) compounds used in methodology II were able to act as substrates for 
α-1,6-ManTs, resulting in fluorescent trisaccharide (2.16) from 2.10 and the same 
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fluorescent trisaccharide (2.16) and tetrasaccharide (2.17) from 2.13, as depicted in 
Figure 2.18.  Non-fluorescent 2.10 was a weaker acceptor compared to fluorescent 2.13 
which gave the same number of products as acceptor substrates employed before in the 
radiolabelled assays.
87
  Again, this difference could be due to slight variation in the 
aglycone length and hydrophobicity that could possibly affect acceptor association with 
mycobacterial membranes.   
 
Figure 2.18 Schematic representation of α-1,6-mannosyltransferase reaction with non-fluorescent and 
fluorescent acceptor substrates using fluorescence-based methodology II.   
 
2.8 Validation of fluorescence-based methodology II against 
established radiolabelled assay 
Published results from radiolabelled assays used to investigate the biosynthesis of cell 
surface glycoconjugates in Trypanosoma brucei were used in the second round as a 
benchmark for our fluorescence-based methodology II.  At this stage, we targeted GalTs 
involved in decoration of the core GPI anchor structures in Trypanosoma brucei. 
 
2.8.1 Insight into studying biosynthesis of glycoconjugates in Trypanosoma brucei  
Trypanosoma brucei is an extracellular protozoan parasite that lives in the blood, lymph 
and intestinal fluids of the infected mammalian host causing a devastating and often 
fatal African sleeping sickness in human and related disease Nagana in cattle.  The 
parasite undergoes a complex life cycle between an insect (tsetse fly) vector and its 
mammalian host.
136
  The blood form of the parasite is able to survive inside the human 
host due to the presence of variant surface glycoprotein (VSG) (10
7
 molecules of 55 
kDa) tightly packed on the cell surface.
137
  This layer protects the parasite from the 
immune system of the host and the subject to antigenic variation of the VSG in order to 
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escape host recognision.
138
  This means that the VSG layer is shed once the host 
develops an immune response to the predominant parasite population and replaced it 
with a new immunologically distinct layer that overexpressed by a new VSG gene.
139
   
Each VSG protein is anchored to the plasma membrane via covalent linkage of C-
terminal amino acid to glycosyl-phosphatidylinositol (GPI) moiety.  The survival of the 
parasite completely depends on the VSG coat and the coat depends on its GPI anchors; 
therefore, intervention in the biosynthesis of GPI anchors makes an attractive 
therapeutic target.  Nevertheless, GPI anchors are present in mammalian cells too and 
the difference in the biosynthetic pathways between mammalian and T. brucei have 
been extensively studied (see chapter 1, section 1.2.1).   
 
2.8.2 Literature radiolabelled assay to probe galactosyltransferase activities 
responsible for decoration of GPI anchors in Trypanosoma brucei 
The core structure of GPI anchors consists of ethanolamine-PO4-6Manα-1,2-Manα-1,6-
Manα-1,4-GlcNα-1,6-mio-inositol with the ethanolamine phosphate linked to the C-
terminus of the protein (Fig. 2.19).
3, 17
  The structural variations of GPI anchors between 
T. brucei and mammals are observed on the side chain and lipid moieties of the anchor.  
A unique feature of GPIs from T. brucei is the presence of a galactoside side chain 
attached through Galα-1,3-Man linkage to the mannose residue adjacent to the α-
GlcNH2 residue of the core structure.  Two additional single galactose residues are 
linked either though Galβ-1,3-Man or Galα-1,2-Man linkages to second and third 
mannose residue of the core structure, respectively.  Galactosylation occurs after the 
transfer of the VSG to the GPI precursor and its role is to fill space in order to preserve 
the tight packed integrity of the VSG coat.
18
  Finding parasite-specific inhibitors for the 
glycosyltransferases involved in the biosynthesis of GPI anchors has clear potential in 
treating African sleeping sickness. 
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Figure 2.19 Diagrammatic representation of GPI anchor biosynthesis in Trypanosoma brucei.  The red box area 
indicates the site of authentic intermediate mimicked by the synthetic acceptors used in the literature radiolabelled 
assays. 
In order to study the specificity of glycosyltransferase activities and to find inhibitors 
for these enzymes, cell-free radiolabelled assays were extensively utilised in Professor 
Ferguson’s group.  Results from one of these studies that investigated substrate 
specificity of chemically synthesised compounds for galactosyltransferases (GalT) 
responsible for the decoration of GPI anchor were used to validate and benchmark our 
fluorescence-based methodology II.
140
  In the published radiolabelled assays, three 
acceptor substrates, namely octyl 6-O-α-D-manopyranosyl-1-thio-α-D-mannopyranoside 
(2.14), octyl thio-α-D-mannopyranoside (2.18) and octyl thio-β-D-mannopyranoside 
(2.19) (Fig. 2.20) were incubated with radiolabelled UDP-[
3
H]Gal in the presence of 
isolated T. brucei membranes.  The progress of enzymatic reactions has been followed 
by TLC.   
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Figure 2.20 Structures of acceptor substrates used in the literature cell-free radiolabelled assays.  (Top image) 
The diagrammatic representation of acceptor substrates.  (Bottom image) Chemical structures.  The red box area 
indicates the site of authentic intermediate mimicked by the synthetic acceptors. 
The published results of these assays indicated that mannoside 2.14 and thioglycosides 
2.18 and 2.19 were capable of accepting one galactose residue in either α- or β-
configuration, with the α-linked products representing approximately 90, 40 and 10 %, 
respectively of these galactosylated products.  The type of the glycosidic bond has been 
investigated only in 2.14 because the main aim of that study was to detect α-GalT 
activity in T. brucei membranes.  The type of glycosidic linkage in this assay has been 
confirmed through utilisation of tandem negative-ion electrospray mass spectroscopy 
prior to periodate oxidation and reduction with NaBH4 and indicated formation of major 
product with α-1,3-linkage and two minor products with α-1,2 and α-1,4-linkages. 
Furthermore, in a separate study it has been demonstrated that chemically synthesised 
trisaccharide octyl α-D-galactopyranosyl-(1→3)-(α-D-mannopyranosyl-(1→6))-α-D-
mannopyranoside (2.20) can act as a substrate for galactosyltransferases involved in 
formation of branching oligo-galactose side chains of GPI anchors.
141
  Incubation of 
2.20 with radiolabelled UDP-[
3
H]Gal donor in the presence of T. brucei microsomal 
membranes generated two radiolabelled tetrameric isomers (Scheme. 2.7).  Using non-
specific exo-glycosidase digestion and tandem negative-ion electrospray mass 
spectrometry prior to periodate oxidation and reduction with NaBH4 the major product 
(2.21) has been assigned to bear an α-1,2- and the minor product (2.22) α-1,6-glycosidic 
linkages in approximately 9:1 ratio.  Activities of both enzymes were believed to reside 
in the Golgi apparatus. 
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Scheme 2.7 Enzymatic transformations of synthetic acceptor substrate by galactosyltransferases responsible 
for branching of GPI anchors as detected by literature radiolabelled assay.  (Top left image) The diagrammatic 
representation of acceptor substrates.  The red box area indicates the site of authentic intermediate mimicked by the 
synthetic acceptors. 
As for previous validation experiments described in section 2.7, in order to benchmark 
our fluorescence-based methodology II we were looking to obtain similar results to the 
radiolabelled assay that utilised octyl 6-O-α-D-manopyranosyl-1-thio-α-D-
mannopyranoside (2.14) as an acceptor substrate.   
 
2.8.3 Fluorescence-based methodology II to probe galactosyltransferase activities 
responsible for α-galactosylation of GPI anchors in Trypanosoma brucei 
In this round of validation of fluorescence-based methodology II, the main aim was to 
demonstrate that non-fluorescent H-α-Man-α-1,6-Man (2.10) and fluorescent α-Man-
1,6-α-Man-HTC (2.13) compounds, already used in benchmarking against M. 
smegmatis radiolabelled assays can equally act as acceptor substrates for 
galactosyltransferases involved in the decoration of the core structure of GPI anchors in 
T. brucei microsomal membranes (Fig. 2.21). 
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Figure 2.21 Structures of non-fluorescent and fluorescent compounds used to benchmark fluorescence-based 
methodology II against radiolabelled literature assay.  (Top image) The diagrammatic representation of acceptor 
substrates.  The red box area indicates the site of authentic intermediate mimicked by the synthetic acceptors. 
In order to detect the GalT activity, both examined mannoside acceptor substrates (2.10 
and 2.13) were incubated with UDP-Gal in the presence of trypanosome membranes 
under the same conditions as used in the literature radiolabelled assay.
140
  Trypanosome 
membranes were kindly donated by Professor Ferguson’s group.  Bloodstream 
Trypanosoma brucei (strain 427 variant MITat 1.4) were obtained from the infected 
rats
137
 centrifuged, washed with ice-cold buffer and lysed using hypotonic buffer.
19
  The 
time course of each enzymatic reaction during 24 h of incubation at 30 °C was 
monitored by TLC.    
During enzymatic assays, aliquots (20 μL) of each reaction mixture that contained H-α-
Man-α-1,6-Man (2.10) and α-Man-1,6-α-Man-HTC (2.13) at 2 h, 6 h, and 24 h were 
obtained and stopped by addition of methanol-chloroform (1:1) solution.  Aliquots of 
reaction mixtures from the non-fluorescent 2.10 were made fluorescent by addition of 3-
azido-7-hydroxycoumarin, catalytic amount of CuSO4 and sodium ascorbate (NaAsc).  
Reaction mixtures were left overnight to ensure complete fluorescent labelling of 
starting material and any potential products.  In order to visualise the progress of 
enzymatic reaction 2 μL were spotted onto the TLC plate, eluted and visualised under 
the UV light (Fig. 2.22 A and C).   
TLC analysis showed no enzymatic activities for H-α-Man-α-1,6-Man (2.10) indicating 
that this compound cannot act as an acceptor substrate for GalTs present in T. brucei 
microsomal membranes.  According to the Rf value and the same intensity at each time 
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point, the faint fluorescent band observed below the acceptor fluorescent band was 
assigned to Cu(I)-catalysed by-product (section 2.4.2.).   
 
 
Figure 2.22 TLC analyses of enzymatic assays of non-fluorescent and fluorescent acceptors used in detection of 
galactosyltransferase activities in Trypanosoma brucei membranes utilising fluorescent methodology II.  (A) 
The TLC plate features reaction mixture of 2.10 after fluorescent labelling with 3-azido7-hydroxycoumarin;  (B) The 
TLC plate features reaction mixture of 2.12.  Assay conditions: acceptor substrate (1 mM), UDP-Gal (1 mM), 
reaction buffer HEPES/KOH (100 mM, pH 7.4), KCl (50 mM), MgCl2/MnCl2 (10 mM), DTT (2 mM), ATP (2 mM), 
N-tosyl-L-lysine chloromethyl ketone (0.2 mM), leupeptin (2μg/mL), tunicamycin (2.5 μg/mL), Triton (0.05%); T. 
brucei microsomal membranes (50 μL, 10x107 cells); Total reaction volume of 200 μL.  TLC plates were eluted with 
CHCl3:MeOH:H2O (10:6:1) and visualised under UV light.  Reaction time points are shown below the corresponding 
TLC image and starting acceptors and products are shown to the left of each TLC image (BP) by-product.  (C) 
Reaction schemes from 2.10 leading to no fluorescent products  
The enzymatic reaction that involved fluorescent α-Man-1,6-α-Man-HTC (2.13) 
acceptor substrate was visualised on the TLC plate without further modifications (Fig. 
2.22 B).  TLC analysis showed formation of one fluorescent band with Rf value of 
expected trisaccharide (2.23) product.   
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In order to increase amount of fluorescent product formed in the enzymatic reaction of 
α-Man-1,6-α-Man-HTC (2.13) with UDP-Gal in the presence of T. brucei microsomal 
membranes variation in two parameters were examined.  Firstly, the reaction was 
carried out with a double amount of T. brucei microsomal membranes, and secondly 
with sequential addition of donor to the reaction mixture over time.  The increase in the 
amount of T. brucei microsomal membranes resulted in little change in formation of 
trisaccharide (2.23) product as followed from a similar fluorescent intensity when 
compared to previous TLC analyses (Fig. 2.23 A vs Fig. 2.22 B).  On the other hand, 
the increase in the amount of enzyme led to increase in hydrolysis of the starting 
acceptor resulting in increased fluorescent intensity of α-Man-HTC (2.12).  The 
sequential addition of UDP-Gal donor resulted in an overall increase in acceptor 
substrate conversion as judged by the increase in intensity of fluorescent band of 2.23 
(Fig. 2.23 B). 
 
Figure 2.23 TLC analyses of enzymatic assays of fluorescent mannoside acceptor to improve 
galactosyltransferase activities in Trypanosoma brucei microsomal membranes utilising fluorescent 
methodology II.  (A) The TLC plate features reaction mixture with addition of enzyme (25 μL 10x108 cells);  (B) 
The TLC plate features reaction mixture with addition of UDP-Gal donor (5μL of 4mM at each time point).  Initial 
assay conditions: acceptor substrate (1 mM), UDP-Gal (1 mM), reaction buffer HEPES/KOH (100 mM, pH 7.4), KCl 
(50 mM), MgCl2/MnCl2 (10 mM), DTT (2 mM), ATP (2 mM), N-tosyl-L-lysine chloromethyl ketone (0.2 mM), 
Leupeptin (2μg/mL), Tunicamycin (2.5 μg/mL), Triton (0.05%); T. brucei microsomal membrane (25 μL, 10x107 
cells);  Total reaction volume of 100 μL.  TLC plates were eluted with CHCl3:MeOH:H2O (10:6:1) visualised under 
UV light.  Reaction time points are shown below the corresponding TLC image and starting acceptor and products 
are shown to the left of the TLC image. 
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2.8.4 Identification of fluorescent product by LC-MS 
In order to confirm formation of trisaccharide (2.23) compound the reaction mixture 
from α-Man-1,6-α-Man-HTC (2.13) was subjected to LC-MS analysis.  The ion 
extracted chromatogram of m/z 788.29 indicated presence of two peaks that were 
designated as 2.23a (retention time 6.14 min) and 2.23b (6.23 min) (Fig. 2.24 A).  The 
MS spectrum of two peaks from the ion extracted chromatogram indicated a signal with 
m/z of 788.29 corresponded to a molecular ion [M+H]
+
 thereby confirming the addition 
of a single galactose residue to 2.13 and formation of trisaccharide fluorescent products 
(2.23a/b).  Masses with m/z of 626.23, 462.16 and 302.12 were assigned to the 
fragmentation of molecular ion [M+H]
+
 and corresponded to the sequential loss of 
hexose unit (m/z 162) and release of α-Man-1,6-α-Man-HTC (2.13), α-Man-HTC (2.12) 
and HTC (2.11), respectively (Fig. 2.24 B). 
 
Figure 2.24 UPLC analyses of reaction mixture obtained from incubation of fluorescent acceptor with UDP-
Gal in the presence of Trypanosoma brucei microsomal membranes.  (A) Extracted ion chromatogram of 2.23.  
UPLC conditions: Acquity UPLC BEH C18 (100 mm/1.0 mm/1.7μm), mobile phase: water- CH3CN (0.1% formic 
acid) (10 to 90 %, 12 min, flow rate: 0.08 mL/min) MS detector.  (B) MS spectrum of 2.23a/b. 
 
2.8.5 Linkage analysis through exo-galactosidase digestions 
Assessment of the anomeric configuration of newly formed glycosidic linkages in 
trisaccharide (2.23) was achieved through utilisation of enzymatic digestions with α-
galactosidase from green coffee beans and β-galactosidase from Escherichia coli.  The 
purification of 2.23 from starting 2.13 was attempted by a reverse phase HPLC method.  
The obtained fraction contained some starting material due to the human error.  The 
semi-purified fraction was subjected to exo-galactosidase digestion with α-galactosidase 
from green coffee beans and β-galactosidase from E. coli and the progress of both 
reactions were monitored by TLC.   
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TLC analysis of mixed fraction treated with α-galactosidase resulted in hydrolysis of 
significant amount of α-linked trisaccharide (2.23a) compound releasing fluorescent α-
Man-1,6-α-Man-HTC (2.13) and leading to increase in fluorescent intensity of this 
compound compared to the intensity of control sample without the enzyme (Fig. 2.25 
lane 1 and 2).  In contrast, TLC analysis of mixed fraction with β-galactosidase indicate 
some hydrolysis of 2.23b compared to the control sample without enzyme (Fig. 2.25 
lane 1 and 3).  Moreover, tere is a slight difference in Rf value of 2.23a and 2.23b where 
the Rf value of 2.23a is slightly higher compared to the Rf value of 2.23b (Fig. 2.25 lane 
2 and 3).   
 
Figure 2.25 Analyses of exo-glycosidase digestion of fluorescent products with α-galactosidase from green 
coffee beans and β-galactosidase from Escherichia coli.  (A) The TLC plate after exo-galactosidase digestion.  
Control experiment L1 (without enzyme) were conducted in parallel with hydrolysis reactions.  The TLC plate were 
eluted with CHCl3:MeOH:H2O (10:6:1) and visualised using mid-wave length range UV light.  The starting acceptor 
and products are shown to the left of the TLC image.  (B) Schematic representation of degradation of two possible 
products by exo-galactosidases and release of fluorescent acceptor. 
According to exo-galactosidase digestion data obtained from radiolabelled assays and 
the structural information of GPI anchor side chains in T. brucei, the major trisaccharide 
(2.23a) product hydrolysed by α-galactosidase was tentatively assigned to have an α-
1,3-linkage to the reducing mannose of 2.13.  The minor (2.23b) product was assigned 
to have a β-1,3-linkage to the non-reducing mannose of 2.13 (Fig. 2.25 B).   
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2.8.6 Investigation of number of isomeric structures by IM-MS 
Ion mobility coupled to mass spectrometry (IM-MS) was used as a platform in order to 
confirmed presence of two isomeric structures in trisaccharide (2.23a/b).  The IM-MS 
technique is very fast (in the millisecond time scale) and requires a nanoscale amount of 
investigated compound.  This technique provides separation and differentiation of 
carbohydrate isomers from biological mixtures
142-144
 on the basis of both ion collisional 
cross section and m/z by IM and MS respectively.
145-147
  During the IM-MS experiment 
ionised compounds are generated by electrospray ionisation (ESI) which then directed 
into the IM drift tube under electric field that filled with a neutral drift gas.  Separation 
is achieved through interaction of ions with a neutral drift gas.  Ions with a smaller 
collisional cross section experience fewer collisions with the neutral drift gas.  Hence, 
they are transmitted through the drift tube faster than an ion with a larger collisional 
cross section.  This gives each ionised compound a unique drift time (tD) value.  When 
coupled to the MS it produces 2D spectrum (m/z over tD) which reveals how many 
isomers are present in the given sample.   
 
Figure 2.26 Ion mobility spectrum to represent isomeric structures present in trisaccharide fluorescent 
products obtained from incubation of UDP-Gal with Trypanosoma brucei membranes.  (A) m/z/drift time 
spectrum of 2.23a/2.23b (m/z 788.29).  (B) % intensity/drift time spectrum of 2.23a/b (m/z 788.29). 
To access this information mixed fraction obtained from reverse phase HPLC 
purification was subjected to IM-MS and drift time of m/z 788.29 was investigated.  The 
mobility spectrum of trisaccharide 2.23 revealed two distinct peaks with m/z of 788.29 
at 7.10 ms corresponding to 2.23a and at 7.76 ms corresponding to 2.23b (Fig. 2.26 A 
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and B).  The peak assignment was based on fluorescent intensities of the released 
product as observed on the TLC plate after exo-galactosidase digestion of 2.23 (Fig. 
2.25 A).  The IM-MS data confirmed formation of two isomers major 2.23a and minor 
2.23b. 
 
2.8.7 Summary of fluorescence-based methodology II in Trypanosoma brucei 
In this round of validation of our fluorescence-based methodology II we obtained 
encouraging results with fluorescent α-Man-1,6-α-Man-HTC (2.13) compound, which 
once more proved to be a good acceptor substrate for a new set of glycosyltransferases, 
this time present in T. brucei microsomal membranes.  The obtained data and structural 
information on GPI anchors led us to believe that 2.13 targeted α-1,3- and β-1,3-GalT 
enzymes involved in the decoration of core structure of GPI anchors and resulted in 
formation of two isomeric fluorescent trisaccharide products (2.23a and 2.23b) in an 
approximate 7:3 ratio (Fig. 2.27). 
 
Figure 2.27 Diagrammatic representation of fluorescent acceptor mimicked sites on the GPI anchor and 
resulted fluorescent products.  (A) Acceptor mimicked site.  (B) Structure of possible isomeric products. 
According to TLC analyses the major 2.23a compound was sensitive to α-galactosidase 
digestion suggesting that a galactose residue was attached to α-Man-1,6-α-Man-HTC 
(2.13) in the α-anomeric configuration.  On the other hand, β-galactosidase digestion of 
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minor 2.23b compound was not that evident on the TLC plate due to the presence of 
some starting fluorescent material in the sample.  Nevertheless, the incomplete α-
galactosidase digestion of 2.23a as well as the presence of two peaks in the IM-MS 
spectrum pointed towards formation of second compound with β-anomeric 
configuration.  Incontrovertibly, additional analysis of digestion reaction mixture using 
the LC-MS method in order to confirm presence of 2.23b compound by observing m/z 
of 626 as well as additional exo-digestion with α-mannosidase to confirm presence of 
branch isomer are required to strengthen above conclusions.  In contrast, non-
fluorescent H-α-Mana-1,6-Man (2.10) acceptor substrate in this round of validation 
showed no enzymatic activity towards galactosyltransferases present in T. brucei 
microsomal membranes.   
 
2.9  Conclusion and future work 
To this point we have designed three fluorescence-based methodologies and 
benchmarked methodology I and II against established radiolabelled assays that were 
used to investigate substrate specificities of chemically synthesised acceptors towards 
GT present in M. smegmatis and T. brucei with insight to find suitable inhibitors.
87, 140, 
141
  Both of these methodologies have shown positive and negative aspects that surfaced 
during validation.  In methodology I non-fluorescent α-Man-EtC (2.04) and fluorescent 
α-Man-EtTC (2.05) compounds showed no activity towards α-1,6-ManT enzymes 
present in M. smegmatis microsomal membranes.  However, it provided a clean and 
rapid method to visualise progress of enzymatic reactions on the TLC plates with 
compound visualisation within minutes on heating the plate.  The cyclooctyne used in 
the TLC visualisation could also be replaced with 4-dibenzocyclooctynol because 
cyclooctyne is a volatile and pungent oil which is difficult to handle and 4-
dibenzocyclooctynol is synthetically quite accessible, nontoxic solid material with 
excellent stability.
148
  In future investigations acceptors used in methodology I should 
undergo some modifications to suite the particular biosynthetic pathways.  For instance 
the hydrophobic linker on α-Man-EtC (2.04) could be extended from ethyl to pentyl to 
improve the membrane association.   
In methodology II the fluorescent labelling prior the biotransformation provided a 
cleaner way to assess the enzymatic activities on the TLC plate compared to the 
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fluorescent labelling after the biotransformation.  Primarily, it is due to formation of 
Cu(I)-catalysed by-product in the latter one.  This creates complication in TLC analyses 
of formed fluorescent products and especially in case of multiple products formation.  In 
general for both methodologies, the fluorescent labelling prior the biotransformation 
proven to be a more straight forward way to assess the enzymatic activities on the TLC 
plate compared to the fluorescent labelling after the biotransformation.  Methodology III 
was not taken beyond the design due to non-existing or poor substrate activities of non-
fluorescent acceptors. 
In terms of enzymatic activities we have demonstrated that fluorescence-based 
methodology II is a feasible method that can be used to study glycosyltransferases 
responsible for the biosynthesis of various glycoconjugates in two different organisms.  
To this point we have shown that fluorescent compound α-Man-1,6-α-Man-HTC (2.13) 
used in this methodology targeted both α-1,6-ManT involved in the biosynthesis of LM 
in M. smegmatis as well as α- and β-GalT responsible for decoration of GPI anchor side 
chains in T. brucei.   
Results from mycobacterial fluorescent study with 2.13 resulted in formation of 
fluorescent α-1,6-linked mannoside trimer and tetramer which was consistent with the 
result obtained from the radiolabelled study.  In our fluorescent study formation of high 
molecular weight products, such as pentamer and higher were no observed.  However, 
literature publication shown that cyclohexylmethyl α-D-mannopyranosyl-(1→6)α-D-
mannopyranoside (2.24) and cyclohexylethyl α-D-mannopyranosyl-(1→6)α-D-
mannopyranoside (2.25) were capable of accepting up to ten additional mannose 
residues when incubated with radiolabelled GDP-[
14
C]Man and mycobacterial 
membranes (Fig. 2.28).
149
  Furthermore, the publication is stating that the transfer of 
mannose residue was not affected by the aglycone.  In our study the obtained results 
lead to slightly different conclusion.  We have shown that incubation of H-α-Mana-1,6-
Man (2.10), which has a shorter slightly less hydrophobic aglycone, with mycobacterial 
membrane resulted in formation of α-1,6-linked trisaccharide whereas incubation of 
2.13 resulted in α-1,6-linked trisaccharide and tetrasaccharide fluorescent products.  The 
difference in aglycone between 2.10 and 2.13 is more pronounced compared to the 
difference in 2.24 and 2.25 therefore we can observe a more profound effect of aglycone 
association with the mycobacterial membrane.  In another publication α-D-
mannopyranosyl-(1→6)α-D-mannopyranoside and α-D-mannopyranosyl-(1→6)-α-D-
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mannopyranosyl-(1→6)α-D-mannopyranoside that containeed no aglycone shown an 
excellent substrate activities toward the α-1,6-ManT in M. smegmatis leading to 
formation of radiolabelled products up to a dodecamer, which is the longest oligomer 
found by addition of [
3
H]mannose to endogenous acceptor.
150
  
 
Figure 2.28 Structural comparison between acceptors used in the literature radiolabelled assays and in the 
fluorescence-based methodology. 
Recently, activities of two α-1,6-ManTs were identified in Corynebacterium 
glutamicum species that share similar orthologue enzymes involved in cell wall 
assembly with M. tuberculosis and M. smegmatis.  The first α-1,6-ManT (MptB) 
enzyme has been shown to be involved in initial stage of AcPIM4 elongation where the 
second α-1,6-ManT involved in further elongation of LM to produce mature LM.  
Therefore, all together these results indicate that with our fluorescent acceptors probably 
target MptB α-1,6-ManT that perhaps requires acceptor association with M. smegmatis 
resulting in activity decrease as the aglycone size is reduced.  While mannoside 
acceptors without aglycone and cyclohexylmethyl/cyclohexylethyl mannoside acceptors 
target MptA α-1,6-ManT.  Nevertheless, in ongoing research where our fluorescence-
based methodology II perhaps can be of assistance and find its place in the research by 
simplifying enzymatic assays and eliminating the need for utilisation of radiolabelled 
donors.   
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Results from trypanosome fluorescent studies utilising α-Man-1,6-α-Man-HTC (2.13) 
had demonstrated addition of one galactose residue to the acceptor leading to formation 
of α- and β-linked fluorescent products.  These results were consistent with the results 
obtained from the radiolabelled study.  Overall using our fluorescent acceptor the 
proportion of galactose product in the β-linkage was approximately 20% as judged by 
peaks intensity in the IM-MS chromatogram compared to 10% for octyl 6-O-α-D-
manopyranosyl-1-thio-α-D-mannopyranoside acceptor from the radiolabelled assays.  In 
addition we did not detect either α-1,2 or α-1,4-linked products. 
Results presented above shown that fluorescence-based methodology II, with 
fluorescent labelling prior to the biotransformation, can be successfully applied to probe 
membrane bound glycosyltransferases involved in the biosynthesis of variety of 
glycoconjugates.  This methodology can be strongly considered as a replacement for 
traditional radiolabelled techniques.  Further, in our study we utilise fluorescence-based 
methodology II to probe the biosynthesis of glycoconjugates in Euglena gracilis. 
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3 The quest for glycosyltransferase activities in Euglena 
gracilis  
  
77 
 
3.1 Insight into Euglena  
Euglena is a unicellular flagellated and free living microorganism which mainly 
inhabits fresh water, although it has a high degree of adaptability and can survive in 
harsher environmental conditions, such as low pH (as low as 0.9), high salinity and 
highly energetic ionising radiation.
151, 152
  Euglena is a unique organism which exhibits 
both plant- and animal-like characteristics: it can live in the light by producing food 
autotrophically employing photosynthesising chloroplast, or it can exist in the dark and 
utilise nourishments heterotrophically from the environment and store it as a paramylon 
(starch-like β-1,3-glycan).  Structurally, it is composed of all organelles present in the 
eukaryotic cell (Fig. 3.1).  It does not have a cell wall like plant; on the contrary, the 
outer part is composed of repetitive membrane domains know as ridges and groves, that 
have a topographic relationship with fibrils and subpellicular ER.
153, 154
   
 
Figure 3.1 The Euglena gracilis cell. (Left) Electron microscope images to represent different shapes E. gracilis can 
adopt; (Right) Diagrammatic representation of Euglena cell to show main organelles.151 
Euglena has been placed in the common phylum of Euglenozoa,
155, 156
 that also includes 
parasitic trypanosomatids, one of which is Trypanosoma brucei.  Glycoconjugates, such 
as GPI anchors and N-linked glycoproteins, on the cell surface of parasites, play an 
important role in their survival and infectivity inside the vector and host organisms 
(refer to Chapter 2 section 2.7.9).
17
  Recently in our group, Dr. Ellis O’Neill resolved 
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the transcriptome of E. gracilis and, based on the homology with known enzymes, he 
was able to demonstrate that it contains sequences for all enzymes involved in the 
biosynthesis of N-linked glycoproteins and GPI anchors.
157
  To the best of our 
knowledge no structural information of GPI anchors or characterisation of 
glycosyltransferase activities involved in their biosynthesis has been investigated in E. 
gracilis (Fig. 3.2).  Previous study described the extraction of glycoproteins rich in 
xylose, mannose, glucose and galactose residues from the outer membrane of the E. 
gracilis flagellum.
158
  The extraction of these glycoproteins was accomplished with 
detergents and under conditions which perturbed hydrophobic interactions, therefore, 
authors suggested that these glycoproteins could contain a hydrophobic, presumably 
membrane-associated region.  Furthermore, no further research has been performed to 
obtain information on whether glycoproteins were GPI anchored or how oligosaccharide 
regions are bound to the protein for these particular glycoproteins.   
Limited research has been performed to elucidate the structural composition of N-linked 
glycoproteins in E. gracilis.
159
  In this study, intact E. gracilis cells were incubated with 
the UDP-[
14
C]Glc and radiolabelled lipid-linked N-glycans and N-linked glycoproteins 
were extracted at different time points of incubation.  Then, lipid-linked N-glycans were 
treated with mild acid hydrolysis to release monosaccharides, while N-linked 
glycoproteins were treated with site-specific endo-β-N-acetylglucosaminidase H 
enzyme, which cleaves the bond between two N-acetylglucosamine subunits to release 
N-linked oligosaccharide.  The released monosaccharides and N-linked oligosaccharides 
were then compared to standards utilising paper chromatography.  Results showed that 
dolichol-P-P-bound oligosaccharide migrated as Glc3Man9GlcNAc2 standard and 
contained glucose, mannose and N-acetylglucosamine residues as shown by acid 
hydrolysis.  Based on these data, the author suggested that the mechanism of protein N-
glycosylation in E. gracilis is similar to that occurring in higher eukaryotic cells (Fig. 
3.2) and the lipid-linked oligosaccharide intermediate is different compared to the 
oligosaccharide structure found in Trypanosoma (Man9GlcNAc2-P-P-Dol).   
The importance of GPI anchors and N-linked glycoproteins on the cell surface of 
parasites and position of Euglena in the same phylum as trypanosomatids as well as lack 
of knowledge in this area of research prompted us to investigate biosynthesis of these 
glycoconjugates in E. gracilis, with the scope that, if relevant activities could be 
detected, Euglena can be used as an alternative model system.   
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Figure 3.2 Diagrammatic representation of conserved N-glycan and GPI anchor biosynthesis to illustrate 
limited information available on glycosyltransferases present in Euglena gracilis.  The red box area indicates the 
site of authentic intermediate mimicked by the synthetic acceptors in the fluorescence-based assays. 
 
3.2 Fluorescence-based methodology II to probe mannosyltransferase 
activities in Euglena gracilis  
To uncover potential mannosyltransferase (ManT) activities in E. gracilis responsible 
for the biosynthesis of either GPI anchor or lipid linked N-glycans we investigated the 
possibility of mannosylation of synthetic acceptors with GDP-mannose by microsomal 
membranes isolated from this organism.  The detection of enzymatic activity was 
accomplished by fluorescence-based methodology II, which requires fluorescent 
labelling of monosaccharide and disaccharide acceptors prior to biotransformation (refer 
to Chapter 2).  The fluorescent acceptors of our choice were α-Man-HTC (2.12) and α-
Man-1,6-α-Man-HTC (2.13), which could potentially mimic the structure of authentic 
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intermediates involved in the biosynthesis GPI-anchor and lipid-linked N-glycan (Fig. 
3.3).   
 
 
Figure 3.3 Schematic and chemical structures of fluorescent acceptors used in fluorescence-based methodology 
II to probe mannosyltransferases activities in Euglena gracilis microsomal membranes.  The red box indicates 
the site of authentic intermediate mimicked by synthetic acceptors.   
 
3.2.1 Microsomal membranes as a source of glycosyltransferases 
Glycosyltransferases that participate in the biosynthesis of vast variety of 
glycoconjugates are located in the ER and Golgi apparatus.
160
 These types of enzymes 
are often directly associated with microsomal membranes.  This association presents a 
major challenge for their isolation from the microsomal membranes with retained 
enzymatic activities.  Indeed, their isolation often leads to enzyme denaturation with 
subsequent loss of activity.  Therefore, in this study E. gracilis microsomal membranes 
containing membrane-bound glycosyltransferases were extracted following the 
literature procedure,
161
 which preserves activities of membrane-bound 
glycosyltransferases; the latter could then be successfully utilised in fluorescence-based 
methodology II.  Microsomal membranes were obtained by growing axenic cultures of 
Euglena gracilis var saccharophila Klebs (stain 1224/7a) in the dark in media 
supplemented with glucose.  After seven days, cells were harvested and lysed by 
ultrasonication.  The larger cell debris was then removed by centrifugation and the 
microsomal membranes were obtained by ultracentrifugation over a sucrose gradient.  
Microsomal membranes were stored at -80 °C and the same batch of microsomal 
membranes was used throughout a year without losing their enzymatic activities. 
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3.2.2 Fluorescence assays to probe mannosyltransferase activities 
In these assays, fluorescent acceptors α-Man-HTC (2.12) and α-Man-1,6-α-Man-HTC 
(2.13) were incubated with GDP-Man in the presence of E. gracilis microsomal 
membranes.  To ensure the absence of endogenous GDP-Man in the membrane 
preparation as well as to rule out the decomposition of starting acceptors, two control 
assays that contained either no enzyme or no donor substrate were run in parallel with 
fluorescent assays (Fig. 3.4 A and B, lane 3 and 4).  The formation of fluorescent 
products, after 24 h of incubation at 30 °C, was monitored by TLC (Fig. 3.4).  
 
Figure 3.4 TLC analyses of fluorescence-based assays to assess mannosyltransferase activities in Euglena 
gracilis microsomal membranes.  TLC images of fluorescent assays (A) α-Man-HTC acceptor (2.12);  (B) α-Man-
1,6-α-Man-HTC acceptor (2.13).  Assay conditions: acceptor (2 mM); donor GDP-Man (4 mM); reaction buffer 
HEPES/KOH (10 mM, pH 7.0), MgCl2/MnCl2 (10 mM), KCl (25 mM), glycerol (10%), E. gracilis microsomal 
membranes (150μL, 195 μg of total proteins) in total reaction volume of 200 μL.  Control experiments, lane 3 
(without enzyme) and lane 4 (without donor), were conducted in parallel with enzymatic reactions.  TLC plates were 
eluted with CHCl3:MeOH:H2O (10:6:1) and visualised using mid-wave length range UV light.  The components of 
each reaction mixture are shown below the corresponding TLC image and acceptors and products are shown to the 
side of each TLC image.   
TLC analysis of enzymatic reaction that involved α-Man-HTC (2.12) acceptor showed 
two distinct fluorescent bands (Fig. 3.4 A, lane 5).  The upper band corresponded to 
starting acceptor substrate (2.12) and the lower band to the disaccharide product (3.01).  
The disaccharide product (3.01) had a similar Rf value as the α-Man-1,6-α-Man-HTC 
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(2.13) standard, suggesting a probable transfer of one mannose residue to the 
corresponding acceptor.  TLC analysis of enzymatic reaction that involved α-Man-1,6-
α-Man-HTC (2.13) acceptor also showed two distinct fluorescent bands (Fig. 3.4 B, 
lane 5).  The upper band corresponded to starting acceptor substrate (2.13) and the 
lower band to the trisaccharide product (3.02) again indicative of probable transfer of 
one mannose residue on the corresponding acceptor.  Products fluorescent band 
intensities visually indicated a higher enzymatic activity in case of α-Man-HTC (2.12) 
acceptor; however, a more precise measurement on the conversion should be done using 
HPLC method.   
 
3.2.3 Purification of fluorescent products by HPLC 
Evidently, above TLC analyses indicated the presence of mannosyltransferase activities 
in E. gracilis microsomal membranes as observed from the formation of disaccharide 
(3.01) and trisaccharide (3.02) products.  In order to establish the structure of above 
fluorescent products, they were first separated from starting acceptor substrates α-Man-
HTC (2.12) and α-Man-1,6-α-Man-HTC (2.13) by reverse phase and normal phase 
HPLC methods.   
Application of reverse phase HPLC allowed separation of disaccharide (3.01) and 
trisaccharide (3.02) products revealing one peak at 8.1 min for 3.01 (Fig. 3.5 A, red 
trace) and one peak at 7.4 min for 3.02 (Fig. 3.5 A, blue trace) under this 
chromatographic condition.  In contrast, application of normal phase HPLC enabled the 
separation of disaccharide (3.01) product into two peaks, designated as 3.01a (retention 
time 5.3 min) and 3.01b (retention time 5.6 min) (Fig. 3.5 B, red trace).  Similarly, 
under the same chromatographic condition, trisaccharide (3.02) product resolved into 
two peaks 3.02a (6.6 min) and 3.02b (7.2 min) (Fig. 3.5 B, blue trace).   
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Figure 3.5 HPLC analyses of reaction mixtures obtained from incubation of fluorescent acceptors with GDP-
Man in the presence of Euglena gracilis microsomal membranes.  UV chromatograms of mannosylated products 
from α-Man-HTC (2.12) assay (red trace) and α-Man-1,6-α-Man-HTC (2.13) assay (blue trace).  (A) Reverse phase 
purification of disaccharide 3.01 and trisaccharide 3.02 products.  HPLC conditions: Phenomenex C18(2) (250 mm x 
10 mm); mobile phase: 0.1% aq. water (0.1% TFA)-CH3CN (10 to 90 % 36 min, flow rate: 5 mL/min); UV detector 
at 347 nm.  (B) Normal phase HPLC purification of disaccharide 3.01 and trisaccharide 3.02 products. HPLC 
conditions: Phenomenex LUNA NH2 (250 mm x 10 mm); mobile phase: CH3CN-water (0.1% TFA) (10 to 80% 32 
min, flow rate: 5 mL/min); UV detector at 347 nm.  
The integration of the peak area of disaccharide (3.01) and trisaccharide (3.02) products 
in comparison to the peak area of starting acceptor substrates α-Man-HTC (2.12) and α-
Man-1,6-α-Man-HTC (2.13) provided information about product percentage 
conversion.  The percentage conversion obtained from the reverse phase HPLC method 
was consistent with the overall calculated percentage conversion obtained from the 
normal phase method (Table 3.1).   
Reaction products  Normal Phase (NH2) Reverse phase (C18) 
  
Peak a  
Conversion  
(%) 
 
Peak b  
Conversion 
(%) 
Peak a/b 
Conversion 
 (%) 
3.01  6.9  3.9 9.3 
3.02  1.2  2.6 3.1 
 
Table 3.1 Percentage conversion of fluorescent products obtained from enzymatic reactions with Euglena 
gracilis microsomal membranes. 
TLC analyses of purified fractions obtained from both HPLC methods above revealed 
trailing of dominant starting material components (data not shown).  The trailing 
resulted in contamination of fractions containing disaccharide (3.01) and trisaccharide 
(3.02) products with starting material when using normal phase HPLC.  Therefore, 
reverse phase HPLC was used to purify fluorescent products because they eluted before 
the dominant acceptor substrates, resulting in a cleaner purification.  Purified fractions 
containing fluorescent products were combined and analysed by LC-MS. 
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3.2.4 Identification of fluorescent products by LC-MS 
Normal phase chromatographic conditions were used for the LC separation of purified 
disaccharide (3.01) and trisaccharide (3.02) compounds applying a steeper gradient 
because it allowed a quick access to the required information on the number of mannose 
residues added to α-Man-HTC (2.12) and α-Man-1,6-α-Man-HTC (2.13) during 
biotransformation (Fig. 3.6 A1, red trace and 3.6 A2, blue trace).   
 
Figure 3.6 Structural identification of fluorescent products obtained from enzymatic reactions with GDP-Man 
and Euglena gracilis microsomal membranes by LC-MS.  (A) UV chromatogram (A1) disaccharide 3.01 from α-
Man-HTC (2.12) assay (red trace); (A2) trisaccharide 3.02 from α-Man-1,6-α-Man-HTC (2.13) assay (blue trace).  
LC conditions: Kinetex LUNA NH2 (50 mm/2.1 mm/2.6 μm); mobile phase: CH3CN- water (0.1% TFA) (10 to 90 %, 
12 min, flow rate: 0.3 mL/min); UV detector at 347 nm.  (B) MS spectra for 3.01 (B1) and 3.02 (B2).  (C) 
MS2spectra of 3.01 (C1) and 3.02 (C2). 
MS data of disaccharide 3.01a/b (retention time 5.3 min) and trisaccharide 3.02a/b (6.7 
min) confirmed addition of single mannose residues to the α-Man-HTC (2.12) and α-
Man-1,6-α-Man-HTC (2.13).  Thus, major peaks observed in the MS spectrum of 3.01 
(m/z 626.31) and 3.02 (m/z 788.16) correspond to [M+H]
+
 of disaccharide and 
85 
 
trisaccharide molecular ions (Fig. 3.6, B1 and B2), respectively.  The MS2 
fragmentation pattern of [M+H]
+
 showed the sequential loss of hexose units (m/z 162) 
and ultimate release of fluorescent HTC (2.11) aglycone (m/z 302.00) in both MS2 
spectra of 3.01 and 3.02 (Fig. 3.6, C1 and C2), respectively.   
 
3.2.5 Linkage analysis through exo-mannosidase digestions 
Information about the anomeric configuration of glycosidic linkages in disaccharide 
3.01 and trisaccharide 3.02 were assessed through exo-glycosidase digestion with jack 
bean α-mannosidase.114  Sequential digestion of 3.01 and 3.02 with three different 
linkage-specific Aspergillus saitoi α-1,2-,88 Xanthomonas manihotis α-1,6- and 
Xanthomonas manihotis α-1,2/3-mannosidases,162 capable of cleaving α-1,2-, α-1,6- and 
α-1,2/3-linked mannosides selectively, gave access to structural information on the 
regioselectivity of linkages formed between transferred mannose residues and α-Man-
HTC (2.12) and α-Man-1,6-α-Man-HTC (2.13) acceptor substrates.  Disaccharide 3.01 
and trisaccharide 3.02 compounds were incubated with exo-glycosidase and the 
outcome of these reactions was analysed by TLC (Fig. 3.7 and 3.8).   
TLC analyses of jack bean α-mannosidase digestion from disaccharide 3.01a/b 
compound revealed formation of fluorescent band with the same Rf value as fluorescent 
HTC (2.11) aglycone, corresponding to removal of two mannose residues from 3.01 
(Fig. 3.7 A, lane 2 and Fig. 3.7 B(i)).  Incubation of disaccharide (3.01a/b) compound 
with Xanthomonas manihotis α-1,6-mannosidase had no effect on fluorescent 
compounds and therefore, formation of the α-1,6-linkage was excluded (Fig. 3.7 A, 
Lane 4).  TLC analysis of disaccharide (3.01a/b) digestion with Aspergillus saitoi α-1,2-
mannosidase released a significant amount of fluorescent product with the same Rf 
value as α-Man-HTC (2.12).  However, a small amount of fluorescent disaccharide 
(3.01b) product remained unhydrolysed, which is indicative of the presence of another 
isomeric compound with a different linkage (Fig. 3.7 A, lane 6 and Fig. 3.7 B (ii)).  In 
order to assess what type of glycosidic linkage the underlying mannoside possessed, it 
was subjected to further digestion with Xanthomonas manihotis α-1,2/3-mannosidase.  
In this case, both fluorescent products were digested.  The disaccharide (3.01 a) was 
mainly converted into a fluorescent product with the same Rf value as HTC (2.11) 
aglycone, along with a minor fluorescent product with the same Rf as α-ManT-HTC 
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(2.12) (Fig. 3.7 A, lane 8 and Fig. 3.7 B (iii)).  Considering the 1,3-mannosidase activity 
of Xanthomonas manihotis α-1,2/3-mannosidase, it is reasonable to suggest that the 
mannose residue was attached to the fluorescent acceptor substrate α-ManT-HTC (2.12) 
mainly through α-1,2-linkage and in minor amount through α-1,3-linkage.   
 
 
Figure 3.7 TLC analyses to assess stereoselectivity and regioselectivity of disaccharide fluorescent products by 
exo-glycosidase digestions.  (A) TLC image of exo-glycosidase digestion of disaccharide 3.01a/b with jack bean α-
mannosidase (α-ManH), Xanthomonas manihotis α-1,6-mannosidase (α-1,6-ManH), Aspergillus saitoi α-1,2-
mannosidase (α-1,2-ManH) and Xanthomonas manihotis α-1,2/3-mannosidase (α-1,2/3-ManH).  Enzymes used in the 
assays are shown below the TLC traces and acceptors and products are shown to the side of each TLC image.  
Control experiments, lane 1, 3, 5 and 7 (without enzyme), were conducted in parallel with hydrolysis reactions.  TLC 
plates were eluted with CHCl3:MeOH:H2O (10:6:1) and visualised using mid-wave length range UV light.  (B) 
Diagrammatic reaction schemes of exo-glycosidase digestion of 3.01a/b  
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Similarly, TLC analysis from jack bean α-mannosidase digestion of trisaccharide (3.02) 
compound revealed removal of three mannose residues releasing a fluorescent product 
with the same Rf value as fluorescent HTC (2.11) aglycone (Fig. 3.8 A, lane 2 and Fig. 
3.8 B(i)).  Incubation of trisaccharide (3.02) compound with Xanthomonas manihotis α-
1,6-mannosidase also had no effect on fluorescent compound therefore, excluding 
formation of the α-1,6-linkage (Fig. 3.8 A, lane 4).  The hydrolysis of 3.02 with 
Aspergillus saitoi α-1,2-mannosidase resulted in formation of only one fluorescent 
product with the same Rf value as fluorescent α-Man-1,6-α-Man-HTC (2.13), thus 
indicating introduction of α-1,2-mannopyranosidic linkage in this product (Fig. 3.8 line 
6, and Fig. 3.8 B (ii)). 
 
 
Figure 3.8 TLC analyses to assess stereoselectivity and regioselectivity of trisaccharide fluorescent products by 
exo-glycosidase digestions.  (A) TLC image of exo-glycosidase digestion of trisaccharide 3.02 with jack bean α-
mannosidase (α-ManH), Xanthomonas manihotis α-1,6-mannosidase (α-1,6-ManH) and Aspergillus saitoi α-1,2-
mannosidase (α-1,2-ManH).  Enzymes used in the assays are shown below the TLC traces and acceptors and products 
are shown to the side of each TLC image.  Control experiments, lane 1, 3 and 5 (without enzyme), were conducted in 
parallel with hydrolysis reactions.  TLC plates were eluted with CHCl3:MeOH:H2O (10:6:1) and visualised using 
mid-wave length range UV light.  (B) Diagrammatic reaction schemes of exo-glycosidase digestion of 3.02 with (i) α-
ManH, (ii) α-1,2-ManH. 
. 
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3.2.6 Confirmation of newly formed linkages in fluorescent mannoside products 
by LC-MS 
TLC analysis of Aspergillus saitoi α-1,2-mannosidase digestion revealed an incomplete 
hydrolysis of disaccharide (3.01a/b) compound, indicating presence of mixed 
fluorescent compounds with major α-1,2- (3.01a) and minor α-1,3-linkages (3.01b) 
(Fig. 3.9 A).  The minor fluorescent disaccharide (3.01b) had a low fluorescent intensity 
on the TLC plate, thereby making final conclusions challenging.  In order to confirm 
these TLC observations, the reaction mixture from Aspergillus saitoi α-1,2-mannosidase 
digestion of disaccharide (3.01) was submitted to LC-MS analyses (Fig. 3.9 B).   
 
 
Figure 3.9 Formation of two fluorescent disaccharide isomeric compounds confirmed by LC-MS analysis. (A) 
Diagrammatic reaction schemes of exo-glycosidase digestion of 3.01a/b.  (B I) UV chromatogram of reaction 
mixture from exo-glycosidase digestion of 3.01a/b with Aspergillus saitoi α-1,2-mannosidase (α-1,2-ManH).  LC 
conditions: Kinetex C18 (50 mm/2.1 mm/2.6 micron); mobile phase: water (0.1% TFA)-CH3CN (10 to 90 %, 18 min, 
flow rate: 0.3 mL/min); UV detector at 347 nm.  (B Ia) MS spectrum of major monosaccharide product α-Man-HTC 
(2.12) obtained from hydrolysis of 3.01a/b; (B Ib) MS spectrum of minor disaccharide product 3.01b obtained from 
hydrolysis of 3.01a/b. 
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The LC chromatogram from Aspergillus saitoi α-1,2-mannosidase digestion of 
disaccharide 3.01a/b revealed presence of two peaks a minor peak (b) at retention time 
4.0 min and a major (a) at 4.4 min (Fig. 3.9, B I).  This result was in agreement with 
TLC observation verifying presence of two isomeric products in 3.01a/b mixed 
compounds.  The MS spectrum of peak (a) had m/z of 464.15, which corresponded to 
fluorescent α-Man-HTC (2.12) formed from 3.01a as a result of the hydrolysis by 
Aspergillus saitoi α-1,2-mannosidase (Fig. 3.9, B Ia).  The MS spectrum of peak (b) had 
m/z of 626.15, which corresponded to unhydrolysed 3.01b (Fig. 3.9, B Ib).   
The LC chromatogram of Aspergillus saitoi α-1,2-mannosidase digestion of 
trisaccharide 3.02 revealed presence of only one peak (a) at retention time 4.0 min (Fig. 
3.10, A and BI).  The MS spectrum of peak (a) had m/z of 626.28, which corresponds to 
fluorescent α-Man-1,6-α-Man-HTC (2.13) (Fig. 3.10, BIa) indicating the complete 
hydrolysis of 3.02 by α-1,2-mannosidase. 
 
 
Figure 3.10 Presence of one fluorescent trisaccharide compound confirmed by LC-MS analysis. (A) 
Diagrammatic reaction schemes of exo-glycosidase digestion of 3.02.  (B I) UV chromatogram of reaction mixture 
from exo-glycosidase digestion of 3.02 with Aspergillus saitoi α-1,2-mannosidase (α-1,2-ManH).  LC conditions: 
Kinetex C18 (50 mm/2.1 mm/2.6 micron), mobile phase: 0.1% aq. TFA-CH3CN (10 to 90 %, 18 min, flow rate: 0.3 
mL/min) UV detector at 347 nm.  (B Ia) MS spectrum of disaccharide product α-Manα-1,6-Man-HTC (2.12) 
obtained from hydrolysis of 3.02. 
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3.2.7 Investigation of number and nature of isomeric structures in fluorescent 
products by IM-MS 
As mentioned in Chapter 2, exo-glycosidase digestion can be a slow method of 
analysing isomeric carbohydrates whereas ion mobility coupled to mass spectrometry 
(IM-MS) is a faster method to analyse numbers and types of isomeric compounds 
present in the mixture.  Therefore, to access these information recorded drift times of 
disaccharide (3.01a/b) and trisaccharide (3.02) compounds were compared to the drift 
time of known α-1,6-linked standards, such as α-Man-1,6-α-Man-HTC (2.13) and α-
Man-1,6-α-Man-1,6-α-Man-HTC (2.16).  The latter was obtained as a product from 
mycobacterial validation of fluorescence-based methodology II (refer to Chapter 2, 
section 2.7).  MS spectra of disaccharide (3.01) and trisaccharide (3.02) showed signals 
for both proton and sodium adducts although only proton adducts were well separated in 
ion mobility spectra whereas signal of sodium adducts of 3.01 and 3.02 were practically 
undistinguishable.  These types of observations have been described in the literature; 
where investigated group I metal ions upon binding to several isomeric carbohydrates 
imposed conformational changes in collision cross section of these carbohydrate 
structures.
142, 163
  The authors demonstrated that out of all group I metal ions sodium ion 
adducts, which are the most common carbohydrate ions analysed by MS, are often not 
suitable charge carrier in IM separation because it resulted in identical drift time for 
investigated isomeric carbohydrates.  For this reason in our investigation only mobility 
spectra of [M+H]
+
 were analysed.   
The drift time IM-MS spectrum of α-Man-1,6-α-Manα-HTC (2.13) standard indicated 
one peak at 5.92 ms (Fig. 3.11, A1).  In contrast, the drift time spectrum of investigated 
mixed isomeric disaccharide (3.01a/b) (m/z 626.25) contained two distinct peaks, one at 
5.60 ms corresponded to 3.01b and another at 6.22 ms corresponded to 3.01a (Fig. 3.11 
B1).  The peak assignment in this case was based on their intensities which were 
compared to the intensities of α-1,2-linked 3.01a and α-1,3-linked 3.01b observed in the 
UV chromatogram obtained from normal phase HPLC separation of 3.01 (refer to 
section 3.2.1, Fig. 3.5 B).  The drift time of disaccharide (3.01) compound did not 
coincide with drift times of standard α-Man-1,6-α-Manα-HTC (2.13) strongly indicating 
the absence of non-reducing α-1,6-linkages to mannose residue in tested 3.01 (Fig. 3.11, 
B1). 
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Figure 3.11 Drift time IM-MS spectra to represent number and nature of isomeric structures present in 
fluorescent mannoside products obtained from incubation with GDP-Man and Euglena gracilis microsomal 
membranes.  (A) Drift time IM-MS spectra of standards (A1) α-Man-1,6-α-Man-HTC (2.13) (m/z 626.25), (A2) α-
Man-1,6-α-Man-1,6-α-Man-HTC (m/z 788.16). (B) Drift time IM-MS spectra of (B1) disaccharide (3.01a/b) (m/z 
626.25) and (B2) 3.02 (m/z 788.16). 
The drift time IM-MS spectrum of α-Man-1,6-α-Man-1,6-α-Man-HTC (2.16) standard 
indicated one peak at 6.92 ms (Fig. 3.11, A2).  The drift time IM-MS spectrum of 
trisaccharide (3.02) (m/z 788) revealed a single peak at 6.82 ms, which did not 
overlapped with α-Man-1,6-α-Man-1,6-α-Man-HTC standard at 6.92 ms (Fig. 3.11, B2).  
Once more, this data strongly indicated the absence of non-reducing α-1,6-linkage to 
mannose residue in tested 3.02. 
 
3.2.8 Summary of fluorescence-based methodology II used to investigate 
mannosyltransferase activities in Euglena gracilis 
Fluorescent α-Man-HTC (2.12) and α-Man-1,6-α-Man-HTC (2.13) were designed to 
mimic α-1,6-linked intermediates and to fit into N-glycan and/or GPI-anchors 
biosynthetic pathways with a view to probing mannosyltransferases that are responsible 
for biosynthesis of these glycoconjugates.  These compounds proved to be acceptor 
substrates for mannosyltransferases present in E. gracilis microsomal membranes.  In 
order to establish which mannosyltransferases were detected, the structures of 
enzymatic fluorescent products were elucidated through a combination of HPLC, LC-
MS, exo-glycosidase digestion and IM-MS methods.  The analysed data convincingly 
indicated the formation of two fluorescent disaccharide (3.01a/b) products from α-Man-
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HTC (2.12); the major product 3.01a, possesses a α-1,2-mannopyranosidic linkage and 
the minor 3.01b, has a α-1,3-mannopyranosidic linkage (Fig. 3.12 A).   
 
Figure 3.12 Schematic enzymatic reaction of monosaccharide acceptor and structural relationship between its 
disaccharide products and authentic N-glycan and GPI anchor intermediates.  (A) Schematic representation of 
mannosyltransferase reactions of monosaccharide fluorescent acceptor in the presence of GDP-Man and Euglena 
gracilis microsomal membranes.  (B) Structural similarity between fluorescent disaccharide products and authentic 
structure of N-glycan; (C) GPI anchor. 
In contrast, normal phase HPLC data obtained from enzymatic reaction with α-Man-1,6-
α-Man-HTC (2.13) acceptor substrate indicated formation of two fluorescent 
trisaccharide (3.02a/b) products (Fig. 3.13 A).  Subsequent analysis with exo-
glycosidase digestion as well as IM-MS analysis indicated presence of one α-1,2-linked 
isomer.  These discrepancies could be explained by either formation of potential artefact 
in normal phase HPLC or by possible formation of branched product that can be 
hydrolysed by Aspergillus saitoi α-1,2-mannosidase and it can have a similar drift time 
in IM-MS spectrum.  Nevertheless, further investigation to determine presence of the 
other isomer is required.  The characterisation of disaccharide 3.01a/b and trisaccharide 
3.02 confirmed that α-Man-HTC (2.12) and α-Man-1,6-α-Man-HTC (2.13) acted as 
acceptor substrates for α-1,2- and α-1,3-ManT present in E. gracilis.  Enzymatic product 
comparison to the authentic structure of N-glycan and GPI anchor indicates that the 
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detected enzymes are most likely involved in the construction of N-glycan in E. gracilis.  
However, the possibility of targeting α-1,2-ManT responsible for the biosynthesis of 
GPI anchors cannot be ruled out at this stage (Fig. 3.12 and Fig 3.13 B and C) 
 
Figure 3.13 Schematic enzymatic reaction of disaccharide acceptor and structural relationship between its 
disaccharide products and authentic N-glycan and GPI anchor intermediates.  (A) Schematic representation of 
mannosyltransferase reactions of disaccharide fluorescent acceptor in the presence of GDP-Man and Euglena gracilis 
microsomal membranes.  (B) Structural similarity between fluorescent trisaccharide products and authentic structure 
of N-glycan; (C) GPI anchor. 
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3.3 Exploration of other glycosyltransferases in Euglena gracilis 
Detection of α-1,2-mannosyltransferase and α-1,3-mannosyltransferase activities in E. 
gracilis microsomal membranes prompted us to probe activities of membrane-bound 
glycosyltransferases involved in further modification and decoration of protein-linked 
N-glycan in this organism.   
The N-glycan biosynthesis up to Glc3Man9GlcNAc2-P-P-Dol oligosaccharide in all 
eukaryotes is conserved, however only multicellular eukaryotes can make complex 
protein-linked N-glycans (Chapter 1, section 1.2.1).  In general, N-glycosylation of 
proteins in mammalian, avian, insect, fungal, and plant cells involves the transfer of 
glycan Glc3Man9GlcNAc2 from dolichol-P-P derivative to asparagine residues of the 
emerging protein.  This process occurs in the ER and is catalysed by oligosaccharyl 
transferase.
164
  In the next stage, the glycoprotein is transferred to the Golgi apparatus 
where protein-linked oligosaccharide undergoes terminal modifications that are 
organism- as well as protein-specific (Fig. 3.14).   
 
Figure 3.14 Structural variations of N-linked glycoproteins in plants, mammalian and yeast systems. 
In mammals, the modification of the protein-linked oligosaccharide to the complex form 
occurs through sequential removal of glucose and mannose residues by glucosidases 
and mannosidases and addition of N-acetylglucosamine, fucose, galactose and sialic 
acid residues by specific transferases.
165
  In plants, the same process takes place, but 
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additionally, the Man3GlcNAc2 core structure undergoes α-1,3-fucosylation and β-1,2-
xylosylation, which is very specific to the plant system.
166
  The fucosylation of the core 
structure is also observed in mammalian cells, however the fucose residues are α-1,6-
linked in contrast to α-1,3-linked in plants.  By contrast, yeast removes all glucose 
residues from the high mannose protein-linked oligosaccharide and extends it with 
extensive numbers of mannose residues without adding the peripheral N-
acetylglucosamine, galactose and sialic acid residues that are characteristic of the 
mammalian cells.
167
   
The only structural information on N-linked glycoproteins present in E. gracilis is that, 
as in all eukaryotic cells, it produces Glc3Man9GlcNAc2-P-P-Dol glycan, which is then 
transferred onto the protein where glucose residues are removed by glucosidases to form 
Man9GlcNAc2 N-linked glycoprotein.
159
  However, to date the N-glycan structure of 
mature glycoproteins has not been characterised yet.  Given the complex nature of 
Euglena and its animal- and plants-like characteristics, we were interested to assess its 
glycosylation pathways. 
 
3.3.1 Fluorescence assays to probe glycosyltransferase activities  
Detecting α-1,2- and α-1,3-ManT activities in E. gracilis microsomal membranes 
prompted us to further probe glycosyltransferase activities that are involved in 
decoration of high mannose protein-linked N-glycans.  In this investigation fluorescent 
acceptors α-Man-HTC (2.12) and α-Man-1,6-α-Man-HTC (2.13) were chosen again 
because the core Man3GlcNac2 structure of N-glycan has Man and Man-1,6-α-Man 
residues that can be mimicked by these acceptors and offer potential for the detection of 
glycosyltransferase activities (Fig. 3.15). 
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Figure 3.15 Structures of fluorescent acceptors used in fluorescence-based methodology II to probe 
mannosyltransferases activities present in Euglena gracilis microsomal membranes.  (Top image) The 
diagrammatic representation of acceptor substrates.  The red box indicates the site of authentic intermediate 
mimicked by synthetic acceptors.   
In this assay system, acceptor substrates α-Man-HTC (2.12) and α-Man-1,6-α-Man-
HTC (2.13) were incubated with various sugar nucleotides, including GDP-Fuc, UDP-
Glc and UDP-GlcNAc in the presence of E. gracilis microsomal membranes.  The 
absence of endogenous sugar nucleotides and the enzymatic hydrolysis of starting 
acceptors were monitored by running controls without donor substrate or enzyme, 
respectively, in parallel with fluorescence assays.  The formation of fluorescent 
products in each enzymatic reaction, after 24 h of incubation at 30 °C, was monitored by 
TLC (Fig. 3.16 and Fig. 3.17 A and B).   
TLC analyses of fluorescent assays with α-Man-HTC (2.12) and α-Man-1,6-α-Man-
HTC (2.13) in the presence of GDP-Fuc and E. gracilis microsomal membranes showed 
that no enzymatic transformation occurred during these reactions (Fig. 3.16 A and Fig. 
3.17 B, lane 3).  This result is consistent with the overall structure of N-glycans in 
plants, where there is no fucose unit attached to the core mannose residue; instead, it is 
found on the GlcNAc residue of core N-glycan structure.
166
   
TLC analysis of fluorescent assay involving α-Man-HTC (2.12) in the presence of 
UDP-Glc and E. gracilis microsomal membranes revealed two fluorescent bands (Fig. 
3.16 A, lane 4).  The fluorescent band with the higher Rf value was assigned to the 
fluorescent disaccharide (3.03) product as judged by comparison with Rf value of the α-
Man-1,6-α-Man-HTC (2.13).  The fluorescent band with the lowest Rf value, initially, 
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was assigned as an oligosaccharide 3.04 with a possible transfer of more than one 
glucose residues (Fig. 3.16 B).   
 
Figure 3.16 TLC analyses of enzymatic assays involving incubation of monosaccharide fluorescent acceptor 
substrate with number of sugar nucleotides in the presence of Euglena gracilis microsomal membranes.  TLC 
images (A) α-Man-HTC acceptor (2.12).  Fluorescent assay conditions: acceptor (2 mM); donor (4 mM); reaction 
buffer HEPES/KOH (10 mM, pH 7.0), MgCl2/MnCl2 (10 mM), KCl (25 mM), glycerol (10%); E. gracilis 
microsomal membrane (150 μL, 195 µg of total proteins).  TLC plates were eluted with CHCl3:MeOH:H2O (10:8:2) 
and visualised using mid-wave length range UV light.  Components of each reaction mixture are shown below the 
corresponding TLC trace and acceptors and products to the side of the TLC image.  Controls experiments, lane 1 
(without enzyme) and lane 2 (without donor), were conducted in parallel with these assays.  (B) Diagrammatic 
assignment of the TLC plate. 
TLC analysis of fluorescent assays with α-Man-HTC (2.12) and UDP-GlcNAc in the 
presence of E. gracilis microsomal membranes revealed one fluorescent band 
corresponding to formation of fluorescent (3.05) product (Fig. 3.16 A, lane 5).  
Surprisingly, the Rf value of this product co-eluted with the Rf value of the fluorescent 
(3.04) product obtained in the reaction of α-Man-HTC (2.12) with UDP-Glc.  In theory, 
the Rf value of product that contains more than one GlcNAc residues is expected to run 
slightly higher on the TLC plate compared to Rf values of 3.04 that contain more than 
one glucose residues due to presence of less polar acetyl group on GlcNAc sugar.
168
  
Furthermore, according to the literature
165, 166
 known structures of N-linked glycans 
from plants and mammals, one could expect a maximum of two GlcNAc residues (β-
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1,2- and β-1,4-linked) to be transferred to synthetic α-Man-HTC (2.12) acceptor.  The 
expected Rf value for such product should be higher compared to the observed Rf value.   
Similarly, TLC analysis of fluorescent assays that contained α-Man-1,6-α-Man-HTC 
(2.13) and UDP-Glc revealed two fluorescent bands (Fig. 3.17 B, lane 4).  The product 
with the higher Rf value was assigned to be a fluorescent trisaccharide (3.06) and the 
product with the lowest Rf was tentatively considered to be an oligosaccharide (3.07) 
with a possible addition of more than one glucose residues.  TLC analysis of fluorescent 
assays that contained α-Man-1,6-α-Man-HTC (2.13) and UDP-GlcNAc has shown one 
fluorescent product (3.08) with the same Rf value as 3.07 product obtained in the 
reaction of α-Man-1,6-α-Man-HTC (2.13) with UDP-Glc (Fig. 3.17 B, lane 5).  These 
results implied that fluorescent products 3.04/3.05 and 3.07 /3.08 went through a similar 
modification with a possible addition of polar sugar residue to α-Man-HTC (2.12) α-
Man-1,6-α-Man-HTC (2.13) acceptors.   
 
Figure 3.17 TLC analyses of enzymatic assays involving incubation of disaccharide fluorescent acceptor 
substrate with number of sugar nucleotides in the presence of Euglena gracilis microsomal membranes.  (A) 
Diagrammatic assignment of the TLC plate.TLC images (B) α-Man-1,6α-Man-HTC acceptor (2.13).  Fluorescent 
assay conditions: acceptor (2 mM); donor (4 mM); reaction buffer HEPES/KOH (10 mM, pH 7.0), MgCl2/MnCl2 (10 
mM), KCl (25 mM), glycerol (10%); E. gracilis microsomal membrane (150 μL, 195 µg of total proteins).  TLC 
plates were eluted with CHCl3:MeOH:H2O (10:8:2) and visualised using mid-wave length range UV light.  
Components of each reaction mixture are shown below the corresponding TLC trace and acceptors and products to 
the side of the TLC image.  Controls experiments, lane 1 (without enzyme) and lane 2 (without donor), were 
conducted in parallel with these assays. 
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3.3.2 Purification of fluorescent products by HPLC 
In order to establish the nature of newly formed linkages in fluorescent 
3.03/3.04/3.06/3.07 products obtained from UDP-Glc incubation, and 3.05/3.08 
obtained from UDP-GlcNAc incubation, all stated products were purified by reverse 
phase HPLC method.  The purification of reaction mixture from α-Man-HTC (2.12) 
allowed separation of glucosylated products into three peaks (Fig. 3.18 A, red trace), 
with fluorescent (3.03) compound separating into two peaks, labelled as 3.03a (retention 
time 8.3 min) and 3.03b (8.4 min).  These retention times corresponded to transfer of 
one glucose residue as judged by the comparison with the retention time of α-Man-1,6-
α-Man-HTC (2.13).  In contrast, fluorescent (3.04) product runs as a single peak (7.0 
min).  Under the same chromatographic conditions, the purification of reaction mixture 
obtained from α-Man-1,6-α-Man-HTC (2.13) allowed separation of glucosylated 
products into two single peaks assigned as 3.06 (retention time 7.7 min) and 3.07 (5.9 
min) (Fig. 3.18 A, blue trace).  The purification of reaction mixtures obtained from 
incubation of α-Man-HTC (2.12) and α-Man-1,6-α-Man-HTC (2.13) with UDP-GlcNAc 
allowed product separation into single peaks designated as (3.05) (retention time 7.2 
min) and (3.08) (6.0 min) (Fig. 3.18 B, red and blue traces).   
 
Figure 3.18 HPLC analyses of reaction mixtures obtained from incubation of fluorescent acceptors with UDP-
Glc and UDP-GlcNAc in the presence of Euglena gracilis microsomal membranes.  UV chromatogram (A) 
Enzymatic incubation of UDP-Glc with α-Man-HTC (2.12) (red trace) and α-Man-1,6-α-Man-HTC (2.13) (blue 
trace).  (B) Enzymatic incubation of UDP-Glc with α-Man-HTC (2.12) (red trace) and α-Man-1,6-α-Man-HTC (2.13) 
(blue trace).  HPLC conditions: Phenomenex C18 (250 mm x 10 mm); mobile phase: 0.1% aq. TFA-CH3CN (10 to 
90 % 36 min, flow rate: 5 mL/min); UV detector at 347 nm.  
The HPLC chromatogram also allowed integration of product peak area against the peak 
area of starting material and gave an estimate for the percentage conversion for each 
enzymatic reaction (Table 3.2).  Overall, the percentage conversions are low but no 
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further improvements were carried out at this stage.  Fractions containing purified 
fluorescent products were combined and subjected to further analysis.   
 α-ManHTC  
(2.12) 
Reaction products 
Conversion 
(%) 
α-Man-1,6α-Man-HTC 
(2.13) 
Reaction products 
Conversion  
(%) 
     
UDP-Glc 3.03a/b 1.6/0.64 3.06 0.7 
 3.04 1.8 3.07 1.4 
     
UDP-GlcNAc 3.05 4.9 3.08 5.8 
     
 
Table 3.2 Percentage conversion of fluorescent products obtained from enzymatic reactions with UDP-Glc and 
UDP-GlcNAc in the presence of Euglena gracilis microsomal membranes. 
 
3.3.3 IM-MS analyses on number of isomeric structures present in trisaccharide 
fluorescent product obtained from UDP-Glc incubation  
Reverse phase HPLC chromatogram revealed presence of two glucosylated disaccharide 
(3.03a and 3.03b) products, which had the same retention time as α-Man-1,6-α-Man-
HTC (2.13) indicating probable formation of mixed isomeric compound.  In order to 
confirm this observation, purified sample of mixed isomeric disaccharide (3.03) 
compounds were subjected to ultra-performance liquid chromatography (UPLC) MS 
coupled to IM-MS (Fig. 3.19).  The UPLC selected ion chromatogram showed no 
separation of mixed isomeric compounds revealing a single peak with retention time at 
6.4 min (Fig. 3.19 A).  In contrast, the mobility spectrum of 3.03 showed two peaks 
with m/z of 626 at 7.10 ms and 7.76 ms (Fig. 3.19 B).  Presence of other contaminants 
with higher m/z value affected peaks resolution.  These results together with HPLC 
observations confirmed the presence of two isomeric glucosylated disaccharide 
compounds in 3.03.  The fact that fluorescence-based assays detected 
glucosyltransferase activities is in agreement with the overall structure of protein linked 
oligosaccharide detected in E. gracilis (Glc3Man9GlcNAc2-Protein).
159
  IM-MS is a 
good technique that gives fast information on numbers of isomeric structures present in 
the mixed sample; however this time no standards were available to identify what 
linkages present in glucosylated disaccharide (3.03a and 3.03b) products. 
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Figure 3.19 .  UPLC and ion mobility analyses of isomeric structures present in glucosylated product obtained 
from incubation of UDP-Glc with Euglena gracilis microsomal membranes.  (A) UPLC selected ion 
chromatogram for trisaccharide (3.03a/b) compound.  UPLC conditions: Acquity UPLC BEH C18 (100 mm/1.0 
mm/1.7μm), mobile phase: water- CH3CN (0.1% formic acid) (10 to 90 %, 12 min, flow rate: 0.08 mL/min) MS 
detector.  (B) top image: m/z/drift time spectrum of trisaccharide 3.03 a/b(m/z 626.23); bottom image: % 
intensity/drift time spectrum of 3.03a/b. 
 
3.3.4 Identification of fluorescent products obtained from incubation of UDP-Glc 
by LC-MS 
LC separation of purified glucosylated disaccharide (3.03) and trisaccharide (3.06) 
compounds was performed utilising reverse phase chromatographic conditions to allow 
a quick access to the required information on the number of glucose residues added to 
α-Man-HTC (2.12) and α-Man-1,6-α-Man-HTC (2.13) during biotransformation.  The 
LC chromatogram of disaccharide (3.03) showed two peaks with retention time of 4.03 
min and 4.16 min (see appendices A1 and A2).  The extraction of a selected ion 
chromatogram with m/z of 626 resulted in only one peak at 4.16 min with this mass.  
The LC chromatogram of trisaccharide (3.06) showed one peak at 3.88 min with a slight 
shoulder at 3.94 min.  These observations could be due to either a carry over or a 
column contamination.   
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LC-MS analysis of MS data from selective ion chromatogram of disaccharide (3.03) 
and trisaccharide (3.06) confirmed addition of a single glucose residue to α-Man-HTC 
(2.12) and α-Man-1,6-α-Man-HTC (2.13) (Fig. 3.20 A and B).  The major peaks 
observed in the MS spectrum of 3.03 was m/z of 626.12 and of 3.06 was m/z of 788.23 
corresponded to [M+H]
+
 of disaccharide and trisaccharide, respectively (Fig. 3.19 B1 
and B2).  The MS2 fragmentation pattern of [M+H]
+
 for both compounds showed a 
sequential loss of one hexose unit (m/z 162) and ultimate release of fluorescent HTC 
(2.11) aglycone (m/z 302.00) (Fig. 3.20 C1 and C2).   
 
Figure 3.20 LC-MS analyses to investigate the nature of glucosylated products obtained from enzymatic 
biotransformation with UDP-Glc in the presence of Euglena gracilis microsomal membranes.  (A) Selective ion 
chromatograms (SIC) of glucosylated products (A1) disaccharide 3.03 (red trace) and (A2) trisaccharide 3.06 (blue 
trace).  LC conditions: Kinetex C(18) (50 mm/2.1 mm/2.6 μm); mobile phase: 0.1% aq. TFA-CH3CN (10 to 90 %, 18 
min, flow rate: 0.3 mL/min); UV detector at 347 nm.  (B) MS spectra for 3.03 (B1) and 3.06 (B2).  (C) MS2 spectra 
of 3.03 (C1) and 3.06 (C2). 
Reverse phase chromatographic conditions were also used with LC separation of 
purified glucosylated (3.04) and (3.07) compounds.  As described above, TLC analyses 
of Rf values of these compounds suggested presence of more than one sugar residue 
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added to α-Man-HTC (2.12) and α-Man-1,6-α-Man-HTC (2.13) acceptor substrates.  In 
contrast, LC-MS data analysis of 3.04 and 3.07 revealed addition of one sugar residue 
with slightly higher mass than that calculated by straight forward addition of single 
glucose reside occurred during these biotransformation (Fig. 3.21).   
 
Figure 3.21 LC-MS analyses to investigate the structure of fluorescent products obtained from enzymatic 
biotransformation with UDP-Glc in the presence of Euglena gracilis microsomal membranes.  (A) Selective ion 
chromatograms (SIC) of glucosylated products (A1) trisaccharide 3.04 (red trace) and (A2) tetrasaccharide 3.07 (blue 
trace).  LC conditions: Kinetex C(18) (50 mm/2.1 mm/2.6 μm); mobile phase: 0.1% aq. TFA-CH3CN (10 to 90 %, 18 
min, flow rate: 0.3 mL/min); UV detector at 347 nm.  (B) MS spectra for 3.04 (B1) and 3.07 (B2).  (C) MS2 spectra 
of 3.04 (C1) and 3.07 (C2). 
The analysis of MS data of 3.04 revealed two signals.  The major signal observed on the 
MS spectrum was m/z of 544.09 and minor m/z of 705.97 that corresponded to [M+H]
+
 
molecular ions (Fig. 3.21 B1).  The MS2 fragmentation pattern of 705.97 showed loss 
of glucose sugar unit (m/z 162.06) and release of fluorescent fragment with m/z of 
543.91 (Fig. 3.21 C1).  The second fragmentation resulted in loss of m/z of 242 
compared to expected  loss of hexose (m/z 162) and further release of fluorescent HTC 
(2.11) aglycone (m/z 301.90).  The difference between the observed and predicted 
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masses was calculated to be m/z of 80, which pointed towards the presence of a 
phosphate group and a possible formation of PO4-α-Man-HTC fluorescent fragment 
with m/z of 543.91. 
The analysis of MS data of 3.07 also revealed two signals.  The major signal observed 
on the MS spectrum was m/z of 706.17 and minor m/z of 868.12 that corresponded to 
[M+H]
+
 (Fig. 3.21 B2).  The MS2 fragmentation pattern of 868.12 showed loss of 
glucose residue (m/z 162.20) and release of fluorescent fragment with m/z of 705.92 
(Fig. 3.21 C2).  The second fragmentation again resulted in loss of m/z of 242 compared 
to calculated loss of hexose (m/z 162) and further release of fluorescent fragment with 
m/z of 463.90, which corresponds to the calculated mass of α-Man-HTC (2.11).  The 
difference between the observed and predicted masses again was calculated to be m/z of 
80, which directed us towards possible formation of PO4-α-Man-1,6-α-Man-HTC 
fluorescent fragment with m/z of 705.92.  Subsequently, the third fragmentation of 
463.90 resulted in loss of expected hexose unit (m/z 162) and release of fluorescent 
HTC (2.11) aglycone (m/z 302.08).   
 
3.3.5 Identification of fluorescent products obtained from incubation with UDP-
GlcNAc by LC-MS 
Purified fluorescent compounds (3.05) and (3.08) obtained from incubation of α-Man-
HTC (2.12) and α-Man-1,6-α-Man-HTC (2.13), respectively, with UDP-GlcNAc in the 
presence of E. gracilis microsomal membranes were subjected to LC-MS analysis.  LC-
MS analyses showed similar results to those described above for fluorescent (3.04) and 
(3.07) (Fig. 3.22).   
Briefly, LC-MS analysis of MS data revealed signals of m/z of 746.97 for 3.05 and m/z 
of 909.16 for 3.08, which corresponded to [M+H]
+
 molecular ions of phosphorylated 
trisaccharide and tetrasaccharide, respectively (Fig. 3.22 B1 and B2).  The MS2 
fragmentation of 746.97 and 909.16 showed loss of GlcNAc sugar unit (m/z 203.23) and 
release of fluorescent fragment with m/z of 543.92 for 3.05 and m/z of 705.93 for 3.08 
(Fig. 3.22 C1 and C2).  The second fragmentation resulted in loss of m/z of 241 for both 
compounds compared to predicted loss of hexose (m/z 162), and further release of 
fluorescent HTC (2.11) aglycone (m/z 302.08) for 3.05 and fluorescent α-Man-HTC 
(2.12) (m/z 463.94) for 3.08.  The difference between the observed and predicted masses 
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was again calculated to be m/z of 80.  The third fragmentation of m/z of 463.94 led to 
release of expected HTC (2.11) aglycone (m/z 302.08) for fluorescent (3.08) compound.   
 
Figure 3.22 LC-MS analyses to investigate the nature of fluorescent products obtained from enzymatic 
biotransformation with UDP-GlcNAc in the presence of Euglena gracilis microsomal membranes.  (A) UV 
chromatograms (A1) 3.05 (red trace), (A2) 3.08 (blue trace).  LC conditions: Kinetex C18 (50 mm x 2.1 mm x 2.6 
micron); mobile phase: CH3CN-water (10 to 90 % 18 min, flow rate 0.3 mL/min); UV detector at 347 nm.  MS.  (B) 
MS spectra for 3.05 (B1) and 3.08 (B2).  (C) MS2 spectra for 3.05 (C1) and 3.08 (C2). 
LC-MS data, that described above are conclusive with formation of phosphate bonds, 
resulting in generation of a new phosphodiester-linkage in trisaccharide (3.04/3.05) and 
tetrasaccharide (3.07/3.08) products.  This was also evident in the MS spectra for all 
analysed compounds that contain a major signal of m/z 544 and m/z 706.  This signal 
corresponded to PO4-α-Man-HTC and PO4-α-Man-1,6-α-Man-HTC, respectively.  At 
this stage the formation of isomeric phosphomonoester bond cannot be ruled out.  
Therefore, the nature of newly formed phosphate bonds in 3.04/3.07 (UDP-Glc) and 
3.05/3.08 (UDP-GlcNAc) were investigated through a series of enzymatic hydrolysis 
with and without chemical degradation.   
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3.3.6 Investigation of newly formed linkages in fluorescent products through 
enzymatic and chemical degradations 
In order to rule out formation of terminal phosphate, 3.04/3.07 (UDP-Glc) and 3.05/3.08 
(UDP-GlcNAc) were submitted to the enzymatic degradation with alkaline phosphatase, 
which catalyses a hydrolytic cleavage of terminal phosphate monoesters releasing an 
inorganic phosphate.
169, 170
  Therefore, compounds 3.04, 3.05, 3.07 and 3.08 were 
treated with alkaline phosphatase under alkaline conditions and the progress of these 
reactions was monitored by TLC.  A positive control experiment was performed in 
parallel with UDP substrate to ensure activity of alkaline phosphatase in the sample, as 
well as negative control without enzymes to rule out the decomposition of starting 
fluorescent compounds under experimental conditions.  TLC analyses of all investigated 
compounds revealed no changes confirming that none of these compounds had terminal 
phosphate groups attached (Fig. 3.23 A and B).   
 
Figure 3.23 TLC analyses to investigate presence of terminal phosphate in fluorescent products through 
application of enzymatic hydrolysis with alkaline phosphatase.  TLC images (A) Enzymatic hydrolysis of 
3.04/3.05 (UDP-Glc) with alkaline phosphatase (AP); (B) Enzymatic hydrolysis of 3.07/3.08 (UDP-GlcNAc) with 
AP.  Components and enzyme used in these assays are shown in the table below the TLC traces.  Control 
experiments, lane 1 and 2 (without enzyme), were conducted in parallel with these assays.  TLC plates were eluted 
with CHCl3:MeOH:H2O (10:8:2) and visualised and visualised using mid-wave length range UV light. 
The formation of phosphodiester-linkages in 3.04, 3.05, 3.07 and 3.08 was examined 
through chemical degradation with trifluoroacetic acid (TFA) following by treatment 
with alkaline phosphatase.  During this reaction, acidic condition promotes hydrolysis 
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of the glycosidic bond between Glc (3.04/3.07)/GlcNAc (3.05/3.08) residue and 
phosphate releasing fluorescent phosphate monoester compounds.  Further treatment 
with alkaline phosphatase removes terminal phosphate group with possible release of 
either fluorescent α-Man-HTC (2.12) or α-Man-1,6-α-Man-HTC (2.13) compounds 
(Fig. 3.24 A and B). 
 
Figure 3.24 Diagrammatic representation of sequential chemical and enzymatic degradation of fluorescent 
trisaccharide and tetrasaccharide products containing phosphodiester bond.  Trifluoroacetic acid (TFA) and 
alkaline phosphatase (AP). 
All four compounds were subjected to acid hydrolysis and alkaline phosphatase 
treatment and the progress of these reactions was monitored by TLC.  TLC analysis 
showed that after acid hydrolysis faint fluorescent bands were detected at the origin of 
the TLC plate for all tested compounds (Fig. 3.25 A and B, lane 1 and 3).  
Subsequently, on treatment with the alkaline phosphatase, the observed fluorescent 
bands for all tested compounds had higher Rf values compared to those detected 
previously.  In particular, in case of 3.04 and 3.05 both fluorescent bands had the same 
Rf value as fluorescent α-Man-HTC (2.12) compound and, in case of 3.07 and 3.08, 
fluorescent bands had same Rf value as fluorescent α-Man-1,6-α-Man-HTC (2.13) 
compound (Fig. 3.25 A and B, lane 2  and 4).  These observations strongly indicated 
presence of phosphodiester bond in all tested compounds. 
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Figure 3.25 TLC analyses to investigate the presence of phosphodiester bond in fluorescent products through 
application of chemical degradation and enzymatic hydrolysis.  Chemical degradation with TFA and enzymatic 
hydrolysis with AP (A) trisaccharide 3.04 and 3.05 (B) tetrasaccharide 3.07 and 3.  Components used in these assays 
are shown in the table below the TLC traces.  Control experiments lane 1 and 2 (without enzyme) were conducted in 
parallel with these assays.  The TLC plates eluted with CHCl3:MeOH:H2O (10:8:2) and visualised using mid-wave 
length range UV light. 
 
3.3.7 Characterisation and confirmation of fluorescent product by NMR 
spectroscopy 
Results discussed above about the possible formation of phosphodiester-linkages in 
3.04/3.07 (UDP-Glc) and 3.05/3.08 (UDP-GlcNAc) suggested the presence of sugar-
phosphate transferase activities in E. gracilis microsomal membranes, which transfer 
sugar-phosphate moieties from UDP-sugar donor substrate to acceptor substrates 
forming a phosphodiester-linkage.  Therefore, in order to further strengthen this 
proposed structural assignment, tetrasaccharide (3.08) compound obtained from UDP-
GlcNAc incubation was subjected to NMR spectroscopy.  For this purpose, the 
enzymatic reaction involving UDP-GlcNAc and acceptor 2.12 in the presence of E. 
gracilis microsomal membranes was scaled up to obtain approximately 0.12 mg of 3.08 
with estimated 10% enzymatic conversion.  In an attempt to increase the yield of 
product, the enzymatic reaction was run for 48 h at 30 °C with further addition of E. 
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gracilis microsomal membranes aliquot after 24 h.  The obtained product was purified 
by reverse phase HPLC resulting in a 43% isolated produc yield (0.48 mg).  The 
purified 3.08 was submitted NMR spectroscopy in order to aid structural assignment 
(Fig. 3.26 and Fig. 3.27). 
 
Figure 3.26 Characterisation of fluorescent phosphodiester-linked product by the NMR spectroscopy.  (A) The 
1H NMR spectra of selected regions to emphasise formation of 3.08.  (B) HSQC 2D spectrum of 3.08 (in red signals 
for CH and CH3 and in blue signals for CH2).  The NMR was run in D2O. 
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The 
1
H NMR spectrum of phosphodiester-linked (3.08) displayed all four coumarin 
signals in the aromatic region and a singlet signal at δ 8.26 ppm for the 1,4-triazole ring 
(Fig. 3.26 A1 and Appendices A6).  The proton signal at δ 5.48 ppm was assigned to the 
anomeric proton of GlcNAc sugar residue by utilising 2D analysis of 
1
H-
13
C HSQC of 
H1 with C1 (δH 5.48, δC 94.3 ppm) (Fig. 3.26 A2 and Fig. 3.27).  The other two 
expected anomeric signals of two mannose sugar residues run under the solvent peak 
but can be again identified through the 
1
H-
13
C HSQC correlation of H1 with C1 (δC 100 
ppm).  The observed doublet of doublets for the anomeric signal of the GlcNAc sugar 
residue, instead of expected doublet of a simple glycoside, is indicative of 
1
H-
1
H spin-
spin coupling between H1 and H2 (J1,2 3.6 Hz) and 
1
H-
31
P spin-spin coupling between 
H1 and P (J1,P 7.2 Hz).  The small value for both coupling constants suggests that 
anomeric centre on the GlcNAc has a α-configuration.171, 172  The proton signal at δ 4.14 
ppm was assigned to H6a and H6b of GlcNAc sugar residue by 
1
H-
13
C HSQC 
correlations of H6a and H6b with C6 (δH 5.48, δC 94.3ppm) and the proton signal at δ 
3.95 ppm was assigned to H2 of GlcNAc residue by 
1
H-
1
H COSY correlations of H2 
with H1.   Another characteristic proton signal, such as CH3 of acetyl group on the 
GlcNAc sugar residue at δ 2.06 ppm was also evident in the 1H NMR spectrum (Fig. 
3.26 A3).  
 
Figure 3.27 Characterisation of fluorescent phosphodiester-linked product by the NMR spectroscopy.  1H-31P 
HMBC spectrum (f1 31P and f2 1H).  
Analysis of the 
31
P NMR spectrum showed one singlet signal at δ -1.26 ppm which is a 
characteristic signal of phosphodiester.
173
  Subsequently, the 2D analysis of the 
31
P 
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signal on the 
1
H- 
31
P HMBC spectrum had cross-peak signals at δ 5.48 ppm for H1, 
4.14 ppm for H6 and 3.95 ppm for H2 (Fig. 3.27, Appendices A7).  These NMR data 
confirmed that the sugar-phosphate transferase enzyme present in E. gracilis 
microsomal membranes catalyses transfer of a GlcNAc-P sugar residue from the UDP-
GlcNAc to the 6’-hydroxyl of the mannose sugar residue of α-Man-1,6-α-Man-HTC 
(2.13) acceptor substrate with formation of 3.08 product, which possesses a 
phosphodiester-linkage (Fig. 3.28). 
 
Figure 3.28 Proposed structure and assignment of fluorescent phosphodiester-linked compound for NMR 
analysis. 
 
3.3.8 Summary of fluorescence-based methodology II used to investigate 
glycosyltransferase activities in Euglena gracilis 
Fluorescence-based methodology II utilising α-Man-HTC (2.12) and α-Man-1,6-α-Man-
HTC (2.13) acceptor substrates allowed detection of glycosyltransferase activities in E. 
gracilis microsomal membranes, which are known to be responsible for biosynthesis of 
lipid-linked N-glycan and further decoration of protein-linked N-glycan in eukaryotic 
cells.  Fluorescent assays with GDP-Fuc donor substrate and fluorescent α-Man-HTC 
(2.12) as well as α-Man-1,6-αMan-HTC (2.13) acceptor substrates did not give any of 
fluorescent product, which is consistent with overall structure of protein-linked N-
glycan where fucose sugar residue is attached to the N-acetylglucosamine but not to 
mannose of the core structure (Fig. 3.29 AI and BI).   
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Figure 3.29 Schematic representation of enzymatic activities detected in Euglena gracilis microsomal 
membranes.  (A) Enzymatic reactions and their products from incubation of α-Man-HTC (2.12) with sugar 
nucleotides (GDP-Fuc, UDP-Glc and UDP-GlcNAc).  (B) Enzymatic reactions and their products from incubation of 
α-Man α-1,6-Man-HTC (2.13) with sugar nucleotides (GDP-Fuc, UDP-Glc and UDP-GlcNAc). 
In contrast, fluorescent assays with UDP-Glc detected glucosyltransferase activities 
resulting in formation of two isomeric glucosylated disaccharides (3.03a/b) from 
incubation of fluorescent α-Man-HTC (2.12) and glucosylated trisaccharide (3.05) from 
incubation of α-Man-1,6-α-Man-HTC (2.13) (Fig. 3.29 AII and BII).  These detected 
glucosyltransferase activities are consistent with the reported lipid-linked structure of N-
glycan in E. gracilis, where three glucose residues are added to the lipid-linked 
oligosaccharide structure.
159
  LC-MS and IMS MS analysis of these products gave 
information about structural and isomeric compositions but not about the type of 
linkages formed during biotransformation.  According to the known conserved structure 
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of lipid linked N-glycan,
41
 we could predict that fluorescent isomeric mixture of 
disaccharide (3.03a/b) and trisaccharide (3.06) compounds to have either α-1,3- or α-
1,2-linkages.  Therefore, in the future, the anomeric configuration of glycosidic linkages 
in these compounds could be accessed through exo-glycosidase digestion with a non-
specific α- or β-glucosidases.  In contrast, regioselectivity of newly formed glycosidic 
linkages cannot be accessed using exo-glycosidase digestion with site specific enzymes 
due to the absence of commercially available linkage specific enzymes of these types.  
The regioselectivity of glycosidic linkages can be detected through application of old 
techniques used in radiolabelled assays, such as permethylation of sugars followed by 
GC-MS analysis or electrospray mass spectrometry prior to periodate oxidation and 
reduction with NaBH4.
87, 140
 
The most exciting and unexpected result obtained from fluorescent assays that involved 
incubation of α-Man-HTC (2.12) and α-Man-1,6-α-Man-HTC (2.13) acceptor substrates 
with UDP-Glc and UDP-GlcNAc was the detection of N-acetylglucosamine-1-
phosphate transferase (GlcNAc-P-Tase) activity in E. gracilis microsomal membranes.  
This enzymatic activity led to formation of glucosylated phosphodiester-linked 
disaccharide (3.04) and trisaccharide (3.07) products from incubation of UDP-Glc with 
α-Man-HTC (2.12) and α-Man-1,6-α-Man-HTC (2.13), respectively.  At the same time, 
it was also responsible for the formation of N-acetylglucosaminylated phosphodiester-
lined disaccharide (3.05) and trisaccharide (3.08) from incubation of UDP-GlcNAc with 
α-Man-HTC (2.12) and α-Man-1,6-α-Man-HTC (2.13), respectivelly (Fig. 3.29 AIII and 
BIII).  Indirectly, formation of phosphodiester linkages in 3.04/3.07 and 3.05/3.08 was 
demonstrated through utilisation of LC-MS and chemical-enzymatic degradations.  
Directly, this type of linkage was confirmed in trisaccharide (3.08) by NMR 
spectroscopy, which indicated transfer of N-acetylglucosamine phosphate to the 6-
hydroxy group of the non-reducing mannose residue in α-anomeric configuration.   
Activities of N-acetylglucosaminyltransferases I and II were not detected in fluorescent 
assays with α-Man-HTC (2.12) and α-Man α-1,6-Man-HTC (2.13) acceptor substrates 
because N-acetylglucosaminyltransferase I requires a branched structure, such as Manα-
1,3-Man(Manα-1,6)Man β-GlcNAc and N-acetylglucosaminyltransferase II is acceptor 
substrate specific enzyme (see Chapter 1, section 1.2.3).
54
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3.4 Conclusion and future work  
In these studies we aimed to detect glycosyltransferases responsible for the biosynthesis 
of N-glycans and GPI anchors in E. gracilis because this organism has been placed in 
the common phylum Euglenozoa
155, 156
 which also includes parasitic trypanosomatids.  
These particular cell surface glycoconjugates play an essential role in parasite survival 
and infectivity inside the host organism.  Therefore, detecting activities of enzymes 
responsible for their biosynthesis in Euglena would allow utilisation of this organism as 
a model system to study substrate specificity of these enzymes.   
Results presented above have demonstrated that fluorescence-based methodology II, 
which utilises fluorescent α-Man-HTC (2.12) and α-Man-1,6-α-Man-HTC (2.13) 
acceptor substrates, was capable of detecting α-1,2ManT and α-1,3ManT activities 
responsible for the biosynthesis of lipid linked N-glycans.  In order to match detected 
activities with the available transcriptome data, we determined if predicted amino acid 
sequence of these enzymes can yield putative enzymes in the transcriptome of E. 
gracilis.  The transcriptome search yielded a putative E. gracilis dolichyl-P-
Man:Man8GlcNAc2-P-P-dolichhol α-1,2-mannosyltransferase (EgAlg9) and dolichyl-P-
Man:Man5GlcNAc2-P-P-dolichhol α-1,3-mannosyltransferase (EgAlg3) proteins (Fig 
3.30, Appendix 8 and 9).  
 
Figure 3.30 Diagrammatic representation of mimicked N-glycan sites by synthetic fluorescent acceptors and 
their resulting products in Euglena gracilis.  The red box area indicates possible site of authentic intermediate 
mimicked by the synthetic acceptors in the fluorescence-based assays. 
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Both of these enzymes belong to the asparagine-linked glycosylation gene that catalyses 
transfer of mannose sugar residue from Man-P-Dol to Man8GlcNAc2-P-P-dolichhol or 
Man5GlcNAc2-P-P-dolichhol resulting in formation of Man9GlcNAc2-P-P-dolichhol or 
Man6GlcNAc2-P-P-dolichhol, respectively.  Amino acid sequence analysis of putative 
EgAlg9 had a percent identity to Homo sapiens, Saccharomyces cerevisiae, Arabidopsis 
thaliana and not found to be present in Trypanosoma brucei proteins.  The EgAlg3 had 
identity with Homo sapiens, Saccharomyces cerevisiae and Trypanosoma brucei 
proteins (Table 3.3). 
 Protein 
size  
Homo sapiens 
 
Saccharomyces 
cerevisiae 
Arabidopsis 
thaliana 
Trypanosoma 
brucei 
  Identity (%) 
      
EgAlg9 66 kDa 31.1 25.8 27.0 N/P 
EgAlg3 50 kDa 42.8 28.9  29.9 
      
 
Table 3.3 Euglena gracilis percent identity of mannosyltransferase to known protein sequences from other 
organisms. 
The TbAlg9 is not present in Trypanosoma brucei because it has a Man8GlcNAc2-P-P-
Dol glycan as a final intermediate.  The depletion of TbAlg3 gene in bloodstream T. 
brucei has shown to unable the production of oligosaccharides higher than 
Man5GlcNAc2 and had no significant effect on parasite growth, morphology or the 
infectivity to the host.  Therefore, this enzyme is not a useful drug target against African 
sleeping disease.
174
  Similarly, the mutation of Alg3 gene in Saccharomyces cerevisiae 
and Arabidopsis thaliana leads to accumulation of underglycosylated intermediated 
resulting in no obvious growth phenotype, thereby showing that it is not essential for 
their viability and growth.
170
  In contrast, the mutation of one amino acid in human Alg3 
gene leads to the deficiency of the α-1,3-mannosyltransferas resulting in no elongation 
of Man5GlcNAc2-P-P-Dol intermediates on the lumenal side of the ER. The 
Man5GlcNAc2-P-P-Dol intermediate becomes a poor substrate for the 
oligosaccharyltransferase complex which prefers the Glc3Man9GlcNAc2-P-P-Dol 
glycan, making difficult to move the incomplete oligosaccharide intermediate to the 
newly expressed protein.  This leads to accumulation of this intermediate in the ER and 
causes under glycosylation of serum glycoproteins transferrin.
175
  The defect of the 
glycosylation in humans causes type IV carbohydrate deficient glycoprotein syndrome 
(CDGS), which is a rare genetic disease characterised by microcephaly, severe epilepsy 
and minimal psychomotor development.
176
  Similarly, single point mutation in human 
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Alg9 gene leads to the incipiency of the α-1,3-mannosyltransferas, resulting in 
accumulation of Man8GlcNAc2-P-P-Dol intermediates and also known to cause CDGS 
type II.  Currently, there are only two people that were diagnosed with CDGS type II 
and six with type VI.
176
   
Overall, finding these particular enzymatic activities in Euglena gracilis microsomal 
membranes do not have real therapeutic applications, however these enzymes could be 
still used to aid chemo-enzymatic synthesis of complex oligosaccharides.  Furthermore, 
to find mannosyltransferase activities that belong to the GPI anchor biosynthesis we 
envisaged chemical synthesis of more authentic fluorescent acceptors, which 
incorporate GlcNAc-myo-inositol sugar moiety attached to fluorescent ceramide (3.09) 
(Fig. 3.31).   
 
 
 
Figure 3.31 Chemical structures of authentic fluorescent acceptors to aid with detection of 
mannosyltransferase activities in Euglena gracilis microsomal membranes. 
Fluorescence-based methodology II with fluorescent α-Man-HTC (2.12) and α-Man-
1,6-α-Man-HTC (2.13) acceptor substrates was also able to detect N-acetylglucosamine-
1-phosphate transferase (GlcNAc-P-Tase) activity responsible for phosphorylation of N-
linked glycoproteins.  The transcriptome search for the predicted E. gracilis GlcNac-P-
Tase with the identified amino acid sequence of the Homo sapiens (EC 2.7.8.17) gene 
yielded a putative Euglena gracilis UDP-N-acetylglucosamine-lysosomal-enzyme N-
acetylglucosamine-1-phosphate transferase (GlcNAc-P-Tase).  This predicted 
transmembrane protein consists of 1140 amino acids (124 kDa) and has 25.5% identity 
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with the Homo sapiens and 25.8% with Dictyostelium discoideum (slime mold) 
(Appendix 10).   
The Homo sapiens GlcNAc-P-Tase is a 540 kDa hexameric transmembrane enzyme 
which comprise of three subunits α2β2γ2 and is coded by two genes GNPTAB and 
GNPTG.  The α2β2 subunits constitute the catalytic domain and carry the substrate 
binding sites for UDP-GlcNAc and high mannose protein-linked N-glycan.
177
  The γ 
subunit is required for the optimum phosphorylation and especially for the addition of a 
second GlcNAc-P to high mannose protein-linked N-glycan by facilitating binding and 
presentation of this high mannose glycan to the catalytic domain in the favourable 
orrientation.
178
  In contrast, the putative D. discoideum GlcNAc-P-Tase
179
 consist of 
1238 amino acids and differs from human enzyme by lacking the DMAP protein 
binding domain in α2 subunit.  Recently, the DMAP domain has been demonstrated to 
participate in protein-protein interactions through recognition of conformation-
dependent lysosomal protein in zebrafish model.
180
  The gene that encode for the γ 
subunit was not found in the genome sequence of D. discoideum; therefore, the 
GlcNAc-P-Tase lack the γ subunit sequence in this species.181  Nevertheless, D. 
discoideum is still able to phosphorylate its lysosomal proteins suggesting that γ subunit 
is dispensable.  Similar to D. discoideum, the E. gracilis GlcNAc-P-Tase lacks the 
DMAP domain and does not contain the γ subunit.   
Deficiency in GlcNAc-P-Tase activity in Homo sapiens leads to lysosomal storage 
disorder, such as mucolipidosis II (MLII), mucolipidosis IIIA (MLIIIA) and 
mucolipidosis IIIC (MLIIIC), where GlcNAc-P-Tase activities is absent in MLII 
(mutation in α/β subunit gene), reduced in MLIIIA (mutation in α/β subunit gene) and 
altered in MLIIIC (mutation in γ subunit gene).182, 183  In the course of these disorders, 
newly synthesised lysosomal enzymes that lack Man-6-P receptors are over secreted 
into the extracellular medium instead of being delivered to the lysosomes.  These 
conditions affect sorting of multiple lysosomal enzymes and result in absent or poor 
degradation of carbohydrates, lipids and other material inside the lysosomes.  One of the 
proposed methods to treat the lysosomal storage disease which affects one or more 
lysosomal enzymes is the generation of phosphorylated lysosomal proteins to be used in 
enzyme replacement therapy.
184
  The enzyme replacement therapy is possible due to 
additional presence of Man-6-P receptors in the plasma membrane, which allows 
tagging of these lysosomal enzymes through Man-6-P recognition site back into the 
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lysosomes.  This therapy implies overexpressing lysosomal enzymes in Chinese-
hamster ovary with subsequent purification of the enzyme and treatment with exo-
glycosidases to expose terminal Man-6-P on the N-glycan following by intravenous 
administration of these enzymes to patients.  Recent studies have shown that it is 
possible to generate mutant of Arabidopsis thaliana seeds deficient in N-
acetylglucosaminyl transferase I activity, involved in the first step of complex and 
hybrid N-glycans biosynthesis, in order to overexpress human α-L-iduronidase enzyme 
in high yields.
185
  This enzyme was then modified in vitro with Man-6-P using soluble 
form of both recombinant GlcNAc-P-Tase and uncovering enzymes.
186, 187
  Despite the 
advances in the downstream processing of a plant-made recombinant lysosomal 
enzyme, the efficiency of the first step of the in vitro modification with GlcNAc-P 
residue required improvements.
185
   
The application of D. discoideum GlcNAc-P-Tase to decorate lysosomal enzymes with 
GlcNAc-P residues is proven to be unsuccessful because although this enzyme is 
capable of transferring GlcNAc-P to a simple chemical substrate, such as α-
methylmannoside
188
 it lacks the ability to recognise human lysosomal glycoprotein, 
such as cathepsin D.
179
  The results described above, demonstrated that E. gracilis 
GlcNAc-P-Tase is capable of phosphorylating in vitro chemically synthesised 
fluorescent α-Man-HTC and α-Man-α-1,6-Man-HTC substrates.  Currently, we are 
investigating if this enzyme can be efficient in phosphorylation of a non-lysosomal 
RNaseB protein using a modified sugar nucleotide (UDP-GlcNAcN3) that was 
synthesised by Dr. Martin Rejzek in Professor Field’s group.  The modification on the 
sugar nucleotide allows a straightforward identification of modified protein through 
application of click conditions in the presence of alkyne fluorophore.  The ability to 
demonstrate that E. gracilis GlcNAc-P-Tase can transfer GlcNAc-P onto the N-glycan 
of the non-lysosomal and in the future to lysosomal proteins could mean that we can 
then look into overexpressing this enzyme in other organisms such as yeast or plant to 
generate soluble form of this enzyme.  Admittedly, the generation of soluble GlcNAc-P-
Tase enzyme will be challenging due to its transmembrane nature and the presence of 
nucleotide thymine modification with β-D-glucosylhydroxymethyluracil in E. gracilis 
genome which is yet to be resolved.  Nevertheless, it was possible to remove 
transmembrane domain from α/β subunits and produce soluble recombinant GlcNAc-P-
Tase enzyme in mammalian cells
187
 that was capable of transferring GlcNAc-P residue 
from UDP-GlcNAc to both synthetic small molecules, such as α-methylmannoside and 
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protein substrates such as lysosomal glycoprotein cathepsin D or uteroferrin and non-
lysosomal glycoprotein RNaseB.
178
  Thereby, if recombinant enzyme will be obtained, 
E. gracilis GlcNAc-P-Tase could be used in enzyme replacement therapy to modify 
lysosomal enzymes in vitro with GlcNAc-P residues.  Furthermore, the nature of 
lysosomal enzymes in E. gracilis can be identified to see if they have any similarity to 
mammalian lysosomal enzymes.  Conversely, the crude microsomal membranes can be 
used to aid in chemo-enzymatic synthesis of phosphordiested bond. 
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4 Synthesis of triazole-linked linear and cyclic oligomers to 
obstruct Trypanosoma cruzi macrophage infection 
The majority of this Chapter has been published in the primary literature: 
 
Click chemistry oligomerisation of azido-alkyne-functionalized galactose accesses 
triazole-linked linear oligomers and macrocycles that inhibit Trypanosoma cruzi 
macrophage invasion 
 
Vanesa L. Campo,*
 
Irina M. Ivanova,*
 
Ivone Carvalho,
 
Carla D. Lopes,
 
Zumira A. Carneiro, 
Gerhard Saalbach, Sergio Schenkman,
 
João Santana da Silva, Sergey A. Nepogodiev, Robert A. 
Field 
 
Tetrahedron, 2015, doi:10.1016/j.tet.2015.04.085  
* Joint first authors 
Contribution: 
(10%) Vanesa L. Campo originally started the project and derived chemical synthesis of 
2-(2-(2-azidoethoxy)ethoxy)ethyl 6-O-(prop-2-ynyl)-β-D-galactopyranoside (4.07). 
(80%) Irina Ivanova performed improvement on the original chemical synthesis of 2-(2-
(2-azidoethoxy)ethoxy)ethyl 6-O-(prop-2-ynyl)-β-D-galactopyranoside (4.07) followed 
by generation, purification and characterisation of cyclic and linear 1,4/1,5-triazole-
linked-pseudo-galctooligomers and in vitro investigation into their substrate activities 
with Trypanosoma cruzi trans sialidases. 
(10%) Ivone Carvalho performed in vivo preliminary biological evaluations in Brazil.  
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4.1 Introduction 
Trypanosoma cruzi is a single-celled flagellated parasite that infects and replicates 
inside the human host in a range of tissues and cells, including macrophages, smooth 
and strained muscle cells and fibroblasts.
189
  In the process, Trypanosoma cruzi cause a 
debilitating and often lethal condition known as Chagas’ disease which afflicts millions 
of people mainly in South and Central America.  According to World Health 
Organisation estimates 7.7 to 10 million people are chronically infected and 10,000-
14,000 die each year from Chagas’ disease.190   
T. cruzi has a very complex life cycle that involves passage of parasites through the 
digestive track of biting insects (Reduviidae) and gaining access to the human host 
through insect-generated puncture wounds.
191
  In general, inside the insect gut the 
parasite exists as a replicative non-infectious epimastigote form that passes to the 
rectum and differentiates into a non-replicative metacyclic trypomastigote form.  This 
form of parasite is then excreted from the insect as it takes a blood meal and the parasite 
gains access to the human host through the mucous membrane.
192
  Once inside the 
human host the non-dividing trypomastigotes attach to macrophages or non-
macrophages cells and enter the cell by stimulating signals that induce formation of 
lysosomes.
193
  The localised fusion of lysosomes with the plasma membrane allows 
parasites to enter the cell through the parasitophorous vacuole.  The low pH inside the 
lysosome triggers two events.  First trypomastigotes differentiate to the amastigote form 
and second includes production of pore-forming enzymes that aid in the disruption of 
the parasitophorous vacuole.
194
  Parasites eventually reach the cytoplasm and complete 
their differentiation to replicative amastigote form, which undergo several cycles of 
binary division and finally transform into blood trypomastigote form.  Parasites then 
break free from the cell into the intercellular space and either begin to infect the 
neighbouring cells or move to the blood stream and begin to infect other tissues (Fig. 
4.1).
195
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Figure 4.1 Diagrammatic representation of Trypanosoma cruzi invasion and differentiation inside the vector 
and mammalian host cells.  Parasites in non-replicative epimastigote form migrate through the insect gut and 
differentiate to metacyclic trypomastigote form.  Inside the mammalian host parasites in non-replicative 
trypomastigote form associate with the cell surface and invade the cell through the parasitophorous vacuole 
employing localised fusion of host lysosomes.  Parasites are released into the cytoplasm differentiate to replicative 
amastigote form, which break through to infect neighbouring cells or tissues. 
During the invasion process T. cruzi
 
makes extensive use of cell surface molecules, such 
as mucins
 
and trans-sialidases in its attempt to effectively adhere and invade host cells 
on one hand and to evade the human immune response on the other.  Mucins are 
glycoproteins that form a dense and protective layer on the surface of the parasite.  The 
core polypeptide is rich in serine and threonine residues, which act as acceptor sites for 
sequential addition of monosaccharides forming O-linked oligosaccharides.  The first 
sugar residue added to the serine or threonine is GlcNAc, which is then elongated with 
up to five galactose residues in either furanose or pyranose configuration depending on 
the strain of Trypanosoma cruzi.
196
  The catalytic activity of UDP-GlcNAc:polypeptide 
N-acetylglucosaminyltransferase (ppGlcNAcT) responsible for the transfer of first 
GlcNAc residue from UDP-GlcNAc to the peptide has been characterised
74
 but there is 
still lack of information about the activities of the other glycosyltransferases involved in 
the elongation of these O-linked oligosaccharides.
197
  The terminal β-galactopyranosyl 
residue of the O-linked oligosaccharide can then act as an acceptor substrate for trans-
sialidase.  The action of Trypanosoma cruzi trans-sialidase (TcTS) is unique because it 
performs sialyl transfer without utilising CMP-sialic acid due to inability of parasite to 
synthesis either of these compounds.  Instead, TcTs prefers a host α-2,3-linked sialic 
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acid to β-galactosyl of glycoproteins, glycolipids and oligosaccharides as a donor 
substrate (Fig. 4.2).
75
  In addition, not all are enzymatically active.  Variants of TcTS 
can possess a single mutation in the active site (Tyr342His) and become catalytically 
inactivated but still can bind to terminal sialic acid and galactose residues, functioning 
as a lectin.
198
  Both mucins
 
and trans-sialidases attached to the parasite plasma 
membrane through the GPI.  
 
Figure 4.2 Representative transfer of sialic acid from the host glycoconjugate to the parasite cell surface mucin 
glycoprotein catalysed by Trypanosoma cruzi trans-sialidase.199   
There is a desperate need for new treatments for Chagas’ disease, with a requirement for 
the identification of new drug targets and potential therapeutic agents.
190, 200, 201
  TcTS is 
considered to be a relevant target.
202
  The most potent TcTs inhibitors described in the 
literature are compounds that able to occupy both donor and acceptor binding sites, 
making the transfer of sialic acid either hindered or blocked.  One of these compounds 
is GM3 ganglioside. When it is modified at C-4 with deoxy or methoxy group or at C-8 
with deoxy demonstrated to act as the inhibitors in a concentration range of 10-100 μM 
(Fig. 4.3 A).
203, 204
  With this in mind, our group have investigated glycopeptide 
substrates and inhibitors of TcTS,
205
 including the application of Cu(I)-catalysed 
alkyne-azido cycloaddition (CuAAC) click chemistry with carbohydrate building blocks 
to access libraries of small molecule inhibitors and multivalent TcTs ligands displayed 
on calixarene cores.
204, 206-208
  When generating libraries of inhibitors the azido group 
was placed either at C-1 or C-6 of galactose residue because the data obtained from the 
X-ray crystallography
209
 showed that these hydroxyl groups do not to take part in the 
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binding process between the enzyme and substrate.  In contrast, only the galactose C-3 
hydroxyl group is well positioned to interact with both the enzyme and the anomeric 
carbon of sialic acid.  Two azido galactose derivatives were coupled to a panel of 
structurally diverse terminal alkynes that differed in steric bulk, presence of 
hydrophobic groups as well as flexibility and rigidity of the side chains (Fig. 4.3 B).  
The in vitro evaluation of TcTS inhibition activities of these compounds revealed that 
they were only a moderate or weak inhibitors and more effective as acceptor 
substrates.
207
  Furthermore, in our group a serious of tetravalent glycol-clusters 
incorporating β-lactosyl residues attached either to the upper or lower rigid rim of a 
central calix[4]arene core ring via 14-21 atom spacer arms were synthesised.
210
  These 
compounds showed in vitro anti-trypanocidal activities with one compound showing 
potency comparable to the established anti-trypanosomal drug benznidazole (Fig. 4.3 C).  
In this compound all lactose residues were attached to the calix[4]arene core ring in syn-
orientation.  Displayed activities were not attributed to the inhibitory binding to the 
TcTs as the lactose residue acts as a substrate for these enzymes but it was suggested 
that it could be due to inability of parasite to manipulate its surface glycosylation in the 
presence of this compound in vitro.   
 
Figure 4.3 Representative examples of potent and moderate TcTs inhibitors.  (A) GM3 ganglioside potent 
inhibitor (10-100 μM); (B) 1,2,3-Triazole-substituted derivatives moderate inhibitors (between 37-0% inhibition at 1 
mM); (C) Lactose modified calix[4]arene. 
A 
B 
C 
125 
 
The current interest lies in the application of multivalent glycoconjugates as parasite 
adhesion blocking agents with potential to prevent host cell invasion.
211, 212
  Click 
chemistry presents opportunities for the generation of oligomeric triazole-linked 
structures,
213
 which have found application in the synthesis of analogues of cyclic 
oligosaccharides,
214
 with medium size macrocycles being prepared in moderate to good 
yields starting both from protected and “free” sugar derivatives.215-217  There are only a 
few examples of the successful oligomerisation/polymerisation of such azide-alkyne-
functionalised carbohydrates leading to linear oligomers, including recent proximity-
driven click-polymerization of an 4-O-propargyl--D-galactopyranosyl azide in a crystal 
lattice.
218
  Previously, in our group we showed that the cyclooligomerisation of azido-
alkyne-functionalised galactose, where the azido group was incorporated either at the 
anomeric position or at C-6 and an alkyne group in the form of either a 6-O- or 1-O-
propargyl functionality, gives rise to novel 1,6-linked cyclic pseudo-
galactooligosaccharides that are recognised by TcTS (Fig. 4.4).
219
  Computational 
studies of two isomeric cyclic trisaccharide structures indicated inherent differences in 
geometric and dynamic preferences where cyclic trimer obtained from monomer 1 is 
more rigid then cyclic trimer obtained from monomer 2 (Fig. 4.4). 
 
 
Figure 4.4 Schematic representation of cyclooligomerisation approach to the synthesis of cyclic pseudo-
oligosaccharides.  (Top) Generalised scheme.  (Bottom) Lowest energy conformers for cyclic trimers.  (Bottom 
left) Structure obtained from monomer 1;  (Bottom right) Structure obtained from  monomer 2.219 
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In the current work, we wished to access linear oligomers and/or larger macrocycles, in 
order to span a greater area that might more adequately map the distribution of trans-
sialidase on the parasite cell surface thereby blocking trans-sialidase-action and 
associated infection processes (Fig. 4.5).
220
  Herein we designed a galactose monomer 
that incorporates a propargyl group on C-6 and a linker between sugar and azide 
functionality, in contrast to previous Field group work where the azido group was 
directly attached to the C-1.
219
  We selected ethylene glycol-based linker to reduce the 
potential for non-specific interactions with proteins and membrane components.
221
  We 
anticipated that this flexible linker might promote oligomerisation at the expense of 
cyclisation under the CuAAC click conditions.  Assessment of the interaction of 
triazole-linked materials with TcTS, along with initial assessment of their ability to 
block macrophage invasion by Trypanosoma cruzi parasites were investigated. 
 
Figure 4.5 Schematic representation of cell surface-presented Trypanosoma cruzi trans-sialidase and potential 
for its blocking by 1,2,3-triazole-linked linear and cyclic pseudo-galactooligomers resulting in potential 
prevention of host cells invasion. 
 
4.2 Synthesis of azido-alkyne galactose-containing monomer 
The azido-alkyne-substituted galactose monomer 4.07 was synthesised in nine steps 
starting from known 6-O-propargyl-D-galactopyranose 4.01,
219
 as outlined in Scheme 
4.1.  Propargyl ether 4.01 was per-O-benzyolated and converted into the required 
hemiacetal 4.03 using a solution of ammonia in methanol-THF.
222
  The resulting 
127 
 
hemiacetal 4.03 was treated with trichloroacetonitrile and DBU to obtain the 
corresponding imidate donor 4.04, which upon activation with trimethylsilyl 
trifluoromethanesulfonate (TMSOTf) in the presence of 2-(2-(2-
chloroethoxy)ethoxy)ethanol gave chlorinated β-galactoside 4.05 in a respectable 85% 
yield for the glycosylation step.  In the presence of NaN3 and NaI, the chlorinated β-
galactoside 4.05 was converted into the azido β-galactoside 4.06 in near quantitative 
yield. 
 
Scheme 4.1 Synthetic route to azido-alkyne-containing galactose monomer.  Reagents and conditions: a) BzCl, 
Py; b) NH3, MeOH/THF (7:3); c) Cl3CCN, DBU, CH2Cl2; d) 2-(2-(2-chloroethoxy)ethoxy)ethanol, TMSOTf, 
CH2Cl2; e) NaN3, NaI, DMF; f) NaOMe, MeOH. 
The presence of azide functionality in 4.06 was evident from a characteristic signal in 
the IR spectrum [2107 cm
-1] and the β-configuration followed from the anomeric proton 
signal (δ 5.75, J1,2=8.0 Hz) in the 
1
H NMR spectrum.  De-O-benzoylation of 4.06 
afforded target azido-alkyne-functionalised galactose monomer 4.07 in an overall yield 
of 25% from 6-O-propargyl galactopyranose 4.01. 
 
4.3 Cyclisation and oligomerisation through CuAAC reactions based 
on azido-alkyne-containing galactose monomer 
Once synthesised, the reactivity of azido-alkyne-functionalised galactose monomer 4.07 
was tested under CuAAC conditions – at 1 M concentration in DMF with CuSO4/Cu 
turnings either at 110 °C (using microwave irradiation; Method A) or at ambient 
temperature (Method B).  The progress of both reactions could conveniently be 
followed by TLC analysis.  The reaction using Method A was complete after 30 min, 
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compared to 2 days for Method B.  TLC analysis showed formation of multiple 
common products, consistent with the intended oligomerisation, while different relative 
spot intensities were evident from the two methods (Fig. 4.6 TLC image lanes A and B).  
The reaction mixtures from both methods were concentrated under reduced pressure, 
redissolved in water and submitted to the reverse phase HPLC purification.  This 
allowed straightforward separation of cyclic from linear products, as well as resolution 
of the variously sized cyclic oligomers from each other (Fig. 4.6 A and B) resulting in 
samples of cyclic monomer 4.08, cyclic dimer 4.09, cyclic trimer 4.10, cyclic tetramer 
4.11, cyclic pentamer 4.12 and cyclic hexamer 4.13, along with mixed linear oligomers 
(Scheme 4.2).  The formation of cyclic 1,4-triazole-linked structures was confirmed by 
virtue of singlet signals of triazole CH protons at δ 8.10 ppm223 and the absence of 
propargyl CH signals at δ 2.83 in 1H NMR spectra. 
 
 
Figure 4.6 Reverse phase HPLC and normal phase TLC analyses of cyclic and linear products obtained from 
azido-alkyne 1,3-dipolar cycloaddition reactions of galactose monomer.  (Left) Reverse phase HPLC purification 
of 1,4-triazol linked cyclic and linear products.  HPLC conditions: Phenomenex C18(2) (250 mm x 10 mm); mobile 
phase: 0.1% aq. TFA-CH3CN (0 to 35 % 50 min, flow rate: 5 mL/min); CAD detector. (Right) Normal phase TLC 
separation of 1,4-triazol linked cyclic and linear products.  HPLC trace/TLC lane: (A) 4.07 (1M in DMF) Method A 
(Cu(I), 110 °C);  (B), Method B (Cu(I), room temperature); (C), Method C (110 °C); (D), Method D (room 
temperature); TLC lane 4.07 starting galactose monomer; TLC lane L mixed linear oligomer fraction obtained from 
HPLC. 
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Scheme 4.2 Cyclisation and oligomerisation of azido-alkyne-containing galactose through CuAAC.  4.07 (1M 
in DMF) Method A (Cu(I), 110 °C) and Method B. (Cu(I), room temperature). 
Reaction products  Method A  Method B 
  Yield (%)  Yield (%) 
4.08  9.0  6.7 
4.09  3.0  2.2 
4.10  1.6  1.0 
4.11  1.1  0.8 
4.12  1.3  0.6 
4.13    0.5 
Cyclic high mol. weight compounds  13.7  6.0 
Mixture of linear compounds  25.8  35.7 
Cyclic overall yield  29.7  17.8 
Overall yield  55.8  53.5 
 
Table 4.1 Yields of 1,4-triazole-linked cyclic and linear products from CuAAC reactions of galactose 
monomer. 
Interestingly, the linear oligomeric products did not resolve under the reverse phase 
HPLC conditions employed to separate the corresponding cyclic materials; instead they 
eluted as a single broad peak at ca 32 min (Fig. 4.6 traces A and B).  These linear 
compounds were well resolved from each other and from the corresponding cyclic 
oligomers on analytical TLC (Fig. 4.6, TLC image lane L) where linear oligomers 4.14-
4.18 have slightly higher Rf values compared to cyclic products of the same molecular 
size.  Galactose monomer 4.07 was shown to undergo oligomerisation up to at least a 
decamer.  In contrast to reverse phase HPLC, gel permeation chromatography (GPC) on 
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TSK-HW40S enabled separation of linear oligomers up to the pentamer (Fig. 4.7).  It 
should be noted that these linear compounds contain unreacted azido and alkyne 
terminal groups capable of further reactions even in the absence of Cu (I) catalyst.  This 
gave rise to complications during handling and storage due to spontaneous cyclisation 
and oligomerisation of purified compounds (data not shown).  These analyses alongside 
isolated yields (Table 4.1) illustrated that the lower reaction temperature (room 
temperature vs 110 °C) favours formation of linear products over the corresponding 
cyclic isomers. 
 
Figure 4.7 Linear oligomerisation products from the reaction of azido-alkyne-containing galactose under 
CuAAC conditions. Compounds 4.14-4.18 were identified by HRMS and obtained in a combined yield of 26% 
(Method A) and 36% (Method B). 
 Calculated  
m/z [M+H]+ 
Cyclic 
compounds 
Found 
m/z [M+H]+ 
Linear 
oligomers 
Found a 
m/z [M+H]+ 
Monomer 376.1714 4.08 376.1710 4.07 376.1708 
Dimer 751.3357 4.09 751.3334 4.14 751.3351 
Trimer 1126.4998 4.10 1126.4961 4.15 1126.4985 
Tetramer 1501.6640 4.11 1501.6511 4.16 1501.6631 
Pentamer 1876.8281 4.12 1876.8248 4.17 1876.8273 
Hexamer 2251.9923 4.13 2251.9792 4.18 2251.9897 
Table 4.2 HRMS data of 1,4-triazole-linked cyclic products and linear oligomers. 
aData obtained from the analysis of the mixture of linear oligomers obtained as a result of reverse-phase HPLC purification. 
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The 1,3-dipolar cycloaddition of azido-alkyne functionalised galactose monomer 4.07 
generates isomeric cyclic and linear products that have the same molecular formula and 
hence the same monoisotopic mass.  While linear and cyclic compounds were 
resolvable, we cannot rule out the formal possibility that some of the cyclic compounds 
may be catenated, although there is not obviously driving force for these particular 
monomers/intermediates to template catenate formation.
224
  The formation of cyclic and 
linear products was confirmed by high resolution MS analyses of individual isolated 
cyclic compounds 4.08-4.13 as well as the mixture of linear oligomers collected as a 
single peak from HPLC purification (Fig. 4.6 trace A and B, TLC image lane L).  Cyclic 
and linear products from trimer upwards run in MS analyses as multiply charged 
species, spectra for which were de-convoluted to obtain monoisotopic masses (Table 
4.2) (Appendices 11).   
Cyclic oligomers are expected to have relatively simple 
1
H NMR spectra of the repeat 
unit for macrocycles compared to more complex spectra for linear oligomers.  This was 
demonstrated by comparing 
1
H NMR spectrum of cyclic 1,4-triazole linked dimer 
(4.09) and linear 1,5-triazole linked dimer (4.25) (Fig. 4.8).  The proton signal at around 
δ 4.32 ppm in both spectra was assigned to the anomeric proton of galactose residue by 
utilising 2D analysis of 
1
H-
13
C HSQC of H1 with C1 (δH 4.32, δC 103.2 ppm for 4.09) 
and (δH 4.32, δC 102.7 ppm for 4.25).  The doublet signal of 4.09 at δ 4.32 ppm had an 
integration value of 1H (Fig. 4.8 A blue trace), whereas the triplet signal of 4.25 at δ 
4.32 ppm had integration value of 2H where two anomeric signal overlap resulting in 
one triplet signal (Fig. 4.8 A red trace).  Furthermore, the linear dimer (4.25) has two 
CH2 signals that belong to free propargyl group (CH2CCH) and triazole-linked 
propargyl group (CH2CC-triazole).  The multiplet signal at δ 4.19 ppm was assigned to 
CH2 signal of the free propargyl group (CH2CCH) by 2D analysis of 
1
H-
13
C HSQC (δH 
4.19, δC 58.12 ppm).  Whereas, the CH2 signal of the triazole-linked propargyl group 
(CH2CC-triazole) was present under the suppressed solvent peak and was evident from 
2D analysis of 
1
H-
13
C HSQC (δH 4.74, δC 60.36 ppm) (Fig. 4.8 B).  The same applies to 
the CH2N3 and CH2N signals.  The 1,4-triazole ring formation was confirmed by the 
presence of singlet at δ 8.05 ppm in 4.09 and 1,5-triazole ring formation at δ 7.77 ppm 
for 4.25 (Fig. 4.8 A blue and red trace).   
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Figure 4.8 Characterisation of cyclic and linear 1,4-triazole-linked galactose dimers by NMR spectroscopy.  
(A) Evaluation of 1H NMR spectra of cyclic 4.09 (blue) and linear 4.25 (red).  (B) 1H-13C HSQC spectrum of 4.25 (in 
blue signals for CH and CH3 and in red signals for CH2). 
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4.4 Fluorescent labelling of 1,4-triazole linked linear oligomers  
Linear 1,4-triazole-linked compounds contained unreacted alkyne and azido functional 
groups on the same molecule.  These presented difficulties in separation of these 
compounds on reverse phase HPLC and additional cyclisation reactions occurred when 
handling purified material after the GPC purification.  Therefore, an analytical amount 
of mixed 1,4-triazole-linked linear compounds were capped with 3-azido-7-hydroxy-
coumarin using Cu(I)-catalysed click conditions in order to investigate if addition of 
hydrophobic cap moiety can improve separation of these compounds on reverse phase 
reverse HPLC.  The outcome of this reaction was analysed by TLC.  TLC analyses 
clearly indicated formation of fluorescent compounds that have a slightly higher Rf 
value compared to the uncapped which is to be expected as the hydrophobic aromatic 
coumarin moiety is being attached (Fig. 4.9 TLC image lane L and F).  Once more this 
result proves formation of linear compounds.  
 
Figure 4.9 Normal phase TLC image and reverse phase HPLC chromatogram of fluorescently labelled 1,4-
triazol-linked linear compounds obtained from azido-alkyne 1,3-dipolar cycloaddition reactions of mixed 1,4-
triazole-linked linear compounds in the presence of 3-azido-7-hydroxy-coumarin.  (Left) Image of TLC plates; 
TLC plates were eluted with CH3CN/EtOAc/iPrOH/H2O (85:20:50:50).  (Right) Reverse phase HPLC 
chromatogram, HPLC conditions: Phenomenex C18(2) (250 mm x 10 mm); mobile phase: 0.1% aq. TFA-CH3CN (0 
to 35 % 50 min, flow rate: 5 mL/min); UV detector at 347 nm.  HPLC trace/TLC lane: 4.07 starting galactose 
monomer; (A) Method A (1M, DMF, Cu(I), 110 °C); (L) mixed linear oligomer fraction obtained from HPLC (Fig. 
4.6); (D), Method D (1M, DMF, room temperature); (F) fluorescent 1,4-triazole-linked linear products.  
The attachment of hydrophobic coumarin fluorophore to some extent allowed separation 
of capped 1,4-triazole-linked fluorescent linear compounds on reverse phase HPLC up 
to a pentamer compared to no separation with un-capped 1,4-triazole-linked linear 
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compounds (Fig. 4.9 trace A and F).  During capping reaction no fluorescent monomer 
was formed because it was removed by HPLC purification. 
 
Figure 4.10 Fluorescent linear oligomerisation products from the reaction of azido-alkyne-containing galactose 
under CuAAC conditions.  Compounds 4.20-4.23 were identified by HRMS.  
Overall capping reaction with 3-azido-7-hydroxy-coumarin resulted in formation of 
fluorescently labelled 1,4-triazole-linked linear products up to a decamer as judged by 
TLC and we were able to isolate analytical amount of 1,4-triazole-linked linear dimer 
(4.20), trimer (4.21), tetramer (4.22) and pentamer (4.23) which were confirmed by HR 
MS (Fig. 4.9, Table 4.3). 
 Fluorescent 
linear compounds 
Calculated 
m/z [M+H]+ 
Found 
m/z [M+H]+ 
Dimer 4.20 954.3687 954.3667 
Trimer 4.21 1329.5328 1329.5308 
Tetramer 4.22 1704.6970 1704.6965 
Pentamer 4.23 2079.8611 2079.8662 
 
Table 4.3 HRMS data of fluorescent 1,4-triazole-linked linear products. 
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4.5 Uncatalysed 1,3-dipolar cycloaddition of azido-alkyne-containing 
galactose monomer  
Given the noted spontaneous but slow 1,3-dipolar cycloaddition of galactose monomer 
4.07 on standing at room temperature (vide supra), the reactivity of 4.07 at 1 M 
concentration in DMF at 110 °C (under microwave irradiation; Method C) and at room 
temperature (Method D) were compared.  Reaction using Method C was completed 
after 30 min, while Method D gave approximately 10% conversion of galactose 
monomer 4.07 after two weeks.  TLC analysis showed even more complex multiple 
product mixtures than the Cu(I)-catalysed reaction (Fig. 2 TLC lanes C and D) due to 
the expected formation of mixed isomeric 1,4- and 1,5-linked triazoles (Scheme 4.3). 
 
 
 
Scheme 4.3 Spontaneous cyclisation and oligomerisation of azido-alkyne-containing galactose leading to a 
mixture of compounds incorporating both 1,4-linked and 1,5-linked 1,2,3-triazole residues. 
The reaction mixture from Method C was concentrated under reduced pressure, 
redissolved in water and submitted to the reverse phase HPLC purification.  This 
procedure again allowed separation of cyclic from linear products, as well as resolution 
of 1,4- and 1,5-linked isomeric cyclic triazole monomer structures 4.08 and 4.24 from 
each other (Fig. 4.11 trace C).  The rest of cyclic oligomers eluted on reverse phase 
HPLC as mixtures of poorly resolved regioisomers, with various combinations of 1,4- 
and 1,5-linked triazole rings incorporated into macrocycle structures.  The ring sizes of 
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mixed 1,4/1,5-linked cyclic dimers (C2), mixed 1,4/1,5-linked cyclic trimers (C3), 
mixed 1,4/1,5-linked cyclic tetramers (C4), mixed 1,4/1,5-linked cyclic pentamers (C5) 
and mixed 1,4/1,5-linked cyclic hexamer (C6) were established by mass spectrometry 
and recorded in Table 4.4.  The 1,5-linked cyclic monomer 4.24 was fully characterised 
by NMR spectroscopy and HRMS.  The formation of the 1,5-linked triazole unit was 
confirmed by observing the triazole CH singlet signal at δ 7.71 ppm and the absence of 
a propargyl CH signal at δ 2.83 in the 1H NMR spectra. 
 
 
Figure 4.11 Reverse phase HPLC and normal phase TLC analyses of cyclic and linear products obtained from 
azido-alkyne 1,3-dipolar cycloaddition reactions of galactose monomer.  (Left) Reverse phase HPLC purification 
of 1,4-triazol linked cyclic and linear products.  HPLC conditions: Phenomenex C18(2) (250 mm x 10 mm) Mobile 
phase: 0.1% aq. TFA-CH3CN (0 to 35 % 50 min, flow rate: 5 mL/min) CAD detector. (Right) Normal phase TLC 
separation of 1,4-triazol linked cyclic and linear products.  HPLC trace/TLC lane: 4.07 (1M in DMF) (A) Method A 
(Cu(I), 110 °C);  (B), Method B (Cu(I), room temperature); (C), Method C (110 °C); (D), Method D (room 
temperature); TLC lane 4.07 starting galactose monomer; TLC lane L mixed linear oligomer fraction obtained from 
HPLC. 
 
  Calculated 
m/z [M+Na]+ 
Found 
m/z [M+Na]+ 
Dimer C2 773.32 773.31 
Trimer C3 1148.48 1148.57 
Tetramer C4 1523.64 1524.45 
Pentamer C5 1898.81 1899.03 
Hexamer C6 2273.97 2273.33 
Heptamer C7 2649.13 2648.28 
 
Table 4.4 MALDI-TOF data of 1,4- and 1,5-triazole-linked cyclic oligomers. 
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The 1,4/1,5-linked mixed linear products were submitted to GPC purification on TSK-
HW40S column which enabled separation of mixed linear products up to a tetramer 
where linear 1,5-linked triazole dimer 4.25 and linear 1,4-linked dimer 4.14, isolable as 
single compounds, were characterised by NMR spectroscopy and mass spectrometry.  
The linear structures of dimers 4.14 and 4.25 were confirmed by NMR spectroscopy, in 
particular by observation of a methylene signal of the intact propargyl group at δ ~4.18 
in the 
1
H NMR spectra.  The triazole linkage type in 4.14 and 4.25 was also evident 
from 
1
H NMR spectra, which showed diagnostic proton resonances of the 1,4-linked 
triazoles at δ 8.04 for 4.14 and of the 1,5-linked triazole at δ 7.80 for 4.25.  In addition, 
DTT reduction of azido group in 4.25 produced amino-terminated compound which was 
detected by MS analysis showing an [M+H]
+
 peak at m/z 725.28, compared to 
unreduced precursor with an [M+H]
+
 peak at m/z 751.33. 
 
4.6 Cyclic triazole-linked oligomers as acceptor substrates for 
Trypanosoma cruzi trans-sialidase (TcTS) 
Cyclic compounds 4.08-4.10 and 4.24 were tested for their ability to act as acceptor 
substrates for TcTS with fetuin serving as a donor substrate for O-3 sialylation of the 
galactose residues in the triazole-linked macrocycles.  Reactions were carried out over 
the course of 9 days, with further addition of fetuin and enzyme after 5 days, and only 
fetuin after 7 days.  The reaction mixtures were monitored by TLC and in all cases 
formation of new compounds was observed (Fig. 4.12), which were identified by 
HRMS (Table 4.5).   
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Figure 4.12 TLC analyses of enzymatic transformations of 1,4-triazole-linked cyclic monomer 4.08, 1,5-
triazole-linked cyclic monomer 4.26, 1,4-triazole-linked cyclic dimer 4.09 and 1,4 triazole-linked cyclic trimer 
4.10 into mono-, di- and tri-sialylated cyclic compounds in the presence of TcTS and a fetuin donor.  Negative 
controls (lanes C1, C2, C3 and C4) were carried out in parallel with a donor and an acceptor without the enzyme.  
The progress of reactions was monitored by taking TLC samples on after 1 day, 7h days and 9 days. TLC was eluted 
with CH3CN/EtOAc/iPrOH/H2O (85/25/50/50). 
 
Starting    Mono-sialylated  Di-sialylated  Tri-sialylated 
material  
Calcd m/z 
([M-H]-) 
Found m/z 
([M-H]-) 
 
Calcd m/z 
([M-H]-) 
Found m/z 
([M-H]-) 
 
Calcd m/z 
([M-H]-) 
Found m/z 
([M-H]-) 
Monomer 4.08  665.2523 665.2519       
Monomer 4.24  665.2523 665.2519       
Dimer 4.09  1040.4164 1040.4237  1331.5118 13315272    
Trimer 4.10  1415.5806 1415.5994   1706.6760 1706.7021  1997.7714 1997.7947 
 
Table 4.5 HRMS data for products of enzymatic sialylation of triazole-linked cyclic oligomers. 
Reaction of 1,4 triazole-linked cyclic trimer 4.10 resulted in formation of mono-, di- and 
tri-sialylated products 4.30, 4.31 and 4.32, respectively (Scheme 4.4).  Related reactivity 
was observed for 1,4-triazole-linked cyclic dimer 4.09 which gave two sialylated 
products, mono-sialylated (4.28) and di-sialylated (4.29) derivatives.  The 1,4-triazole-
linked cyclic monomer 4.08 and 1,5-triazole-linked cyclic monomer 4.24 gave mono-
sialylated products 4.26 and 4.27, respectively.  It is therefore evident that cyclic 
triazole-linked pseudo-galactooligomers are recognised by, and can act as acceptor 
substrates for TcTS.  
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Scheme 4.4 Structures of proposed sialylated products obtained from enzymatic transformation of compound 
4.10.  Reagents and conditions: 3 mM fetuin, 1 mM compound 4.10, T. cruzi trans-sialidase  in 100 mM, pH 7.5 
phosphate buffer, 28 °C, 9 days. 
 
4.7 Preliminary biological evaluation of triazole-linked oligomers 
As the trans-sialidase is an important enzyme associated with host cell invasion by T. 
cruzi,
220, 225
 we evaluated the biological potential of our triazole-linked oligomers as 
blockers of parasite mammalian cell entry.  The trypomastigote form of the parasite 
invades mammalian cells, where it differentiates into amastigote form that replicate and 
subsequently de-differentiates to trypomastigotes (section 1.1).  The latter then exit the 
cell in search of the cells to infect.  Our assays were therefore twofold: assessment of 
the number of trypomastigotes present in the medium, or assessment of the number of 
amastigotes inside macrophages.   
Parasites were mixed with bovine macrophages and triazole-linked oligomers, with or 
without a pre-incubation of the parasite and oligomers; where the pre-incubation was 
employed free triazole-linked oligomers were removed by washing before adding the 
parasites to macrophages.  The parasites were left to invade the macrophages and after 6 
days, the trypomastigote form found in the medium was removed and counted.  As 
shown in Fig. 4.13 A ( ), the incubation of parasite with triazole-linked oligomers 
substantially inhibited the invasion of macrophage by parasites (˃90% for trimer-
hexamer).  To rule out a direct impact of the triazole-linked compounds on the 
macrophages, pre-incubation of parasite with triazoles, plus washing to remove excess 
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triazole, was accessed.  While the impact on parasite invasion was more modest than 
when the triazole was present throughout (Fig. 4.13 A ), this is to be expected given 
the dramatic reduction in concentration of the inhibitor in these experiments.  
Gratifyingly, inhibition of macrophage invasion was still pronounced. 
 
 
 
Figure 4.13 Inhibition of T. cruzi invasion of bovine macrophages in the presence of 1,4/1,5-triazole-linked 
cyclic dimers (C2), trimer (C3), tetramer (C4), pentamer (C5), hexamer (C6), heptamer (C7) and a series of 
mixed 1,4/1,5-triazole-linked linear oligomers.  (A) Parasites were applied to macrophages without ( ) or with ( ) 
pre-incubation with triazoles and following 6 days incubation the numbers of trypomastigotes in the medium was 
quantified as % reduction in the numbers of parasite released from macrophages (% Inhibition).  (B) Parasites and 
triazoles were applied to macrophages and the number of amastigotes present inside the macrophages was quantified 
as an average number of parasites per macrophage (T. cruzi/Macrophage) due to preliminary nature os these tests 
only two repeats were done. 
To complement the above assays, we also assessed differentiated amastigote-form T. 
cruzi numbers inside infected macrophages, and the impact of triazole-linked oligomers 
on these numbers.  In keeping with the trypomastigote results (Fig. 4 A), triazole-linked 
oligomers resulted in a reduction in the number of parasites found inside macrophages 
(Fig. 4.13 B; Fig. 4.14), with a general trend towards larger structures giving greater 
effect.  Taken together, these data confirms the potential of triazole-linked trans-
sialidase ligands to block macrophage invasion by T. cruzi parasites.  The toxicity 
experiments were no caried out due to prelimenary nature of these experiments.   
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Figure 4.14 Representative images illustrating amastigote-form parasite numbers present inside macrophages 
infected with T. cruzi in (A) the absence and (B) the presence of 250 M mixed length 1,4/1,5 triazole- linked linear 
oligomers.  Arrows indicate cells infected with T. cruzi.  
 
4.8 Conclusion 
In this study we have investigated the CuAAC-mediated oligomerisation of an azido-
alkyne-functionalised galactose building block 4.07 for the development of novel 
oligomeric, triazole-linked compounds with potential for impact against the human 
parasite T. cruzi.  Despite our initial expectation that the installation of flexible 
ethylene-glycol-based linker might favour polymerisation of monomer over cyclisation, 
mixed populations of linear and cyclic triazole-linked oligomers of d.p. 1 to >10 were 
evident.  The cyclic compounds were separable from each other and from the 
corresponding linear materials by reverse phase HPLC, whilst separation of linear 
materials up to d.p. 5 could be achieved by gel permeation chromatography.  
Furthermore, capping of linear 1,4-triazole-linked compounds with 3-azido-7-hydroxy-
coumarin resulted in formation of linear fluorescent compounds that were separated up 
to a pentamer by reverse phase HPLC compared to no separation of linear uncapped 
material.  The overall yield of triazole-linked products obtained from polymerisation 
and cyclooligomerisation of galactose monomer 4.07 was around 54%, with a higher 
proportion of linear products (36%) compared to cyclic products (18%) formed in 
CuAAC reactions conducted at room temperature.  
Judicious choice of the sites of galactose modification in galactose monomer 4.07 (the 
1- and 6-positions) results in oligomeric triazole-linked materials that present the 2-, 3- 
and 4-hydroxyl groups of the sugar units that are required for binding to T. cruzi trans-
A B 
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sialidase.
226
  This was borne out by in vitro biotransformations, which established that 
triazole-linked 1,6-substituted pseudo-galactoligomers are indeed recognised as 
acceptor substrates by T. cruzi trans-sialidase.  Given the high copy number 
presentation of trans-sialidase on the surface of T. cruzi, multivalent ligands for the 
enzyme might block the surface of the parasite and inhibit TcTS-mediated host cell 
invasion.  Encouragingly, preliminary assessment of linear and cyclic triazole-linked 
pseudo-galactooligomers clearly establishes their ability to block T. cruzi invasion of 
macrophages, with distinct advantage demonstrated by pre-incubation of triazole-linked 
oligomers with parasite prior to exposure to macrophages.  While this phenomenon 
would be difficult to reproduce medicinally, it suggests that there is scope for 
optimisation of ligand presentation.  The versatile nature of CuAAC-based 
oligomerisation approach offers significant scope in this regard. 
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5 Materials and methods 
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5.1  Chemical methods 
5.1.1 General experimental section 
Chemicals were purchased as reagent grade and used without further purification.  
Ammonia solution (7 N NH3 in methanol) and methanolic sodium methoxide (0.5 M 
NaOMe in methanol) were purchased from Sigma Aldrich.  All moisture-sensitive 
reactions were performed under a dry nitrogen atmosphere using oven-dried glassware.  
Anhydrous solvents were purchased from Sigma Aldrich and CH2Cl2 was freshly 
distilled from calcium hydride prior to use.  Microwave-assisted reactions were carried 
out in Biotage Initiator microwave.   
 
Thin layer chromatography (TLC) 
Reactions were monitored by thin-layer chromatography (TLC) on pre-coated silica gel 
glass (60A) or aluminium plates (Silica Gel 60 F254, E. Merck) with indicated eluents.  
Compounds were visualised under UV light (λ 254 nm), by dipping in ethanol-sulphuric 
acid (95:5, v/v) or in orcinol solution (20 mg/mL orcinol monohydrate in 
EtOH/H2SO4:H2O 75:10:5, v/v) followed by heating.  Fluorescent products were 
purified on semi-preparative TLC on pre-coated silica gel aluminium plates (Silica Gel 
1000 UV254, Analtech).  
 
Flash chromatography  
Flash chromatography was performed on a Biotage Isolera MPLC system using pre-
packed silica gel cartridges.   
 
High Performance Liquide Chromatography (HPLC) 
HPLC was carried out using a Dionex HPLC system with reverse phase (C18 stationary 
phase) column, equipped with Corona charged aerosol detector (CAD) or UV detector 
(at 347 nm).   
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Purification of cyclic and linear triazole-linked products 
Cyclic and linear 1,4-triazole linked, 1,4/1,5-triazole linked and 1,4-triazole linked 
fluorescent products were redissolved in water and subjected to purification using semi-
prep reverse phase HPLC Phenomenex Luna C18 (250 x 10 mm) column.  The column 
was pre-conditioned with 0.1% aqueous solution of TFA.  The elution program was as 
follows: linear gradient to 35% acetonitrile for 50 min further linear gradient to 100% 
acetonitrile (held at 100% for 2 min) then equilibrated back to 0.1% aqueous solution of 
TFA.  The flow rate was 5 mL/min.   
 
Gel Permeation Chromatography (GPC)  
Non-fluorescent linear oligomers were re-dissolved in water, applied onto the TSK-
HW40S gel filtration column (1.6 x 80 cm) and eluted using the Perkin Elmer Series 
200 system at a flow rate of 0.5 mL/min for 400 min.  Compounds were detected with 
IOTA 2 refractive index detector coupled to UV detector (λ 347 nm).  Fractions (1 mL) 
were collected at rate of thirty per hour.  
 
Optical rotation 
Optical rotations were measured at 20 ᵒC in 1 mL cell in the stated solvent using a 
Perkin-Elmer 341 polarimeter equipped with a sodium lamp.   
 
Nuclear Magnetic Resonance spectroscopy (NMR) 
Nuclear magnetic resonance spectra were recorded on a Bruker Avance III 400 NMR or 
Bruker Avance 800 spectrometer at 298 K.  Chemical shifts (δ) are reported in parts per 
million (ppm) with respect to internal tetramethylsilane (TMS) in CDCl3 and residual 
HOD signal in D2O.  NMR signal assignments were made with the aid of COSY and 
HSQC experiments.   
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Mass spectrometry (MS) 
The samples were dissolved and diluted in appropriate solvent and run on the Orbitrap 
using manual injection from a syringe. The instrument was calibrated according to the 
manufacturer’s instructions before use.  Positive electrospray data were collected at a 
resolution of 60,000. Spray chamber conditions were 8 units sheath gas, no other gases, 
275°C capillary temperature, 100V tube lens, and a spray voltage of 3.3kV using a steel 
needle kit. MS2 data were collected at various collision energies and isolation widths as 
appropriate to the precursor ion. 
High resolution ESI MS data of linear and cyclic 1,4-triazole-linked compounds were 
obtained using the Waters Synapt G2 mass spectrometer.  The sample was diluted into 
50% methanol/water with 0.1% formic acid and infused into a Synapt G2 mass 
spectrometer (Waters, Manchester, UK) at 5-10 µl min
-1
 using a Harvard Apparatus 
syringe pump. The mass spectrometer was controlled by Masslynx 4.1 software 
(Waters). It was operated in resolution and positive ion mode and calibrated using 
sodium formate. The sample was analysed for 2 min with 1 s MS scan time over the 
range of 50-1200 m/z (or as appropriate) with 3.5 kV capillary voltage, 40 V cone 
voltage, 100°C cone temperature. Leu-enkephalin peptide (2 ng ml
-1
, Waters) was 
infused at 10 µl min
-1
 as a lock mass (m/z 556.2766). It was measured every 10 s and 
was applied during the acquisition. For low mass range acquisitions it was fragmented 
for dual point calibration (m/z 278.1135 and 556.2766). Spectra were generated in 
Masslynx 4.1 by combining a number of scans, and peaks were centred using automatic 
peak detection.  Data for multiply charged species were deconvoluted using the Mass 
X3 program.   
 
Infra-Red spectrometry (IR) 
Infra-red spectra were obtained on a Perkin-Elmer FTIR Spectrum BX instrument 
equipped with MIRacle single reflection horizontal accessory.  
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Fluorescence spectrometry 
Compounds 2.05 and 2.13 were redissolved in MeOH and water, respectively, at wide 
concentration range and fluorescence intensities were measured on a Perkin Elmer 
lambda 55 instrument.   
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5.2 Chemical synthesis of non-fluorescent and fluorescent α-D-
mannopyranoside derivatives to utilise in fluorescence-based 
methodology I 
5.2.1 Chemical synthesis of non-fluorescent azidocoumarinyl α-D-
mannopyranoside derivatives 
2,3,4,6-Tetra-O-benzoyl-α-D-mannopyranosyl bromide (2.01)116, 117 
 
 
Benzoyl chloride (72 mL, 622 mmol) was added dropwise to a stirred solution of D-
mannose (8.0 g, 45 mmol) in pyridine (300 mL) at 0 °C, the mixture was stirred for 1 h 
at room temperature and ice-cold water (300 mL) was carefully added.  The product 
was extracted with CH2Cl2 (3 x 150 mL), the organic extracts were combined and 
washed with ice-cold 1M HCl (3 x 150 mL), saturated aqueous NaHCO3 solution (4 x 
150 mL), dried (MgSO4), filtered, concentrated under reduced pressure, and co-
evaporated with toluene.  The obtained residue was purified by flash column 
chromatography (hexane/EtOAc, 6:4) to give perbenzoylated mannose 2.00 (31.0 g, 
99%, mixture of α/β-anomers) as a colourless solid.  To a solution of perbenzoylated 
mannose (19.4 g, 27.7 mmol) in anhydrous CH2Cl2 (250 mL) stirred at 0 °C, 33% HBr 
(glacial acetic acid, 109 mL) was added.  The reaction mixture was allowed to warm to 
room temperature and stirred for 3.5 hours.  Solvents were removed under reduced 
pressure followed by co-evaporation with toluene (2 x 75 mL) and the resulting residue 
was re-dissolved in ice-cold CH2Cl2 (75 mL) and neutralised with ice-cold saturated 
aqueous NaHCO3 solution (75 mL).  The organic phase was separated, washed with ice-
cold water (3 x 75 mL), saturated aqueous NaHCO3 solution (4 x 75 mL) and brine (3 x 
75 mL).  The resulting organic extract was dried (MgSO4) and concentrated under 
reduced pressure to give known compound 2.01 as a colourless amorphous solid (17.8 
g, 97%). 
1
H NMR: (400 MHz, CDCl3) δ 8.11-7.83 (8H, m, Ar), 7.63-7.52 (3H, m, Ar), 
7.51-7.37 (7H, m, Ar), 7.30-7.26 (2H, m, Ar), 6.58 (1H, d, J1,2 1.4 Hz, H-1), 6.29 (1H, 
dd, J2,3=3.0 Hz, J3,4=10.4 Hz, H-3), 6.23 (1H, t, H-4), 5.90 (1H, dd, J1,2=1.4 Hz, J2,3=3.0 
Hz, H-2), 4.74 (1H, dd, J5,6a=2.4 Hz, J6a,6b=12.4 Hz, H-6a), 4.67-4.64 (1H, m, H-5), 4.51 
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(1H, dd, J5,6a=3.7 Hz, J6a,6b =12.4 Hz, H-6b).  
1
H NMR data are in accordance with the 
literature.
116, 117
 
 
2-Bromoethyl 2,3,4,6-tetra-O-benzoyl-α-D-mannopyranoside (2.02)227 
 
 
To a solution of mannosyl bromide 2.01 (4.0 g, 6.1 mmol) and 2-bromoethanol (0.6 mL, 
9.1 mmol) in anhydrous CH2Cl2 (100 mL) containing 4 Å mol. sieves, at -20 °C, a 
solution of AgOTf (2.2 g, 8.5 mmol) in anhydrous toluene (60 mL) was added.  The 
reaction mixture was allowed to warm to room temperature and stirred for 3 h, 
neutralised with Et3N (3.0 mL), filtered through Celite and concentrated under reduced 
pressure.  The residue was purified by flash column chromatography (hexane/EtOAc 
7:3) to give protected 2-bromoethyl mannoside 2.02 as a colourless amorphous solid 
(3.6 g, 83%).  Rf 0.73 (hexane/EtOAc, 6:4);  [α]D -48.9 (c 1.0, CHCl3);  
1
H NMR (400 
MHz, CDCl3) δ 8.11-8.03 (4H, m, Ar), 7.97-7.95 (2H, m, Ar), 7.85-7.82 (2H, m, Ar), 
7.61-7.25 (12H, m, Ar), 6.12 (1H, t, J=10.1 Hz, H-4), 5.93 (1H, dd, J2,3=3.3 Hz, 
J3,4=10.1 Hz, H-3), 5.73 (1H, dd, J1,2=1.7 Hz, J2,3=3.3 Hz, H-2), 5.16 (1H, d, J1,2=1.7 
Hz, H-1), 4.70 (1H, dd, J5a,6b=2.4 Hz, J6a,6b=12.1 Hz, H-6a), 4.60-4.56 (1H, m, H-5), 
4.50 (1H, dd, J5a,6b=4.6 Hz, J6a,6b=12.1 Hz, H-6b), 4.15-4.09 (1H, m, OCHaCH2Br), 
4.03-3.98 (1H, m, OCHbCH2Br), 3.63-3.60 (2H, m, OCH2CH2Br);  
13
C NMR (100.6 
MHz, CDCl3) δ 166.1-165.4 (C=O), 133.5-128.3 (aromatic C), 97.8 (JC-H=171 Hz, C-1), 
70.3 (C-2), 69.9 (C-3), 69.4 (C-5), 68.6 (OCH2CH2Br), 66.7 (C-4), 62.8 (C-6), 29.7 (-
OCH2CH2Br);  HRMS (ESI): Calculated for C36H31BrO10 Na, 725.0993; Found, 
725.0997.  This compound has been reported before but without full characterisation.
227
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3-Azido-7-hydroxy-2H-cromen-2-one
118
 
 
2,4-Dihydroxybenzaldehyde (20.0 g, 145 mmol), N-acetylglycine (16.9 g, 144 mmol) 
and anhydrous sodium acetate (38.0 g, 463 mmol) were suspended in acetic anhydride 
(500 mL) and refluxed at 140 °C under stirring for 12 h.  The solvent was evaporated 
and resulting mixture was redissolved in water, extracted with EtOAc and organic 
solvent dried under reduced pressure to yield brown slurry.  The resulting mixture was 
dispersed in a mixture of concentrated HCl and ethanol (400 mL), stirred under reflux 
for 2 h, then iced cold water (350 mL) was added to dilute the solution.  The resulting 
solution was then cooled to 0 °C on ice bath, following addition of NaNO2 (20 g, 290 
mmol).  The mixture was stirred for 30 min and NaN3 (28 g, 434 mmol) was added in 
portions.  After stirring for 12 h, the resulting precipitate was filtered off, washed with 
water and dried under reduced pressure to give azidocoumarin as a brown solid (3.7 g, 
12%).  
1
H NMR (400 MHz, DMSO) δ 7.57 (1H, s, H-f), 7.47 (1H, d, Jd,e=8.5 Hz, H-e), 
6.81 (1H, dd, Jc,d=2.3 Hz, Jd,e=8.5 Hz, H-d), 6.76 (1H, d, Jc,d=2.3 H-c).  
1
H NMR data 
are in accordance with the literature.
118
 
 
2-(3-Azido-coumarin-7-yloxy)ethyl 2,3,4,6-tetra-O-benzoyl-α-D-
mannopyranoside (2.03) 
 
 
A solution containing protected 2-bromoethyl mannoside 2.02 (600 mg, 0.9 mmol), 3-
azido-7-hydroxy coumarin (347 mg, 1.7 mmol), anhydrous K2CO3 (236 mg, 1.7 mmol) 
and 18-crown-6 (451 mg, 1.7 mmol) in anhydrous DMF (4 mL) was stirred at 35 °C for 
14 hours.  Solvent was partially evaporated and the product was extracted with ethyl 
acetate (3 x 30 mL), dried (Mg2SO4), filtered and concentrated under reduced pressure.  
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The obtained residue was purified by flash column chromatography (hexane/EtOAc 7:3) 
to give coumarinyl ether 2.03 as a yellow/orange solid (284 mg, 40%).  Rf 0.58 
(hexane/EtOAc, 6:4);  [α]D -42.6 (c 1.1, CHCl3);  IR (neat) 2122, 1720, 1618, 1602, 
1584, 1450, 1256, 1067 cm
-1
;  
1
H NMR (400 MHz, CDCl3) δ 8.08-8.04 (4H, m, Ar), 
7.94-7.91 (2H, m, Ar), 7.83-7.80 (2H, m, Ar), 7.62-7.49 (3H, m, Ar), 7.45-7.36 (7H, m, 
Ar), 7.30 (1H, d, Jd,e=8.6 Hz, H-e), 7.28-7.24 (3H, m, Ar), 7.16 (1H, s, H-f), 6.95 (1H, 
dd, Jc,d=2.4 Hz, Jd,e=8.6 Hz, H-d), 6.91 (1H, d, Jc,d=2.4 H-c), 6.10 (1H, t, J=10.0 Hz, H-
4), 5.87 (1H, dd, J2,3=3.4 Hz, J3,4=10.1 Hz, H-3), 5.71 (1H, dd, J1,2=1.8 Hz, J2,3=3.3 Hz, 
H-2), 5.21 (1H, d, J1,2=1.8 Hz, H-1, 4.77-4.67 (1H, m, H-6a), 4.51-4.46 (1H, m, H-5, H-
6b), 4.32-4.29 (1H, m, OCHaCH2O), 4.24-4.18 (1H, m, OCHbCH2O), 4.05-4.00 (2H, m, 
OCH2CH2O);  
13
C NMR (100.6 MHz, CDCl3) δ 166.1-165.4 (C=O), 160.7, 157.7, 
152.9, 133.5-128.3 (aromatic C), 126.2, 123.6, 113.6, 113.1, 101.6, 97.1 (C-1), 70.3 (C-
2), 69.8 (C-3), 69.1 (C-5), 67.4 (OCH2CH2O), 66.9 (C-4), 66.5 (OCH2CH2O), 62.9 (C-
6);  HRMS (ESI): Calculated for C45H35N3O13 Na, 848.2075; Found, 848.2062. 
 
2-(3-Azido-coumarin-7-yloxy)ethyl α-D-mannopyranoside (α-Man-EtC (2.04)) 
 
 
A solution of coumarinyl ether 2.03 (284 mg, 0.3 mmol) in anhydrous MeOH (2 mL) 
was treated with 1M NaOMe in MeOH (0.1 mL, 0.1 mmol).  The solution was kept at 
room temperature for 24 hours, neutralised with ion-exchange resin (Amberlite IR-120 
H
+
) and concentrated under reduced pressure.  The resulting residue was purified by 
flash column chromatography (CH2Cl2/MeOH 9:1) to give unprotected mannoside 2.04 
as an off-white colour solid (141 mg, 71%).  Rf 0.52 (CH2Cl2/MeOH 9:1);  [α]D + 40.5 
(c 1.0, MeOH);  
 1
H NMR (400 MHz, CD3OD) δ 7.47 (1H, d, Jd,e=9.4 Hz, H-e), 7.40 
(1H, s, H-f), 6.99-6.95 (2H, m, H-c and H-d), 4.85 (1H, under D2O signal, H-1), 4.27 
(2H, t, J=4.7 Hz OCH2CH2O), 4.11-4.06 (1H, m, OCHaCH2O), 3.92-3.86 (1H, m, 
OCHbCH2O), 3.83-3.80 (2H, m, H-2, H-6a), 3.72-3.67 (2H, m, H-6b, H-3), 3.64-3.60 
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(2H, m, H-5, H-4);  
13
C NMR (100.6 MHz, CD3OD) δ 162.7, 159.4, 154.4, 129.8, 
128.3, 124.4, 114.7, 114.3, 102.4, 101.9 (C-1), 74.8 (C-4), 72.5 (C-3), 72.1 (C-2), 69.2 
(OCH2CH2O), 68.5 (C-5), 66.9 (OCH2CH2O), 62.9 (C-6);  HRMS (ESI): Calculated for 
C17H19N3O9 Na, 432.1014; Found, 432.1014. 
 
5.2.2 Chemical synthesis of fluorescent coumarinyl α-D-mannopyranoside 
derivative under strain-promoted click condition 
Cyclooctyne
120
 
 
Cis-cyclooctene (500 mg, 4.54 mmol, 0.5 mL) was dissolved in CH2Cl2 (4 mL) and a 
solution of bromide (870 mg, 5.44 mmol, 0.3 mL) was added gradually at 0 °C until a 
yellow colour persisted.  The reaction mixture was quenched with 10% Na2SO4 (20 mL) 
and the product was extracted with CH2Cl2 (3 x 20 mL).  The resulting organic extracts 
were combined, dried (MgSO4), filtered and concentrated under reduced pressure to 
give 1,2-dibromocyclooctane as clear oil (1.2 g, 100%).  The 1,2-dibromocyclooctane 
(1.2 g, 4.54 mmol) was dissolved in THF (20 mL), cooled to 0 °C, and a solution of 
KOtBu (560 mg, 5.00 mmol) was gradually added.  The reaction mixture was refluxed 
for 2 h, allowed to cool to room temperature and quenched with saturated aqueous 
NH4Cl solution (20 mL).  The product was extracted with CH2Cl2 (3 x 30 mL), dried 
(MgSO4), filtered and concentrated under reduced pressure.  The obtained residue was 
purified by flash column chromatography (100 % hexane) to give 1-bromocyclooctene 
as yellow oil (570 mg, 67 %) b.p. 90-95 °C/22torr.   
To a solution of lithium diisopropylamide in anhydrous TFA (50 mL) cooled at -25 °C, 
1-bromocyclooctene (570 mg, 3.01 mmol) was added.  The reaction mixture was 
gradually brought up to 15 °C and poured onto iced cold 1 M HCL (50 mL).  The 
product was extracted with pentane (4 x 40 mL), dried (MgSO4) and filtered.  The 
residue obtained was purified by flash column chromatography (100% pentane).  
Solvent was carefully distilled to give cyclooctyne (208 mg, 64%) b.p. 51-52°C/22torr.  
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1
H NMR: (400 MHz, CD3OD) δ 2.18 (4H, m, H-j,j’), 1.88-1.84 (4H, m, H-k, k’), 1.63-
1.61 (4H, m, H-m, m’);   1H NMR data are in accordance with the literature. 120 
 
2-(3-(4,5,6,7,8,9-Hexahydro-1H-cycloocta[d][1,2,3]triazole-1-yl)-coumarin-7-
yloxy)ethyl α-D-mannopyranoside (α-Man-EtTC (2.05)) 
 
 
To a solution of azidocoumarin glycoside 2.04 (9.9 mg, 0.02 mmol) in MeOH (1 mL) 
cyclooctyne (3.1 mg, 0.03 mmol, 3.6 μL) was added.  The reaction mixture was allowed 
to stir at room temperature for 2 h and solvent was removed under reduced pressure.  
The resulting residue was purified by flash column chromatography (CH2Cl2/MeOH, 
9:1) to give click adduct 2.05 as an off-white amorphous solid (13 mg, 99%).  Rf 0.65 
(CH2Cl2/MeOH, 9:1);  
 1
H NMR: (400 MHz, CD3OD) δ 8.27 (1H, s, H-f), 7.71 (1H, d, 
Jc,d= 8.8 Hz, H-c), 7.09-7.07 (2H, m, H-d, H-e), 4.87 (1H, d, J1,2= 1.7 Hz, H-1), 4.33 
(2H, t, J=4.7 Hz, OCH2CH2O), 4.13-4.08 (1H, m, OCHaCH2O), 3.92-3.86 (1H, m, 
OCHbCH2O), 3.84-3.81 (2H, m, H-2, H-6a), 3.73-3.61 (2H, m, H-6b, H-3, H-5, H-4), 
2.96 (2H, t, J=6.4 Hz, H-j), 2.78 (2H, t, J=6.2 Hz, H-j’), 1.88-1.78 (4H, m, H-k, k’), 
1.61-1.52 (4H, m, H-m, m’);  13C NMR (100.6 MHz, CD3OD) δ 165.4, 159.1, 157.4, 
144.1, 138.2, 131.9, 120.8, 115.3, 113.0, 102.7, 101.9 (C-1), 74.8 (C-4), 72.5 (C-3), 
72.1 (C-2), 69.4 (OCH2CH2O), 68.5 (C-5), 66.9 (OCH2CH2O), 62.9 (C-6);  HRMS 
(ESI): Calculated for C25H31N3O9 Na, 540.1953; Found, 540.1952.  
 
 
 
 
 
154 
 
5.3 Chemical synthesis of non-fluorescent and fluorescent α-D-
mannopyranoside derivatives to utilise in fluorescence-based 
methodology II 
5.3.1 Chemical synthesis of non-fluorescent 5-hexynyl α-D-mannopyranoside 
derivatives 
5-Hexynyl 2,3,4,6-tetra-O-benzoyl-α-D-mannopyranoside (2.06) 
 
 
To a solution of mannosyl bromide 2.01 (11.7 g, 17.9 mmol) and 5-hexyn-1-ol (2.1 g, 
21.5 mmol) in anhydrous CH2Cl2 (40 mL) containing 4 Å mol. sieves cooled at -20 °C, 
a solution of AgOTf (6.4 g, 25.1 mmol) in anhydrous toluene (160 mL) was added.  The 
reaction mixture was allowed to warm to room temperature and stirred for 3.5 hours.  
The reaction mixture was neutralised with Et3N (2.0 mL), filtered through Celite and 
concentrated under reduced pressure.  The residue was purified by flash column 
chromatography (hexane/EtOAc 7:3) to give protected hexynyl mannoside 2.06 as a 
colourless amorphous solid (10.2 g, 85%).  Rf 0.6 (hexane/EtOAc, 6:4); [α]D - 55.0 (c 
1.0, CHCl3);  
1
H NMR: (400 MHz, CDCl3) δ 8.11-8.05 (4H, m, Ar), 7.98-7.96 (2H, m, 
Ar), 7.85-7.83 (2H, m, Ar), 7.61-7.24 (12H, m, Ar), 6.12 (1H, t, J=10.8 Hz, H-4), 5.93 
(1H, dd, J2,3=3.4 Hz, J3,4=8.0 Hz, H-3), 5.71 (1H, dd, J1,2=1.6 Hz, J2,3=3.4 Hz, H-2), 
5.10 (1H, d, J1,2=1.6 Hz, H-1), 4.70 (1H, dd, J5,6a=2.5 Hz, J6a,6b=12.1 Hz, H-6a), 4.50 
(1H, dd, J5,6b=4.5 Hz, J6a,6b=12.1 Hz, H-6b), 4.45-4.41 (1H, m, H-5); 3.90-3.84 (1H, m, 
OCHaHb), 3.66-3.58 (1H, m, OCHaHb), 2.30-2.26 (2H, m, OCH2CH2CH2CH2CCH), 
2.00 (1H, t, J=2.6 Hz OCH2CH2CH2CH2CCH), 1.86-1.81 (2H, m, 
OCH2CH2CH2CH2CCH), 1.72-1.66 (2H, m, OCH2CH2CH2CH2CCH); 
13
C NMR: (100.6 
MHz, CDCl3) δ 166.1-165.4 (C=O), 133.4-128.3 (aromatic C), 98.4 (JC-H=171.9 Hz, C-
1), 84.0, 70.6 (C-2), 70.1 (C-3), 68.9 (C-4), 68.8, 68.1, 67.0 (C-5), 62.9 (C-6), 28.4, 
25.0, 18.2; HRMS (ESI) Calculated for C40H36O10Na, 699.2201; Found, 699.2202. 
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5-Hexynyl α-D-mannopyranoside (H-α-Man (2.07)) 
 
 
A solution of protected hexynyl mannoside 2.06 (3.10 g, 4.8 mmol) in absolute MeOH 
(60 mL) was treated with 1 M NaOMe in MeOH (1.9 mL, 1.9 mmol).  The solution was 
kept at room temperature for 4 h, neutralised with ion-exchange resin (Amberlite IR-
120 H
+
) and concentrated under reduced pressure.  The resulting residue was re-
dissolved in water (50 mL) and the aqueous phase was washed with dichloromethane (3 
x 50 mL).  The aqueous extract was evaporated to give unprotected hexynyl mannoside 
2.07 as a colourless syrup (1.1 g, 92%).  Rf 0.2 (CH2Cl2/MeOH, 9:1);  [α]D +72.0 (c 1.0, 
CHCl3);  
1
H NMR: (400 MHz, D2O) δ 4.87 (1H, d, J1,2=1.7 Hz, H-1), 3.94 (1H, dd, 
J1,2=1.7 Hz, J2,3=3.4 Hz, H-2), 3.89 (1H, dd, J5,6a=1.8 Hz, J6a,6b=12.4 Hz, H-6a), 3.81-
3.73 (3H, m, H-3, H-6b, OCHaHb), 3.68-3.55 (3H, m, H-4, H-5, OCHaHb), 2.28-2.23 
(3H, m, OCH2CH2CH2CH2CCH, OCH2CH2CH2CH2CCH), 1.77-1.68 (2H, m, 
OCH2CH2CH2CH2CCH), 1.66-1.56 (2H, m, OCH2CH2CH2CH2CCH);  
13
C NMR; 
(100.6 MHz, D2O) δ 98.4 (C-1), 84.2, 71.5 (C-5), 69.4 (C-3), 68.8 (C-2), 67.9, 66.1, 
65.5 (C-4), 59.7 (C-6), 26.5, 23.3, 16.1; HRMS (ESI): Calculated for C12H20O6Na, 
283.1152; Found, 283.1147. 
 
5-Hexynyl 2,3,4-tri-O-benzoyl-6-O-trityl-α-D-mannopyranoside (2.08) 
 
 
To a solution of unprotected hexynyl mannoside 2.07 (1.2 g, 4.4 mmol) in anhydrous 
pyridine (15 mL) triphenylmethyl chloride (1.8 g, 6.6 mmol) and 4-
dimethylaminopyridine (108 mg, 0.88 mmol) were added.  The reaction mixture was 
warmed to 37 °C for 40 h, diluted with pyridine (45 mL) and cooled down to 0 °C for 
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benzoyl chloride (51.0 mL, 44.2 mmol) addition.  The mixture was stirred for 1 h at 
room temperature and ice-cold water was carefully added.  The product was extracted 
with CH2Cl2 (3 x 75 mL), the organic extracts were combined and washed with ice-cold 
1M HCl (3 x 75 mL), saturated aqueous NaHCO3 solution (4 x 75 mL), dried (MgSO4), 
filtered and concentrated under reduced pressure.  The obtained residue was purified by 
flash column chromatography (hexane/EtOAc 7:3) to give ester protected tritylether 
2.08 as a colourless amorphous solid (3.3 g, 92%).  Rf 0.77 (hexane/EtOAc, 6:4); [α]D -
95.0 (c 1.0, CHCl3); 
1
H NMR: (400 MHz, CDCl3) δ 8.16-8.10 (2H, m, Ar), 7.85-7.82 
(2H, m, Ar), 7.75-7.73 (2H, m, Ar), 7.50-7.40 (10H, m, Ar), 7.33-7.24 (6H, m, Ar), 
7.17-7.07 (8H, m, Ar), 6.02 (1H, t, J=10.2, H-4), 5.78 (1H, dd, J2,3=3.4 Hz, J3,4=10.2 
Hz, H-3), 5.67 (1H, dd, J1,2=1.6 Hz, J2,3=3.4 Hz, H-2), 5.12 (1H, d, J1,2=1.6 Hz, H-1), 
4.20-4.16 (1H, m, H-5), 3.93-3.87 (1H, m, OCHaHb), 3.65-3.59 (1H, m, OCHaHb), 3.38 
(1H, dd, J5,6a=2.2 Hz, J6a,6b=10.5 Hz, H-6a), 3.28 (1H, dd, J5,6b=4.8 Hz, J6a,6b=10.5 Hz, 
H-6b), 2.30-2.26 (2H, m, OCH2CH2CH2CH2CCH), 1.97 (1H, t, J=2.6 Hz, 
OCH2CH2CH2CH2CCH), 1.86-1.81 (2H, m, OCH2CH2CH2CH2CCH), 1.74-1.66 (2H, 
m, OCH2CH2CH2CH2CCH); 
13
C NMR: (100.6 MHz, CDCl3) δ 165.7-165.1 (C=O), 
146.8-126.8 (aromatic C), 97.5 (C-1), 84.0, 70.9 (C-2), 70.6 (C-3), 70.9 (C-5), 68.7, 
67.7, 67.0 (C-4), 62.3 (C-6), 28.4, 25.1, 18.2;  HRMS (ESI): Calculated for 
C52H46O9Na, 837.3034; Found, 837.3029. 
 
6-O-Hexyn-5-yl (2,3,4,6-tetra-O-benzoyl-α-D-mannopyranosyl)-2,3,4-tri-O 
benzoyl-α-D-mannopyranoside (2.09)  
 
 
To a solution of esterified tritylether  2.08 (3.7 g, 4.5 mmol) and mannosyl bromide 
2.02 (4.5 g, 6.8 mmol) in anhydrous CH2Cl2 containing 4 Å mol. sieves, at -20 °C, a 
solution of AgOTf (1.6 g, 6.4 mmol) in anhydrous toluene (110 mL) was added.  The 
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reaction mixture was allowed to warm to room temperature and stirred for 18 h, 
neutralised with Et3N (3.0 mL), filtered through Celite and concentrated under reduced 
pressure.  The resulting residue was purified by flash column chromatography 
(hexane/EtOAc 7:3) to give protected hexynyl disaccharide 2.09 as a colourless 
amorphous solid (2.3 g, 45%). Rf 0.6 (hexane/EtOAc, 1:1);  [α]D - 54.0 (c 1.0, CHCl3);  
1
H NMR: (400 MHz, CDCl3) δ 8.17-8.15 (2H, m, Ar), 8.04-7.98 (8H, m, Ar), 7.87-7.84 
(4H, m, Ar), 7.58-7.48 (6H, m, Ar), 7.44-7.34 (10H, m, Ar), 7.30-7.21 (5H, m, Ar), 
6.11-6.06 (2H, m, H-4, H-4’), 6.00 (1H, dd, J2’,3’=3.2 Hz, J3’,4’=10.1 Hz, H-3’), 5.94 
(1H, dd, J2,3=3.3 Hz, J3,4=10.1 Hz, H-3), 5.78 (1H, dd, J1’,2’=1.5 Hz, J2’,3’=3.2 Hz, H-2’), 
5.75 (1H, dd, J1,2=1.6 Hz, J2,3=3.3 Hz, H-2), 5.15 (1H, d, J1’,2’=1.5 Hz, H-1’), 5.12 (1H, 
d, J1,2=1.6 Hz, H-1), 4.51 (1H, dd, J5’,6a’=2.4 Hz, J6a’,6b’=12.2 Hz, H-6’a), 4.44-4.37 (2H, 
m, H-5’ H-5), 4.30 (1H, dd, J5’,6a’=4.2 Hz, J6a’,6b’=12.2 Hz, H-6’b), 4.13 (1H, dd, 
J5,6a=5.4 Hz, J6a,6b=10.9 Hz, H-6b), 4.00-3.95 (1H, m, OCHaHb), 3.78 (1H, dd, J5a,6b=2.0 
Hz, J6a,6b=10.8 Hz, H-6a), 3.70-3.64 (1H, m, OCHaHb), 2.35-2.31 (2H, m, 
OCH2CH2CH2CH2CCH), 1.98 (1H, t, J=2.6 Hz, OCH2CH2CH2CH2CCH), 1.95-1.87 
(2H, m, OCH2CH2CH2CH2CCH), 1.80-1.72 (2H, m, OCH2CH2CH2CH2CCH); 
13
C 
NMR: (100.6 MHz, CDCl3) δ 166.0-165.1 (C=O), 133.5-132.9 (aromatic C), 130.1-
128.3 (aromatic C),  97.8 (C-1), 97.7 (C-1’), 84.1, 70.6 (C-2), 70.3 (C-2’),  70.2 (C-3; 
3’), 69.6 (C-5), 68.9 (C-5’),  68.7, 68.1, 67.0 (C-6), 66.7 (C-4), 62.3 (C-6’), 28.5, 25.1, 
18.2;  HRMS (ESI): Calculated for C67H58O18Na,1173.3515; Found, 1173.3517. 
 
Hexyn-5-yl α-D-mannopyranosyl-(1→6)-α-D-mannopyranoside (H-α-Man-1,6-α-
Man (2.10)) 
 
 
A solution of protected hexynyl disaccharide 2.09 (880 mg, 0.8 mmol) in absolute 
MeOH (60 mL) was treated with 1M NaOMe in MeOH (0.5 mL, 0.54 mmol).  The 
158 
 
solution was kept at room temperature for 24 h, neutralised with ion-exchange resin 
(Amberlite IR-120 H
+
) and concentrated under reduced pressure.  The resulting residue 
was purified by flash column chromatography (CH3CN/H2O/NH3 6:3:1) to give 
unprotected hexynyl disaccharide 2.10 as a colourless amorphous solid (323 mg, 84%).  
Rf 0.66 (CH3CN/H2O/NH3 6:3:1);  [α]D  + 80.0 (c 1.0, MeOH);  1H NMR: (400 MHz, 
D2O) δ 4.91 (1H, d, J1’,2’=1.7 Hz, H-1’), 4.87 (1H, d, J1,2=1.2 Hz, H-1), 4.00 (1H, dd, 
J1’,2’=1.7 Hz, J2’,3’=3.4 Hz, H-2’), 4.00-3.95 (2H, m, H-2; H-6b’), 3.92 (1H, dd, 
J5’,6a’=1.6 Hz, J6a’,6b’=11.8 Hz, H-6a’), 3.85 (1H, dd, J2,3=3.4 Hz, J3,4=9.0 Hz, H-3), 
3.81-3.65 (8H, m, H-4’, H-4, H-6a, H-6b, OCHaHb, H-3’, H-5’, H-5), 3.62-3.57 (1H, m, 
OCHaHb), 2.39 (1H, t, J=2.6 Hz, OCH2CH2CH2CH2CCH), 2.29-2.25 (2H, m, 
OCH2CH2CH2CH2CCH), 1.78-1.71 (2H, m, OCH2CH2CH2CH2CCH), 1.67-1.58 (2H, 
m, OCH2CH2CH2CH2CCH);  
13
C NMR: (100.6 MHz, D2O) δ 99.8, 99.4, 85.8, 72.6 (C-
5), 70.9 (C-3, 3’), 70.0 (C-2), 69.9 (C-2’), 67.3, 67.3, 66.7 (C-4), 66.6 (C-4’), 65.7 (C-
6), 60.9 (C-6’), 27.6, 24.5, 17.2;  HRMS (ESI): Calculated for C18H30O11Na, 445.1680; 
Found, 445.1677. 
 
5.3.2 Chemical synthesis of fluorescent coumarinyl α-D-mannopyranoside 
derivatives under Cu(I)-catalysed click conditions 
4-(1-(7-Hydroxy-coumarin-3-yl)-1H-1,2,3-triazol-4-yl)-)propyl (HTC)(2.11)  
 
 
A solution of 5-hexynol (25 mg, 0.1 mmol) and 3-azido-7-hydroxycoumarin (19 mg, 
0.1 mmol) in MeOH (0.8 mL) was treated with 1 M aq. CuSO4 (10 µL) and 1 M aq. 
sodium ascorbate (25 µL).  The reaction mixture was allowed to stir at room 
temperature for 2 h and concentrated under reduced pressure.  The resulting residue was 
purified by semi-prep TLC (CH2Cl2/MeOH/H2O, 80:20:3) to give click adduct 2.11 as a 
yellow amorphous solid (29 mg, 70%).  Rf 0.84 (CH2Cl2/MeOH/H2O, 10:8:2);  
1
H 
NMR: (400 MHz, MeOD) δ 8.37 (1H, s, H-f), 8.24 (1H, s, H-j), 7.54 (1H, d, Jc,d= 8.6 
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Hz, H-c), 6.80 (1H, dd, Jc,d=8.6, Jd,e=2.3 Hz, H-d), 6.72 (d, Jd,e=2.3 Hz, H-e), 3.51 (2H, 
t, J=6.5 Hz, CH2-triazole), 2.72 (2H, t, J=7.5 Hz, HO-CH2), 1.74-1.66 (2H, m, CH2), 
1.56-1.49 (2H, m, CH2);  
13
C NMR (100.6 MHz, CD3OD) δ 137.1, 131.9, 122.3, 115.6, 
103.4, 33.1, 26.9, 26.0;  HRMS (ESI): Calculated for C15H15N3O4 Na, 324.0960; Found, 
432.1014. 
 
4-(1-(7-Hydroxy-coumarin-3-yl)-1H-1,2,3-triazol-4-yl)-)propyl α-D-mannopyranoside 
(α-Man-HTC)(2.12)  
 
 
A solution of hexynyl mannoside 2.07 (17 mg, 0.06 mmol) and 3-azido-7-hydroxy 
coumarin (16 mg, 0.05 mmol) in MeOH/H2O (1:1) (1 mL) was treated with 1 M aq. 
CuSO4 (10 µL) and 1 M aq. NaAsc (25 µL).  The reaction mixture was allowed to stir at 
room temperature for 2 h and concentrated under reduced pressure.  The resulting 
residue was purified by semi-prep TLC (CH2Cl2/MeOH/H2O, 80:20:3) to give click 
adduct 2.12 as a yellow amorphous solid (25 mg, 84%).  Rf 0.62 (CH2Cl2/MeOH/H2O, 
10:8:2);  
1
H NMR: (400 MHz, MeOD) δ 8.23 (1H, s, H-f), 8.17 (1H, s, H-j), 7.36 (1H, 
d, Jc,d= 8.8 Hz, H-c), 6.60 (1H, dd, Jc,d= 8.8, Jd,e=2.2 Hz, H-d), 6.46 (d, Jd,e= 2.2 Hz, H-
e), 4.64 (1H, d J1,2= 1.5 Hz, H-1), 3.76-3.67 (3H, m, H-2, H-6a, OCHaHb), 3.62-3.59 
(2H, m, H-3, H-6b), 3.51-3.35 (3H, m, H-4, H-5, OCHaHb), 2.72 (2H, t, J=7.5 Hz, 
OCH2CH2CH2CH2), 1.78-1.71 (2H, m, OCH2CH2CH2CH2), 1.65-1.57 (2H, m, 
OCH2CH2CH2CH2);  
13
C NMR; (100.6 MHz, D2O) δ 159.3, 158.0, 138.5 131.3, 124.2, 
119.5, 104.7, 101.4 (C-1), 74.7 (C-5), 72.6 (C-3), 72.3 (C-2), 68.7 (C-4), 68.2 (C-6), 
30.0, 27.3, 26.0; HRMS (ESI): Calculated for C21H25N3O9Na, 486.1488; Found, 
486.1476. 
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4-(1-(7-Hydroxy-coumarin-3-yl)-1H-1,2,3-triazol-4-yl)-)propyl α-D-mannopyranosyl-
(1→6)-α-D-mannopyranoside (α-Man-1,6-α-Man-HTC)(2.13)  
 
 
A solution of hexynyl disaccharide 2.10 (15 mg, 0.04 mmol) and 3-azido-7-
hydroxycoumarin (7.2 mg, 0.04 mmol) in MeOH/H2O (1:1) (1 mL) was treated with 1 
M aq. CuSO4 (10 µL) and 1 M aq. NaAsc (25 µL).  The reaction mixture was allowed 
to stir at room temperature for 2 h and concentrated under reduced pressure.  The 
resulting residue was purified by semi-prep TLC (CH2Cl2/MeOH/H2O, 80:20:3) to give 
click adduct 2.13 as a yellow amorphous solid (20 mg, 90%).  Rf 0.37 
(CH2Cl2/MeOH/H2O, 10:8:2);  
1
H NMR: (400 MHz, CD3OD) δ 8.37 (1H, s, H-f), 8.25 
(1H, s, H-j), 7.52 (1H, d, Jc,d= 8.7 Hz, H-c), 6.78 (1H, dd, Jc,d= 8.7, Jd,e=2.3 Hz, H-d), 
6.71 (1H, d, Jd,e= 2.3 Hz, H-e), 4.72 (1H, d, J1’,2’=1.7 Hz, H-1’), 4.63 (1H, d, J1,2=1.5 
Hz, H-1), 3.81-3.50 (14H, m, H-6a, H-6b, H-2’, H-2; H-3, H-3’, OCHaHb, H-6’a, H-6’b, 
H-5’, H-5, H-4’, H-4), 3.41-3.36 (1H, m, OCHaHb), 2.73 (2H, t, J=7.5 Hz, 
OCH2CH2CH2CH2), 1.77-1.70 (2H, m, OCH2CH2CH2CH2), 1.64-1.56 (2H, m, 
OCH2CH2CH2CH2);  
13
C NMR: (100.6 MHz, D2O) δ 157.8, 156.8, 138.6, 131.8, 124.3, 
115.9, 103.4, 101.6 (C-1), 101.3 (C-1’), 74.8, 74.4, 73.2, 72.8, 72.6, 72.2, 68.7 (H-4, H-
4’), 68.6 (OCHaHb), 68.2 (C-6), 67.5, 62.9 (C-6’), 30.0, 27.4, 26.0; HRMS (ESI): 
Calculated for C27H35N3O14Na 648.2011; Found, 648.2002. 
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5.4 Chemical synthesis of azido-alkyne galactose-containing monomer  
2,3,4-Tri-O-benzoyl-6-O-(prop-2-ynyl)-1-O-trichloroacetimidoyl-α-D-galactopyranose 
(4.04) 
 
Benzoyl chloride (25 mL, 215 mmol) was added dropwise to a stirred solution of 6-O-
propargyl galactose 4.01
32
 (9.7 g, 43 mmol) in pyridine (95 mL) at 0 °C, the mixture 
was stirred for 1 h at room temperature and ice-cold water (100 mL) was carefully 
added.  The product was extracted with CH2Cl2 (3 x 125 mL), the organic extracts were 
combined and washed with ice-cold 1M HCl (3 x 100 mL), saturated aqueous NaHCO3 
solution (4 x 100 mL), dried (MgSO4), filtered and concentrated under reduced 
pressure.  The obtained residue was purified by flash column chromatography 
(toluene/EtOAc, 7:3) to give compound 4.02 (21.9 g, 81%, mixture of α/β-anomers) as a 
colourless solid.  Benzoate 4.02 (6.6 g, 104 mmol) was dissolved in anhydrous THF (70 
mL), 7 N NH3 in methanol (23 mL) was added, the solution was stirred for 26 h at room 
temperature and the solvent was removed under reduced pressure. The residue was 
purified by flash column chromatography (hexane/EtOAc, 7:3) to give compound 4.03 
(3.5 g, 64%).  Hemiacetal 4.03 (2.8 g, 5.2 mmol) and trichloroacetonitrile (1.9 g, 13.0 
mmol) were then dissolved in anhydrous CH2Cl2 (10 mL), the solution was cooled to 0 
°C and DBU (80 mg, 0.5 mmol) was added.  The mixture was allowed to warm to room 
temperature, stirred for 2 h and concentrated under reduced pressure.  The residue was 
purified by flash column chromatography (hexane/EtOAc, 7:3) to give compound 4.04 
(2.9 g, 99 %) as a colourless syrup.  Rf 0.55 (hexane/EtOAc, 7:3);  [α]D + 1.2 (c 0.6, 
CHCl3);  δH (400 MHz, CDCl3): 8.61 (1H, s, NH), 8.09-8.07 (2H, m, Ph), 7.96-7.93 
(2H, m, Ph), 7.81-7.79 (2H, m, Ph), 7.63 (1H, m, Ph), 7.52-7.24 (8H, m, Ph), 6.88 (1H, 
d, J1,2=3.6 Hz, H-1), 6.08 (1H, dd, J3,4=3.4 Hz, J4,5=1.3 Hz, H-4), 6.04 (1H, dd, J3,4=3.4 
Hz, J2,3=10.6 Hz, H-3), 5.92 (1H, dd, J1,2=3.6 Hz, J2,3=10.6 Hz, H-2), 4.68 (1H, m, H-
5), 4.12 (2H, m, CH2C≡CH), 3.75 (2H, d, J=6.2 Hz, H-6, H-6’), 2.24 (1H, t, J=2.3 Hz, 
CH2C≡CH);  δC (100.6 MHz, CDCl3) 165.7-165.4, 133.6-133.2, 129.9-128.3, 93.9, 
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75.3, 70.3, 68.6, 68.1, 67.5, 67.1, 58.7;  HRMS (ESI) m/z Calculated for 
C32H26Cl3NO9Na, 696.0571;  Found: 696.0565. 
 
2-(2-(2-Chloroethoxy)ethoxy)ethyl 6-O-(prop-2-ynyl)-2,3,4-tri-O-benzoyl-β-D-
galactopyranoside (4.05)  
 
 
To a solution of imidate 4.04 (2.9 g, 5.2 mmol) and 2-(2-(2-
chloroethoxy)ethoxy)ethanol (730 mg, 4.3 mmol) in anhydrous CH2Cl2 (50 mL) 
containing 4 Å mol. sieves, at -30 °C, TMSOTf (90 µL, 0.5 mmol) was gradually added, 
the reaction mixture was allowed to warm to room temperature and stirred for 3 h.  The 
reaction was quenched by addition of Et3N (1.0 mL) and concentrated under reduced 
pressure.  The residue was purified by flash chromatography (EtOAc/hexane, 7:3) to 
give compound 4.05 (2.7 g, 85%) as a colourless solid.  Rf 0.17 (EtOAc/hexane, 7:3);  
[α]D + 0.9 (c 0.7, CHCl3);  IR (neat) 2877, 2360, 1725, 1601, 1584, 1451, 1260, 1094, 
750 cm
-1
;  δH (400 MHz, CDCl3) 8.09-8.07 (2H, m, Ph), 7.98-7.96 (2H, m, Ph), 7.79-
7.77 (2H, m, Ph), 7.61 (1H, m, Ph), 7.53-7.36 (8H, m, Ph), 5.90 (1H, dd, J3,4=3.5 Hz, H-
4), 5.75 (1H, dd, J1,2=8.0 Hz; J2,3=10.5 Hz, H-2), 5.56 (1H, dd, J3,4=3.5 Hz; J2,3=10.5 
Hz, H-3), 4.90 (1H, d, J1,2=8.0 Hz, H-1), 4.19-4.12 (3H, m, H-5, CH2C≡CH), 4.11-4.04 
(1H, m, GalOCH2), 3.87-3.81 (1H, m, GalOCH2), 3.76 (2H, m, H-6, H-6’), 3.69-3.60 
(4H, m, CH2), 3.59-3.53 (2H, m, CH2Cl2), 3.51-3.47 (2H, m, CH2), 3.44-3.38 (2H, m, 
CH2), 2.30 (1H, t, J=2.3 Hz, CH2C≡CH);  δC (100.6 MHz,  CDCl3) δ 165.6-165.2, 
133.4-133.2, 130.0-128.3, 101.7, 79.1, 75.0, 72.7, 71.9, 71.3, 70.7, 70.5, 70.4, 69.9, 
69.5, 68.5, 67.8, 58.7, 42.7; HR-MS (EI) m/z Calculated for C36H37ClO11Na, 703.1922;  
Found: 703.1917. 
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2-(2-(2-Azidoethoxy)ethoxy)ethyl 6-O-(prop-2-ynyl)-2,3,4-tri-O-benzoyl-β-D-
galactopyranoside (4.06) 
 
 
To a solution of chloro-β-galactoside 4.05 (5.2 g, 7.6 mmol) in DMF (50 mL) NaN3 (2.5 
g, 38.0 mmol) and NaI (1.1 g, 8.0 mmol) were added and the reaction mixture was 
stirred at 70 °C for 28 h.  The reaction mixture was diluted with water (20 mL) and 
extracted with CH2Cl2 (3 x 30 mL).  The resulting organic extracts were dried (MgSO4), 
and concentrated under reduced pressure to give compound 4.06 (5.0 g, 97%) as a 
colourless syrup.  Rf 0.17 (hexane/EtOAc, 7:3);  [α]D + 0.9 (c 0.7, CHCl3);  IR (neat) 
2874, 2359, 2107, 1724, 1601, 1584, 1451, 1259, 1094, 752 cm
-1
;  δH (400 MHz, 
CDCl3) 8.09-8.07 (2H, m, Ph), 7.98-7.96 (2H, m, Ph), 7.79-7.77 (2H, m, Ph), 7.61 (1H, 
m, Ph), 7.53-7.36 (8H, m, Ph), 5.90 (1H, dd, J3,4=3.5 Hz, H-4), 5.75 (1H, dd, J1,2=8.0 
Hz; J2,3=10.5 Hz, H-2), 5.56 (1H, dd, J3,4=3.5 Hz; J2,3=10.5 Hz, H-3), 4.90 (1H, d, 
J1,2=8.0 Hz, H-1), 4.19-4.12 (3H, m, H-5, CH2C≡CH), 4.11-4.04 (1H, m, GalOCH2), 
3.87-3.81 (1H, m, GalOCH2), 3.76 (2H, m, H-6, H-6’), 3.69-3.59 (2H, m, CH2), 3.57-
3.52 (2H, m, CH2), 3.52-3.46 (2H, m, CH2), 3.44-3.37 (2H, m, CH2), 3.51-3.29 (2H, m, 
CH2N3), 2.30 (1H, t, J=2.3 Hz, CH2C≡CH);  δC (100.6 MHz, CDCl3) 165.6-165.2, 
133.4-133.2, 130.0-128.3, 101.5, 79.1, 75.0, 72.7, 71.9, 71.3, 70.7, 70.5, 70.4, 69.95, 
69.9, 69.5, 68.5, 67.8, 58.7, 50.6; HRMS (ESI) m/z Calculated for C36H37N3O11Na, 
710.2326; Found: 710.2320. 
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2-(2-(2-Azidoethoxy)ethoxy)ethyl 6-O-(prop-2-ynyl)-β-D-galactopyranoside (4.07)  
 
 
A solution of azido-β-galactoside compound 4.06 (2.4 g, 3.48 mmol) in absolute MeOH 
(20 mL) was treated with 0.5 M NaOMe in MeOH (2.7 mL, 1.39 mmol), the solution 
was kept at room temperature for 1 h, neutralized with dry ice, concentrated under 
reduced pressure and purified by flash chromatography (CH2Cl2-MeOH, 9:1) to give 
compound 4.07 (1.2 g, 91%) as a colourless syrup.  Rf 0.89 
(CH3CN/EtOAc/iPrOH/H2O, 85:20:50:50);  [α]D -1.6 (c 1.3, MeOH);  δH (600 MHz, 
Methanol-d4) 4.16 (1H, d, J1,2=7.6 Hz, H-1), 4.11 (2H, d, J=2.4 Hz, CH2C≡CH), 3.94-
3.84 (1H, m, H-6a), 3.69 (1H, dd, J3,4=3.4 Hz, J4,5=1.1 Hz, H-4), 3.67-3.54 (12H, m, H-
5, H-6b, 5 x CH2), 3.43 (1H, dd, J1,2=7.6 Hz, J2,3=9.7 Hz, H-2), 3.37 (1H, dd, J2,3=9.7 
Hz, J3,4=3.4 Hz, H-3), 3.28 (2H, t, J=5.0 Hz, CH2N3), 2.76 (1H, t, J=2.4 Hz, 
CH2C≡CH);  δC (100.6 MHz, D2O)  105.0, 80.6, 76.0, 75.0, 74.7, 72.5, 71.6 (2C), 71.4, 
71.1, 70.4, 70.3, 69.7, 59.3, 51.8; HRMS (ESI) m/z Calculated for C15H25N3O8Na, 
398.1539;  Found: 398.1534. 
 
5.5 Cu(I)-catalysed oligomerisation of azido-alkyne galactose-
containing monomer 
5.5.1 General procedure for catalysed cyclisation and oligomerisation 
A solution of azido-alkyne monomer 4.07 (100 mg, 0.3 mmol) containing Cu turnings 
(260 mg, 4.1 mmol) and CuSO4 (11 mg, 0.1 mmol) in DMF (0.27 mL) was placed into 
a sealed microwave tube.  The tube was either submitted to microwave irradiation at 
110 °C at 50 W magnetron power (Method A) or stirred at room temperature for 2 days 
(Method B).  The reaction progress was followed by the TLC (solvent mixture F) taking 
samples at 15 min intervals (Method A) or 24 h intervals (Method B).  After completion 
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the reaction mixtures were separated from Cu turnings and the solvent was removed by 
repeated evaporation with toluene under reduced pressure.  
Cyclic monomer 4.08  
HPLC retention time 16.3 min; yield 9.0 mg (9.0%) (Method A), 6.7 mg (6.7%) 
(Method B);  δH (400 MHz, D2O) 8.15 (1H, s, CH triazole), 4.93 (1H, d, J=13.4 Hz, 
CH2a-triazole), 4.71-4.61 (3H, m, CH2b-triazole, CH2N), 4.38 (1H, d, J1,2=7.9 Hz, H-1), 
4.02-3.94 (3H, m, OCH2CH2N, H-6a), 3.91 (1H, d, J3,4=3.5 Hz, H-4), 3.90-3.66 (10H, 
m, CH2, H-5, H-6b), 3.64 (1H, dd, J2,3=9.7 Hz; J3,4=3.5 Hz, H-3), 3.50 (1H, dd, J1,2=7.9 
Hz; J2,3=9.7 Hz, H-2);  δC (100.6 MHz, D2O) 143.6, 126.2, 102.2, 74.2, 72.7, 70.6, 69.6, 
69.4, 69.4, 69.1, 68.9, 68.5, 62.4, 49.7;  HR-MS (EI) m/z Calculated for C15H26N3O8, 
376.1714;  Found 376.1710.  
Cyclic dimer 4.09 
HPLC retention time 21.3 min; yield 3.0 mg (3.0%) (Method A), 2.2 mg (2.2%) 
(Method B);  δH (400 MHz, D2O) 8.12 (2H, s, CH triazole), 4.74 (4H, m, CH2-triazole), 
4.65 (4H, m, CH2N), 4.38 (2H, d, J1,2=7.9 Hz, H-1), 4.02-3.92 (6H, m, OCH2CH2N, H-
6a), 3.91 (2H, d, J3,4=3.6 Hz, H-4), 3.86-3.70 (8H, m, CH2, H-5, H-6b), 3.69-3.57 (14H, 
m, CH2, H-3), 3.53 (2H, dd, J1,2=7.9 Hz, J2,3=9.9 Hz, H-2); δC (100.6 MHz, D2O) 143.7, 
125.6, 102.8, 73.5, 72.6, 70.6, 69.6, 69.4, 68.9, 68.7, 68.6, 63.4, 50.1;  HRMS (ESI) m/z 
Calculated for C30H51N6O16, 751.3357;  Found: 751.3334. 
Cyclic trimer 4.10 
HPLC retention time 23.9 min; yield 1.6 mg (1.6%) (Method A), 1.0 mg (1.0%) 
(Method B);  δH (400 MHz, D2O) 8.10 (3H, s, CH triazole), 4.72 (6H, m, CH2-triazole), 
4.63 (6H, m, CH2N), 4.39 (3H, d, J1,2=7.8 Hz, H-1), 4.00-3.93 (9H, m, OCH2CH2N, H-
6a), 3.90 (3H, d, J3,4=3.4 Hz, H-4), 3.85-3.73 (12H, m, CH2, H-5, H-6b), 3.70-3.58 
(21H, m, CH2, H-3), 3.53 (3H, dd, J1,2=7.9 Hz, J2,3=9.9 Hz, H-2);  δC (100.6 MHz, D2O) 
143.8, 125.5, 102.8, 73.5, 72.6, 70.6, 69.7, 69.6 (2C), 69.4, 68.9, 68.7, 63.4, 50.0;  
HRMS (ESI) m/z Calculated for C45H76N9O24, 1126.4998;  Found: 1126.4961. 
Cyclic tetramer 4.11 
HPLC retention time 25.5 min; yield 1.1 mg (1.1%) (Method A), 0.8 mg (0.8%) 
(Method B);  δH (400 MHz, D2O) 8.10 (4H, s, CH triazole), 4.72 (8H, m, CH2-triazole), 
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4.63 (8H, m, CH2N), 4.39 (4H, d, J1,2=7.8 Hz, H-1), 4.00-3.93 (12H, m, OCH2CH2N, H-
6a), 3.90 (4H, d, J3,4=3.4 Hz, H-4), 3.85-3.73 (16H, m, CH2, H-5, H-6b), 3.70-3.58 
(28H, m, CH2, H-3), 3.53 (4H, dd, J1,2=7.9 Hz, J2,3=9.9 Hz, H-2);  δC (100.6 MHz, D2O) 
143.8, 125.5, 102.8, 73.5, 72.6, 70.6, 69.7, 69.6, 69.5, 69.4, 68.9, 68.7, 63.4, 50.0;  
HRMS (ESI) m/z Calculated for C60H101N12O32, 1501.664;  Found: 1501.6511. 
Cyclic pentamer 4.12 
HPLC retention time 26.5 min; yield 1.3 mg (1.3%) (Method A), 0.6 mg (0.6%) 
(Method B);  δH (400 MHz, D2O) 8.10 (5H, s, CH triazole), 4.71 (10H, m, CH2-triazole), 
4.63 (10H, m, CH2N), 4.39 (5H, d, J1,2=7.9 Hz, H-1), 4.01-3.94 (15H, m, OCH2CH2N, 
H-6a), 3.90 (5H, d, J3,4=3.4 Hz, H-4), 3.85-3.73 (20H, m, CH2, H-5, H-6b), 3.70-3.58 
(35H, m, CH2, H-3), 3.53 (5H, dd, J1,2=7.9 Hz, J2,3=9.9 Hz, H-2);  δC (100.6 MHz, D2O) 
143.8, 125.5, 102.8, 73.5, 72.6, 70.6, 69.6, 69.6, 69.5, 69.4, 68.9, 68.7(2 C), 63.4, 50.0;  
HRMS (ESI) m/z Calculated for C75H126N15O40, 1876.8281;  Found: 1876.8248. 
Cyclic hexamer 4.13 
HPLC retention time 27.2 min; 0.5 mg (0.5%) (Method B);  δH (400 MHz, D2O) 8.11 
(6H, s, CH triazole), 4.72 (12H, m, CH2-triazole), 4.67-4.62 (12H, m, CH2N), 4.39 (6H, 
d, J1,2=7.8 Hz, H-1), 4.01-3.96 (18H, m, OCH2CH2N, H-6a), 3.90 (6H, d, J3,4=2.8 Hz, 
H-4), 3.87-3.71 (24H, m, CH2, H-5, H-6b), 3.70-3.59 (42H, m, CH2, H-3), 3.53 (6H, dd, 
J1,2=7.9 Hz, J2,3=9.8 Hz, H-2);  δC (100.6 MHz, D2O) 102.8 , 73.4 , 72.5 , 70.6 , 69.5 , 
69.3 , 68.8 , 68.7 , 63.4 , 50.0; HRMS (ESI) m/z Calculated for C90H151N18O48, 
2251.9923;  Found: 2251.9792. 
Cyclic oligomers (DP>6) 
HPLC retention time min 28 to 30 min; yield 13.7 mg (13.7%) (Method A), 6.0 mg 
(6.0%) (Method B). 
Linear oligomers 
HPLC retention time 32.0 min; yield 25.8 mg (25.8%) (Method A), 35.7 mg (35.7%) 
(Method B); HRMS (ESI) m/z Calculated for ([M+H]
+
): 376.1751, 751.3357, 
1126.4998, 1501.6640, 1876.8281, 2251.9923;  Found: 376.1708; 751.3351; 
1126.4985; 1501.6631; 1876.8273; 2251.9897. 
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5.6 Uncatalysed oligomerisation of azido-alkyne galactose-containing 
monomer  
5.6.1 General procedure for uncatalysed cyclisation and oligomerisation 
A solution of compound 4.07 (100 mg, 0.3 mmol) was placed into a sealed microwave 
tube.  The tube was either submitted to microwave irradiation at 110 °C at 50 W 
magnetron power (Method C) or stirred at room temperature (Method D).  The reaction 
progress was followed by TLC (solvent mixture F) taking samples at 15 min intervals 
(Method C).  After 30 min the solvent was removed by repeated evaporation with 
toluene under reduced pressure.  
Linear dimer (4.14) 
HPLC retention time 32.0 min; yield 1.2 mg (1.2%);  δH (400 MHz, D2O) 8.02 (s, 1H), 
4.60 - 4.52 (2H, m, CH2-triazole), 4.36 - 4.27 (2 H, m, H-1, H-1’), 4.23-4.14 (2 H, m, 
CH2C≡CH), 3.98-3.87 (4H, m, OCH2CH2N), 3.84-3.81 (2H, m, H-4), 3.78-3.52 (26H, 
m, CH2, H-6, H’, H5, H-3), 3.47-3.41 (4 H, m, H-2, CH2N3);  δC (100.6 MHz, D2O) 
102.7, 76.9, 73.4, 72.5, 70.5, 68.7, 68.5, 63.3, 58.1, 50.0, 49.9. 
Cyclic monomer (4.24) 
HPLC retention time 14.9 min; yield 8.7 mg (8.7%);  δH (400 MHz, D2O) 7.88 (1H, s, 
CH triazole), 4.92-4.83 (2H, m, CH2-triazole), 4.72-4.56 (2H, m, CH2N), 4.42 (1H, d, 
J1,2=7.9 Hz, H-1), 4.06-4.02 (2H, m, OCH2CH2N), 3.97-3.82 (6H, m, CH2, H-4, H-5,H-
6), 3.74-3.57 (7H, m, CH2, H-3), 3.53 (1H, dd, J1,2=7.9 Hz; J2,3=9.9 Hz, H-2); δC (100.6 
MHz, D2O) 140.5, 102.2, 74.4, 72.7, 71.1, 70.6, 70.3, 69.7, 69.5, 69.3, 68.8, 61.2, 48.5; 
HRMS (ESI) m/z Calculated for C15H26N3O8, 376.1751;  Found: 376.1701. 
Linear dimer (4.25) 
HPLC retention time 32.0 min; yield 1.5 mg (1.5%);  δH (400 MHz, D2O) 7.77 (1H, s, 
CH triazole), 4.60 - 4.54 (2H, m, CH2N), 4.35 - 4.29 (2 H, m, H-1, H-1’), 4.23-4.14 (2 
H, m, CH2C≡CH), 3.97-3.88 (4H, m, OCH2CH2N), 3.84-3.81 (2H, m, H-4),3.78-3.52 
(26H, m, CH2, H-6, H’, H5, H-3), 3.47-3.41 (4 H, m, H-2, CH2N3);  δC (100.6 MHz, 
D2O) 102.7, 73.1, 72.4, 70.6, 68.7, 68.6, 60.3, 58.1, 50.0, 48.1.  
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5.7 Biological methods 
5.7.1 General experimental section 
Mycobacterium smegmatis and Trypanosoma bruce membranes were kindly donated by 
Professor Besra’s group (Birmingham) and Professor Ferguson’s group (Dundee), 
respectively.  Euglena gracilis var saccharophila Klebs (strain 1224/7a) culture was 
obtained from the Culture Collection of Alga and Protozoa (CCAP).  All reagents used 
were of analytical grade and all solvents were HPLC grade.  In fluorescence-based 
assays concentrations for buffer, acceptors and donors are stated as a total concentration 
used in enzymatic reactions.  Stated concentration in each fluorescence-based assays is 
final concentration in solution. 
 
Thin layer chromatography (TLC) 
TLC separations were performed at room temperature on aluminium-backed silica gel 
60 F254 or glass plated silica gel 60Å TLC plates.  Samples of reaction mixtures were 
applied onto the TLC plate in 2 μL aliquots and dried with a hairdryer between 
applications.  The TLC plates were eluted with the stated eluent system (Table 1), air 
dried and directly visualised with the gel imager (Synoptics 2.0 MP) and processed with 
the GENE SYS ver 1.2.5.0 program or sprayed with cyclooctyne/EtOH (v/v 1:1), heated 
and then visualised with the gel imager. 
A CH2Cl2/MeOH 9:1 
B CH2Cl2/MeOH/H2O 80:20:3 
C CH2Cl2/MeOH/H2O 6:4:1 
D CHCl3/MeOH/H2O 10:6:1 
E CHCl3/MeOH/H2O 10:8:1 
F CH3CN/EtOAc/iPrOH/H2O 85:20:50:50 
Table 5.1 Solvents mixtures used for TLC elution.  
 
High performance liquid chromatography (HPLC) 
HPLC was carried out using a Dionex HPLC system with reverse phase (C18 stationary 
phase) column, equipped with Corona charged aerosol detector (CAD) or UV detector 
(347 nm) at the flow rate of 5 mL/min..  Obtained fractions were collected using 
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Teledyne ISCO fraction collector.  Fractions containing pure product were collected and 
concentrated using freeze drying. 
Purification of fluorescent products under HILIC conditions 
Fluorescent products (2.16 and 2.17) were redissolved in in water and subjected to 
purification using semi-prep normal phase HPLC Phenomenex Luna NH2 (250 x 10 
mm).  The column was pre-conditioned with 0.1% aqueous solution of TFA 90% 
acetonitrile.  The elution program was as follows: linear gradient to 10% acetonitrile for 
32 min (held at 10% for 12 min) then equilibrated back to 0.1% aqueous solution of 
TFA, 90% acetonitrile.   
Purification of fluorescent products under reverse phase conditions  
Products obtained from fluorescent assays were purified from starting fluorescent 
acceptor by reverse phase HPLC on the C18 reverse phase column (Phenomenex Luna 
C18(2) 100 A, 250 x 10 mm).  The column was pre-conditioned with 0.1% aqueous 
solution of TFA, 10% acetonitrile.  The elution program was as follows: linear gradient 
to 90% acetonitrile for 36 min (held at 90% for 12 min) then equilibrated back to 0.1% 
aqueous solution of TFA, 10% acetonitrile.   
 
Liquid Chromatography Mass Spectrometry (LC-MS) 
LC-MS was carried out using Thermo Finnigan Surveyour HPLC system with either 
reverse phase (C18) or normal phase (NH2) columns equipped with UV detector and 
LCQ Deca XP plus (ion trap) MS detector as well as Acquity UPLC equipped with 
Waters Synapt G2-S MS detector and T-wave ion mobility for IM-MS.   
 
Mass spectrometry (MS) 
High resolution ESI MS and IM-MS data were obtained using the Waters Synapt G2 
and Water Synapt G2-S MS detector coupled to T-wave ion mobility.   
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Nuclear magnetic resonance spectroscopy (NMR) 
Nuclear magnetic resonance spectra were recorded on a Bruker Avance 800 
spectrometer at 298 K.  Chemical shifts (δ) are reported in parts per million (ppm) with 
respect to internal tetramethylsilane (TMS) in CDCl3 and residual HOD signal in D2O.  
NMR signal assignments were made with the aid of COSY, HSQC and HMBC 
experiments.   
 
Exo-glycosidase digestions 
Jack bean α-mannosidase and green coffee beans α-galactosidase were obtained from 
Sigma Aldrich, β-galactosidase from Calbiochem, Xanthomonas manihotis α-1,6-
mannosidase from New England Biolabs and Aspergillus saitoi α-1,2-mannosidase from 
Prozyme.   
Green coffee bean α-galactosidase 
Fluorescent products (2.20a and 2.20b) (30 μM) were redissolved in 50 mM phosphate 
buffer (pH 7.3) containing 10 mM of MgCl2 and the reaction mixture was incubated at 
37 °C for 24 h with and without 0.7 U of green coffee bean α-galactosidases (10 μL 
final volume).  After incubation, reactions were terminated by addition of 10 μL of 
MeOH. 
Escherichia coli β-galactosidase 
Fluorescent products (2.20a and 2.20b) (30 μM) were redissolved in 50 mM phosphate 
buffer (pH 6.5) and the reaction mixture was incubated at 21 °C for 24 h with and 
without 0.9 U of E.coli β-galactosidase (10 μL final volume).  After incubation, 
reactions were terminated by addition of 10 μL of MeOH. 
Jack bean α-mannosidase 
Purified fluorescent mannosylated products (3.01 and 3.02) (30 μM) were redissolved in 
0.1 M sodium acetate buffer (pH 5.0) and incubated at 37 °C for 24 h with and without 
0.75 U of jack bean α-mannosidase (30 μL final volume).  After incubation, reactions 
were terminated by boiling for 5 min. 
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Xanthomonas manihotis α-1,6-mannosidase 
Purified fluorescent mannosylated products Fluorescent (2.16/2.17) and (3.01/3.02) (30 
μM) were redissolved in GlycoBuffer 1 (5 mM CaCl2, 50 mM sodium acetate, pH 5.5), 
supplemented with 100 μg/mL of BSA and incubated at 37 °C for 24 h with and without 
80 mU of Xanthomonas manihotis α-1,6-mannosidase (30 μL final volume).  After 
incubation, reactions were terminated by boiling for 5 min. 
Aspergillus saitoi α-1,2-mannosidase 
Purified fluorescent mannosylated products (3.01 and 3.02) (30 μM) were redissolved in 
reaction buffer (pH 5.0) and incubated at 37°C for 24 h with and without 80 mU of 
Aspergillus saitoi α-1,2-mannosidase from Prozyme (10 μL final volume).  After 
incubation, reactions were terminated by boiling for 5 min. 
Xanthomonas manihotis α-1,2/3-mannosidase 
Purified fluorescent mannosylated products (3.01 and 3.02) (30 μM) were redissolved in 
GlycoBuffer 1 (5 mM CaCl2, 50 mM sodium acetate, pH 5.5), supplemented with 100 
μg/mL of BSA and incubated at 37 °C for 24 h with and without 64 mU of 
Xanthomonas manihotis α-1,2/3-mannosidase (30 μL final volume).  After incubation, 
reactions were terminated by boiling for 5 min. 
Alkaline phosphatase digestion 
To purified fluorescent product (3.04/3.05 and 3.07/3.08) (80 μM, 10 μL) were digested 
with 1 U of alkaline phosphatase in reaction buffer (50 mM, pH 8.0 Tris/HCl).  The 
enzymatic reaction was mixed and incubated at 25 °C for 20 h in 20 μL of final volume.  
After incubation, reactions were terminated by boiling for 5 min. 
 
Trifluoroacetic acid and alkaline phosphatase degradation 
Purified fluorescent product (3.04/3.05 and 3.07/3.08) (60 μM, 10 μL) was treated with 
40 mM of trifluoroacetic for 15 min at 100 °C.  After drying, the sample was dissolved 
in 10 μL of water and digested with 1 U of alkaline phosphatase in reaction buffer (50 
mM, pH 8.0 Tris/HCl).  The enzymatic reaction was incubated at 25 °C for 20 h in 20 
μL of final volume.  After incubation reactions were terminated by boiling for 5 min. 
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Determination of total microsomal membrane proteins concentration  
Total protein concentration was determined using a commercially available Bradford 
test.
228
  In this test a standard solution of BSA (2mg/mL) was diluted to produce a series 
of known concentrations (from 0.1 to 1.5 mg/mL).  To each known concentration of 
BSA standard solution a BradfordUltra reagent was added (1:15 v/v).  The absorption 
of standard BSA solutions was measured at 595 nm to produce a standard curve.  The 
unknown protein solution was diluted in order to fall within the linear range of known 
concentration of standard BSA solutions, the absorption was measured and the 
concentration of protein extrapolated from the standard curve. 
 
5.8 Mycobacterium smegmatis  
5.8.1 Fluorescence-based assays to probe mannosyltransferase activities in 
Mycobacterium smegmatis  
Buffers and incubation conditions from previously established cell-free radiolabelled 
assay were used to probe α-1,6-mannosyltransferase activities in both fluorescence-
based methodologies.
87
   
Fluorescence-based methodology I 
In the fluorescence-based assay 50 μL acceptor (2.04 and 2.05) (0.5 mM) was incubated 
with 50 μL of GDP-Man (1 mM) in 50 μL of reaction buffer (50 mM, pH 7.9 
MOPS/KOH, 10 mM MgCl2, 5 mM DTT).  The reaction was initiated by the addition of 
50 μL of mycobacterial membranes (500 μg of proteins) in a total volume of 200 μL.  
Aliquots of 20 μL at 20 min, 40 min, 60 min, 2 h, 4 h and 18 h were taken and each 
aliquot was stopped by addition of 20 μL of CHCl3/MeOH (1:1, v/v).  After incubation 
for 18 h at 37 °C the main reaction was stopped with CHCl3/MeOH (1:1, v/v) (80 μL).  
The resulting denatured mycobacterial membranes were removed by several 
centrifugations (16000 g for 5 min) and washed with CHCl3/MeOH:H2O (10:6:1) (3 x 
100 μL).  The washings were combined and solvents dried under gentle stream of air.  
The residue was re-dissolved in deionised water and passed through a 0.45 μm PPTE 
filter, the filtrate was collected and the sample was freeze dried. 
 
173 
 
Fluorescence-based methodology II 
In the fluorescence-based assay 250 μL acceptor (2.10 and 2.13) (1 mM) was incubated 
with 250 μL of GDP-Man (2 mM) in 250 μL of reaction buffer (50 mM, pH 7.9 
MOPS/KOH, 10 mM MgCl2, 5 mM DTT).  The reaction was initiated by the addition of 
250 μL of mycobacterial membranes (4000 μg of protein) in a total volume of 200 μL.  
Aliquots of 20 μL at 2 h, 4 h, 6 h, and 29 h were taken and each aliqoutes was stopped 
by addition of 20 μL of CHCl3/MeOH (1:1, vv).  After incubation for 29 h at 37 °C the 
main reaction was stopped with CHCl3/MeOH (1:1, v/v) (80 μL).  The denatured 
mycobacterial membranes were removed by several centrifugations (16000 g for 5 min) 
and washed with CHCl3/MeOH:H2O (10:6:1) (3 x 100 μL).  The washings were 
combined and solvents dried under gentle stream of air.  The residue was re-dissolved in 
deionised water and passed through a 0.45 μm PPTE filter, the filtrate was collected and 
the sample was freeze dried. 
 
5.9 Trypanosoma brucei  
5.9.1 Fluorescence-based assays to probe galactosyltransferase activities in 
Trypanosoma brucei  
Buffers and incubation conditions from previously established cell-free radiolabelled 
assay were used to probe galactosyltransferase activities in fluorescence-based 
methodology II.
140
   
In the fluorescence-based assay T. brucei microsomal membranes were centrifuged 
(12000 rpm for 2 min) and resuspended in reaction buffer (100 mM, pH 7.4 
HEPES/KOH, 50 mM KCl, 10 mM MgCl2/MnCl2, 2 mM ATP, 2 mM dithiothreitol, 2 
mg/mL leupeptin, 2.5 μg/mL tunicamycin, 0.2 mM N-tosyl-L-lysine chloromethyl 
ketone, 0.05% Triton X-100).  Subsequently, 25 μL of UDP-Gal donor (1 mM) and 25 
μL of acceptor (2.10 and 2.13) (1 mM) were dried and resuspended in 50 μL of reaction 
buffer.  The reactions were initiated by the addition of 50 μL of T. brucei microsomal 
membranes (10x10
7
 cells) in a total volume of 100 μL.  Aliquots of 20 μL at 2 h, 6 h, 
and 24 h were taken and each reaction was stopped by addition of 20 μL of 
CHCl3/MeOH (1:1, v/v).  After incubation for 24 h at 30 °C the main reaction was 
stopped with CHCl3/MeOH (1:1, v/v) (40 μL).  The resulting denatured T. brucei 
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microsomal membranes were removed by several centrifugations (16000 g for 5 min) 
and washed with CHCl3/MeOH:H2O (10:6:1) (3 x 50 μL).  The washings were 
combined and solvents dried under gentle stream of air.  The residue was re-dissolved in 
deionised water and passed through a 0.45 μm PPTE filter, the filtrate was collected and 
the sample was freeze dried. 
Increasing enzyme concentration 
The fluorescence assay was performed as described above where enzymatic reactions 
were initiated by the addition of 50 μL of T. brucei microsomal membranes (5x108 
cells) in total volume of 100 μL.   
Increasing donor concentration 
The fluorescence assay was performed as described above where after incubation, at 30 
°C, 10 μL aliquots were taken at 4h, 8h, 12h, 24h and 36h and supplemented with 5 μL 
of UDP-Gal donor (4 mM).   
 
5.10 Euglena gracilis 
5.10.1 Preparation of Euglena gracilis cells  
A culture of axenic Euglena gracilis was grown in the dark at 30 °C, with shaking (200 
rpm), in modified Euglena gracilis plus Jaworski’s medium (1xEG + 1xJM medium) 
supplemented with glucose (15 g/L) for 7 days.  Dark grown culture after seven days 
was harvested by centrifugation (800 g for 5 min), washed twice with deionised water 
and once in HEPES buffer (10 mM, pH 7.0 HEPES/KOH, 25 mM KCl).  The harvested 
cells were re-suspended in HEPES buffer and de-flagellated by the method of cold-
shock
229
 that required incubation of cells on ice for 2 h.  The de-flagellated cells were 
removed by centrifugation (800 g for 5 min) for further isolation of microsomal 
membranes. 
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5.10.2 Isolation of microsomal membranes from Euglena gracilis161 
All isolation steps described were carried out at 0 to 4 °C.  Dark-grown de-flagellated 
cells were re-suspended in Euglena lysis buffer [20 mM, pH 7.0 HEPES/KOH, 50 mM 
NaCl, protease inhibitor (1 tablet per 100 mL) and ribonuclease A (1 mg)] and disrupted 
by three 15 s bursts of ultrasonic waves (1 s ON, 3 s OFF) over three consecutive 
cycles.  Residual cell debris (un-lysed cells, large pellicle fragments and paramylon) 
were removed by centrifugation (300 g for 3 min) and supernatant was centrifuged at 
4200 g for 30 min to remove mitochondria.  The supernatant was layered onto a 1.5 M 
sucrose cushion in 20 mM HEPES buffer (pH 7.0) and centrifuged at 15000 g for 45 
min.  The supernatant was removed and layered over a step gradient consisted of 1.3 M, 
1.0 M, 0.8 M and 0.5 M sucrose in 20 mM HEPES buffer (pH 7.0).  The separation of 
microsomal fraction was achieved by centrifugation at 150000 g for 3 h.  Microsomal-
enriched fractions were collected, re-suspended in 20 mM HEPES buffer (pH 7.0) and 
centrifuged at 150000 g for 2 h.  The pellets were re-homogenised in 20 mM HEPES 
buffer (pH 7.0) and stored at -80 °C.  Euglena membranes remained active for up to a 
year. 
 
5.10.3 Fluorescence-based assays to probe glycosyltransferase activities in Euglena 
gracilis  
In each fluorescence-based assay 4 mM donor (GDP-Man/GDP-Fuc/UDP-Glc/UDP-
Gal/UDP-GlcNAc) and 2 mM acceptor (2.10 and 2.13) were freeze dried and re-
dissolved in 50 μL reaction buffer (40 mM, pH 7.0 HEPES/KOH, 100 mM KCl, 40 mM 
MgCl2/MnCl2, 40% glycerol).  The reactions were initiated by the addition of 150 μL of 
freshly thawed E. gracilis microsomal membranes (195 μg of membrane protein).  
Control assays without donor were also performed in parallel to correct for the presence 
of endogenous acceptors.  After incubation for 24 h at 30 °C reactions were stopped by 
addition of CHCl3/MeOH (1:1, v/v).  The resulting denatured E. gracilis microsomal 
membranes were removed by several centrifugations (16000 g for 5 min) and washed 
with CHCl3/MeOH:H2O (10:6:1).  The washings were combined and solvents dried 
under gentle stream of air.  The residue was re-dissolved in deionised water and passed 
through a 0.45 μm PPTE filter, the filtrate was collected and the sample was freeze 
dried. 
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5.10.4 Generation of product carrying N-acetylglucosamine-6-Phosphate motif for 
structural characterisation 
4-(1-(7-Hydroxy-coumarin-3-yl)-1H-1,2,3-triazol-4-yl)-)propyl 6-(2-acetomido-2-
deoxy-α-D-glucopyranosyl)-phosphonato-1-α-D-mannopyranosyl-(1→6)-α-D-
mannopyranoside (3.08) 
 
 
A large scale reaction was performed to generate sufficient material for structural 
characterisation by NMR spectroscopy.  In this reaction acceptor (2.13) (0.8 mg, 1.28 μ 
mol) and donor (UDP-GlcNAc) (3.2 mg, 4.9 μmol) were dissolved in 150 μL of 
reaction buffer (40 mM, pH 7.0 HEPES/KOH, 100 mM KCl, 40 mM MgCl2/MnCl2, 
40% glycerol).  The reactions were initiated by the addition of 450 μL of E. gracilis 
microsomal membranes (585 μg membrane proteins) in a total volume of 600 μL.  After 
incubation for 24 h at 30 °C the reaction was supplemented with another portion of E. 
gracilis microsomal membranes (150 μL, 195 μg of membrane proteins) and incubated 
for a further 24 h at 30 °C.  The reaction was stopped by addition of CHCl3/MeOH (1 
mL).  The denatured E. gracilis microsomal membranes were removed by several 
centrifugations (14000 rpm for 5 min) and washed with CHCl3/MeOH:H2O (10:6:1) (3 
x 1 mL).  The washings were combined and solvents dried under gentle stream of air.  
The residue was re-dissolved in deionised water and passed through 0.45 μm PPTE 
filter, the filtrate was collected and the sample was freeze dried.  The residue was 
purified by reverse phase HPLC to give compound 3.08 (0.48 mg, 43%).  
1
H NMR (800 
MHz, D2O) δ 8.43 (1H, s, H-f), 8.26 (1H, s, H-j), 7.73 (1H, d, Jc,d= 8.6 Hz, H-c), 7.06 
(1H, dd, Jc,d= 8.6, Jd,e=2.2 Hz, H-d), 7.01 (bd, H-e), 5.48 (1H, dd J1,2= 3.6 Hz, J1-P= 7.2 
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Hz, H-1), 4.13 (2H, m, H-6a’ and H-6b’), 3.95 (4H, m, H-2’’, H-6a, H-6b, H-2’), 3.83-
3.54 (m, sugar signals, OCHaHb, OCHaHb), 2.86 (2H, t, JH-H=7.2 Hz, 
OCH2CH2CH2CH2), 2.07 (3H, s, CH3), 1.87-1.78 (2H, m, OCH2CH2CH2CH2), 1.72-
1.70 (2H, m, OCH2CH2CH2CH2);  
32
P NMR; (100.6 MHz, D2O) δ 1.23; HRMS (ESI): 
Calculated for C35H50N4O22, 909.2649; Found, 909.2653. 
 
5.11 Trypanosoma cruzi 
5.11.1 Trans-sialidase-mediated sialylation of triazole-linked pseudo-
galactooligomers 
To a solution of fetuin
42
 as a donor substrate (25 μL, 3 mM in 0.1 mM phosphate buffer 
pH 7.0) and oligo-triazole acceptor substrates 8-10 and 19 (25 μL, 1 mM in 0.1 mM 
phosphate buffer pH 7.0) was added TcTS enzyme (25 μL).  The mixture was incubated 
at 28 °C for 5 days when additional 25 μL aliquots of TcTS enzyme and fetuin were 
added; after a further 2 days additional 25 μL aliquot of fetuin was added.  Reaction 
progress was followed by TLC (CH3CN/EtOAc/iPrOH/H2O, 85:20:50:50, v/v).  The 
protein was precipitated by heating the mixture at 100 °C for 1 min and the denatured 
enzymes were removed by centrifugation (14000 rpm, 5 min).  The supernatant was 
transferred to a new Eppendorf tube, concentrated by freeze drying and submitted to 
HR-MS analysis. 
 
5.11.2 Macrophage invasion assays 
Compounds used in macrophage invasion assays includeda  series of mixed 1,4/1,5- 
triazole-linked cyclic compounds C2, C3,C4, C5, C6, andC7 and a mixure of linear 
1,4/1,5-triazole-linked oligomers generated by Method C (Section 4.6).  Trypanosoma 
cruzi Y strain was cultivated in the LLC-MK2 host cells, as described elsewhere.
43
   
 
Preparation of macrophages 
The macrophages derived from bone marrow (BMMOs) were obtained as described 
previously.
44
 Briefly, total bone marrow cells were cultured in RPMI 1640 medium 
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(Sigma-Aldrich), supplemented with 10% Fetal Bovine Serum (Cutilab) and 30% L-929 
cell-conditioned media at 37°C under 5% CO2 atmosphere.  On the seventh day of 
culture BMMOs were harvested and plated in 96 or 24 well microplates (at 5 x 10
5
 
cells/mL).   
Preparation of trypomastigotes 
In two parallel series of tests trypomastigotes of Trypanosoma cruzi Y strain (1.5 x 10
6
 
cells/mL) and triazole-linked compound were added into wells containing BMMOs in 
two different ways: (Treatment 1) trypomastigotes and tested compounds at a final 
concentration of 250 µM were plated at the same time and (Treatment 2) 
trypomastigotes and tested compounds at a final concentration of 250 µM were first pre-
incubated for 1 hour, then the parasite was washed from the tested compound and plated 
to the wells containing BMMOs.  In both methods the trypomastigotes were maintained 
for 2 h in contact with BMMOs.  The parasites that had not invaded macrophages were 
removed by serial washing after 2 h incubation. 
Analysis of released trypomastigotes 
The free trypomastigotes were counted after six days of incubation in a Neubauer 
chamber and results are expressed as a percentage inhibition with respect to 
trypomastigotes counted released from infected cells without triazole treatment.   
Analysis of amastigotes inside BMMOs 
Macrophages infected with trypomastigotes as described above (Treatment 1) were 
maintained in culture for four days.  The infected macrophages were fixed with 
methanol, stained with Giemsa and analysed using Leica DMI 4000B microscope.  The 
results are expressed as an average number of amastigotes per macrophage.  
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6 Appendices 
A1 
 
Figure 6.1 LC-MS data of peak 1 of fluorescent disaccharide (3.03) product obtained from incubation of 
monosaccharide acceptor substrate with UDP-Glc in the presence of Euglena gracilis microsomal membranes. 
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A2 
 
Figure 6.2 3LC-MS data of peak 2 of fluorescent disaccharide (3.03) product obtained form incubation of 
monosaccharide acceptor substrate with UDP-Glc in the presence of Euglena gracilis microsomal membranes. 
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A3 
 Calculated 
m/z [M+H]
+ 
Found 
m/z [M+H]
+
 
MS2 fragmentation pattern 
F1 (2.11) F2 (2.12) F3 (2.13) 
2.11 302.11     
2.12 464.17     
2.13 626.22     
3.03 626.22 626.31 302.00 463.94  
3.06 788.27 788.16 302.01 463.93 625.94 
 
Table 6.1 MS and MS2 data from LC-MS analysis of glucosylated fluorescent products obtained from 2.12 and 2.13. 
A4 
Entry Calculated 
m/z [M+H]
+ 
Found 
m/z [M+H]
+
 
MS2 fragmentation pattern 
F1 (2.11) F2 (2.12) 
 
 Difference 
F2-2.11  
1 2.11 302.11      
2 2.12 464.17      
3 2.13 626.22      
5 3.04 706.19 705.97 301.90 543.91  79.74 
6 3.07 747.21 746.97 302.08 543.92  79.75 
 
Table 6.2 MS and MS2 data from LS-MS analysis of products obtained from 2.12  with UDP-Glc. 
A5 
Entry Calculated 
m/z [M+H]
+ 
Found 
m/z [M+H]
+
 
MS2 fragmentation pattern 
F1 (2.11) F2 (2.12) F3 (2.13) Difference 
F3-2.12 
1 2.11 302.11      
2 2.12 464.17      
3 2.13 626.22      
5 3.05 868.24 868.12 301.99 463.90 705.92 79.70 
6 3.08 909.27 909.16 302.00 463.94 705.93 79.71 
 
Table 6.3 MS and MS2 data from LS-MS analysis of products obtained from 2.13 with UDP-GlcNAc. 
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A6 
 
Figure 6.4 The 1H NMR spectra of fluorescent phosphodiester-linked product. 
A7 
 
Figure 6.5 The 31P NMR spectra of fluorescent phosphodiester-linked product. 
183 
 
A8 
 
Entry Organism
 
Identity 
% 
Similarity Gaps 
% % 
1001 Euglena gracilis    
1002 Homo sapiens 42.8 55.4 17.7 
1003 Trypanosoma brucei 29.9 43.9 33.7 
1004 Saccharomyces cerevisiae 28.9 42.3 26.7 
 
Table 6.4 Euglena gracilis percent identity, similarity and gaps of EgAlg3 to known protein sequences. 
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A9
 
Entry Organism
 
Identity 
% 
Similarity Gaps 
% % 
1001 Euglena gracilis    
1002 Saccharomyces cerevisiae  25.8 41.0 23.5 
1003 Arabidopsis thaliana 27.0 41.2 23.3 
1004 Homo sapiens 31.1 41.4 22.8 
 
Table 6.5 Euglena gracilis percent identity, similarity and gaps of EgAlg9 to known protein sequences. 
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186 
 
Entry Organism
 
Identity 
% 
Similarity Gaps 
% % 
1001 Euglena gracilis    
1002 Dictyostelium discoideum 25.8 39.8 26.6 
1003 Homo sapiens  25.5 36.4 35.5 
 
Table 6.6 Euglena gracilis percent identity, similarity and gaps of GlcNAc-P-Tase to known protein sequences. 
 
A11 
 
Figure 6.6 The HRMS spectrum of the series of 1,4-triazole-linked linear products obtained from CuAAC 
oligomerisation of galactose monomer. 
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